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ABSTRACT 
Four new (+)-ketopinic acid-derived Mn(III) complexes, three of which possess  pseudo C2-
symmetry, were synthesised as chiral catalyst candidates. The ligands were prepared by refluxing 
(+)-ketopinic acid with ethane-1,2-diamine, the resolved (R,R)- and (S,S)-1,2-diaminocyclohexanes, 
and 1,2-diaminobenzene in chloroform. Treatment of the ligands with manganese(II) acetate 
tetrahydrate in refluxing ethanol afforded the respective complexes as brown amorphous powders. 
Characterisation of the ligands and the corresponding complexes was achieved using 1-D and 2-D 
NMR, IR spectroscopy, and elemental analysis. Various homogeneous asymmetric transformations, 
were investigated using these four complexes, viz., aldol, and Baylis-Hillman reactions, aza-Michael 
addition of piperidine to the Baylis-Hillman adducts, epoxidation, and ketone and imine reduction.  
Asymmetric aldol reactions of benzaldehyde with the aryl ketones, acetophenone, 
propiophenone, -tetralone, 4-nitroacetophenone, and 4-methoxyacetophenone, conducted in the 
presence of 10 mole % of the chiral catalysts, afforded enantioselectivities of up to 99% e.e. 
Asymmetric Baylis-Hillman reactions of methyl- and tert-butyl acrylates with pyridine-2- 
carbaldehyde, 6-methylpyridine-2-carbaldehyde, 5-chlorosalicylaldehyde, benzaldehyde, 4-chloro- 
benzaldehyde, and 2-nitrobenzaldehyde were conducted in the presence of catalyst 139 (10 mole %) 
to afford enantioselectivities of up to 44% e.e. Aza-Michael addition of piperidine to racemic Baylis-
Hillman adducts in the presence of the catalyst 139 (10 mole %) was found to proceed with 
diastereoselectivities of up to 91% d.e. Asymmetric epoxidation of trans-methyl styrene, styrene, 
trans-stilbene, cis-stilbene, and indene, using a 5 mole % chiral catalyst loading and m-CPBA as the 
oxygen source, gave enantioselectivities of up to 32 % e.e. Asymmetric reductions of acetophenone, 
3-chloropropiophenone, 4-hydroxyacetophenone, -tetralone, and 2-hydroxy-1-acetonapthone were 
investigated using NaBH4 as the reducing agent and a 10 mole % loading of the chiral catalysts. A 
stereoselectivity of 68% e.e. was obtained in the reduction of acetophenone, but attempts to reduce 
the selected imines to the corresponding chiral amines proved to be unsuccessful — even in the 
absence of the catalysts. It thus became apparent that the catalytic version of the reaction was not 
feasible. 
iii 
 
ACKNOWLEDGEMENTS 
I would like to begin by expressing my sincere gratitude to my supervisor, Dr. Rosa Klein for 
accepting and training me as her graduate student. The success of this project became real due to her 
excellent contributions. During my undergraduate days, I used to envisage the field of 
stereochemistry to be so abstruse. However, the enormous talent of Rosa in asymmetric synthesis 
had helped me to comprehend the empirical aspects of 3-D chemistry very easily. Besides academic 
partnership, I wish to admit that her ‘motherly care’ for her students honestly made me feel at home. 
A special thankyou goes out to Professor (Emeritus) Perry T. Kaye for co-supervising me. The 
success of this project is indeed a testimony to his tremendous contributions. In the field of Organic 
Chemistry, I would always remember Prof. Kaye as a true incarnation of the likes of Wȍhler, 
Kekulé, Wurtz, and Van’t Hoff. I must also express my admiration for his compassion to us, despite 
elderly age, his door had always been opened for us the young learners to come and discuss some of 
our difficulties. 
I wish to extend my warm appreciation to Dr. Kevin Lobb, Dr. Sam Khene, Marcel Lazouda, 
and Lester Sigauke for helping on the aspect of computational chemistry. Prof. Gareth Watkins and 
Dr. David Khanye had contributed immensely on the aspect of coordination chemistry, I thank both 
of them. My words of appreciation to Prof. Rui Krause for valuable suggestions on the polymer 
chemistry section of this project and Dr. Pierre Kempgens for the variable temperature NMR. To all 
staff members of chemistry department, you are such wonderful people! I thank you all. 
My entire organic chemistry colleagues; Postdocs, PhDs, Masters, and Honours during the 
period 2011-2015; such as Dr. Idris, Dr. Adeloye, Dr. Faridoon, Dr. Swarup, Dr. Jaya, Dr. Lulama, 
Dr. Marius, Dr. Tope, Dr. Idahosa, Dr. Gaelle, Dr. Xavier, Dr. Yollande, Melody, Khethobole, Bola, 
Christiana, Alicia — all quite amazing people. I appreciate all their inputs. Colleagues in the other 
laboratories are also worthy of mentioning, my esteem gratitude goes to them all. Across the 
department, I wish to thank Solomon Uriri from Physics and Electronics, for assisting me with the 
SigmaPlot software. 
I am highly grateful to my fellow country people such as; Dr. Folake, Bridget, Dr. Rachel, Dr. 
Zikrullah, Magaji, Aminu, Dr. Eric and his wife, Dr. Chucks and his wife, Dr. Dayo, Dr. Ogunlaja, 
Dr. Nelson, Bukky, Wale and to those whose names could not be mentioned due to the limited space. 
In Grahamstown, I met people who became like an extension of my Nigerian family, they were: 
iv 
 
Omardien family from Worcester, Western Cape, Ali and his very friendly wife (Boshra) from 
Egypt. I will forever cherish their hospitality.  
Whatever I achieve in my life could not have been possible without the love, moral upbringing, 
and support that I enjoyed from my parents. I pray that may Almighty Allah shower His infinite 
mercy upon them, amen. My siblings have always been supportive of me all the time. I am really 
indebted to them all. I wish to thank my wife, Fatima for her incredible love, understanding, patience 
and prayers. I don’t have enough words to express my gratitude to her towards taking good care of 
me and our toddler daughter Bilkisu. To all my friends, especially, from my home-town I thank you 
all for always wishing me the best during my research work.  
In conclusion, I remain grateful to the Tertiary Education Trust Fund of Nigeria (TETfund) for 
funding me.   
v 
 
 
CONTENTS 
           Page  
Abstract.......................................................................................................i 
Acknowledgements.....................................................................................ii 
Glossary......................................................................................................vii 
 
 
1. INTRODUCTION.................................................................................1 
1.1. Asymmetric synthesis....................................................................2 
1.1.1. Substrate-controlled approaches....................................................2 
1.1.2. Auxiliary-controlled approaches....................................................2 
1.1.3. Reagent-controlled approaches......................................................2 
1.1.4. Catalyst-controlled approaches......................................................3 
1.2. Asymmetric Catalysis.....................................................................3 
1.2.1. Chiral organic molecules...............................................................3 
1.2.2. Enzymes.....................................................................................4 
1.2.3. Chiral metal complexes.................................................................4 
1.3. Camphor as a source of chirality.......................................................7 
1.3.1. Aldol reactions..............................................................................7 
1.3.2. Baylis-Hillman reactions................................................................19 
1.3.3. Epoxidation reactions....................................................................22 
1.3.4. Reduction reactions.......................................................................27 
1.4. Model Catalyst.................................................................................33 
1.5. Previous work in the group..............................................................34 
1.6. Aims of the present work..................................................................36 
 
2. RESULTS AND DISCUSSION...............................................................37 
2.1. Catalyst synthesis..............................................................................37 
2.1.1. Ligand synthesis.............................................................................37 
2.1.1.1. Resolution of (±)-trans-diaminocyclohexane.............................41 
2.1.1.2. Conformational search...........................................................46 
2.1.1.3. Variable temperature studies...................................................47 
2.1.2. Preparation of manganese complexes..................................................48 
vi 
 
2.1.2.1. Elemental composition.........................................................49 
2.1.2.2. Computational methods........................................................51 
2.1.3. Reactions under investigation...........................................................52 
2.2. Asymmetric aldol reactions................................................................53 
2.2.1. Method development.......................................................................54 
2.2.2. Method optimisation........................................................................56 
2.2.3. Exploration of substrate scope...........................................................60 
2.3. Asymmetric Baylis-Hillman reactions.................................................64 
2.3.1. Synthesis of the Baylis-Hillman adducts.............................................66 
2.3.2. Aza-Michael addition of piperidine to Baylis-Hillman adducts...............72 
2.3.2.1. Configurational assignment....................................................79 
2.4. Asymmetric epoxidation reactions.......................................................82 
2.4.1. Method development........................................................................82 
2.4.1.1. Use of sodium hypochlorite.....................................................83 
2.4.1.2. Use of hydrogen peroxide and tert-butylhydroperoxide................86 
2.4.1.3. Use of iodosylbenzene............................................................89 
2.4.1.4. Use of m-chloroperbenzoic acid...............................................93 
2.4.2. Exploration of substrate scope............................................................98 
2.5. Asymmetric reduction reactions..........................................................100 
2.5.1. Asymmetric reduction of ketones.......................................................100 
2.5.1.1. Method development.............................................................101 
2.5.1.2. Exploration of substrate scope.................................................106 
2.5.2. Asymmetric reduction of imines........................................................106 
2.6. Exploratory studies on catalyst immobilisation....................................111 
2.7. Summary and conclusions..................................................................116 
 
3. EXPERIMENTAL......................................................................................119 
4. REFERENCES............................................................................................158 
 
 
 
 
 
 
 
vii 
 
 
GLOSSARY 
 
9-BBN  -        9-Borabicyclo[3.3.1]nonane     
BINAP  -        2,2’- Bis(diphenylphosphino)-1,1’-binaphthalene 
BINOL  -        1,1’-Bi-2-naphthol 
BOX   -        Bisoxazaline 
BuLi   -        Butyllithium 
CAMP  -        Cyclohexylanisylmethyl phosphine 
CDCl3   -        Deuterated chloroform 
m-CPBA  -        meta-Chloroperbenzoic acid 
COSY   -        Correlation spectroscopy 
DABCO  -        Diazabicyclooctane 
DBSA   -        Dodecylbenzenesulfonic acid 
DEPT   -        Distortionless enhancement by polarisation transfer 
DFT   -        Density functional theory 
DIBAL-H  -        Diisobutyl aluminium hydride 
DIOP   -        o-isopropylidine-2,3-dihydroxy-1,4-bis(diphenylphosphino)butane 
DIPAMP  -        Ethane-1,2-diylbis[(2-methoxyphenyl)phenylphosphane] 
DMAP  -        Dimethyl aminopyridine 
DMSO-d6  -        Deuterated dimethylsulphoxide 
DUPHOS  -        DuPont phospholanes 
EDTA   -        ethane-1,2-diamine tetraacetic acid 
Eu(hfc)3  -        Europium tris[3-(heptafluoropropylhydroxymethylene)-(+)-camphorate] 
1H NMR  -        Proton nuclear magnetic resonance 
HMBC  -        Heteronuclear multiple bond correlation 
HPLC   -        High performance liquid chromatography 
HSQC   -        Heteronuclear single quantum coherence 
IR   -        Infrared 
KHMDS  -        Potassium hexamethyl disilazide 
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LDA   -  Lithium diisopropyl amide 
MNDO  -  Modified neglect of diatomic overlap 
MS 3Å  -  Molecular sieves (three Angstrom) 
MS 4Å  -  Molecular sieves (four Angstrom) 
2D-NMR  -  Two dimensional nuclear magnetic resonance 
NMO   -  N-methyl morpholine-N-oxide 
NOESY  -  Nuclear overhauser effect spectroscopy 
PTC   -  Phase transfer catalyst 
PPTS   -  Pyridinium p-toluenesulfonate 
PYBOX  -  Pyridine bisoxazoline 
SALEN  -  Salicylaldehyde ethylene diamine 
TADDOL  -  Tetraaryl-2,2-disubstituted 1,3-dioxolane-4,5-dimethanol 
TBAF   -  Tetra-n-butylammonium fluoride 
TFA   -  Trifluoroacetic acid 
TFOH   -  Trifluoromethane sulfonic acid 
THF   -  Tetrahydrofuran 
TLC   -  Thin layer chromatography 
TMSO  -  Tetramethylenesulfoxide 
UHP   -  Urea hydrogen peroxide 
UHP/TFAA  -  Urea hydrogen peroxide/trifluoroacetic anhydride 
µ-Waves  - microwaves 
XYLIPHOS  -  Xylilphosphane 
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1. INTRODUCTION 
 
In 1874 Jacobus Van’t Hoff and Joseph Le Bel recognised that a compound that contains a 
single tetrahedral carbon atom with four different substituents could exist in two forms that are non-
superimposable mirror images of each other. This phenomenon is termed chirality and the carbon 
atom is referred to as a chiral centre.1 The presence of a chiral centre in lactic acid (Figure 1) permits 
the existence of stereoisomeric forms with each form being the non-superimposable mirror image of 
the other. Conventionally, these mirror images are called enantiomers. 
 
     
   Figure 1.  Illustration of  lactic acid enantiomers
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Under achiral conditions enantiomers exhibit the same chemical and physical properties. This 
poses a challenge in their synthesis because in the absence of a chiral influence, they are always 
obtained in an equimolar ratio, called a racemic mixture.2 However due to the ingenuity of organic 
chemists, novel approaches to the selective synthesis of one enantiomer in preference to the other 
have been developed.3 
The importance of obtaining enantiomerically pure compounds cannot be overemphasised. 
Chemical products that are manufactured for the promotion of human health are now increasingly 
concerned with enantiomeric purity. A significant proportion of such products contain at least one 
chiral centre.2 Since biological activity is frequently associated with only one enantiomer and, due to 
the fact that enantiomers may exhibit different types of activity which may be good or harmful, 
production of only one enantiomer permits separation of the effects.2 The undesired isomer is, at 
best, ‘isomeric ballast’4 unnecessarily applied to the environment; hence, in certain countries, 
registration of materials as the required enantiomer has become law.5 From an industrial perspective, 
the switch from racemate to enantiomer provides an opportunity to effectively double the capacity of 
a process, granting improved cost-efficiency. A situation where the optically active component of the 
synthesis is not the most costly may allow significant savings to be made in some other achiral but 
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relatively expensive intermediate process. A difference in the solid-state physical characteristics of 
enantiomers versus racemates may further bestow processing or formulation advantages.2 
In light of the above, different methods have been developed for the generation of 
enantiomerically pure compounds. This can be broadly categorised into: (i) resolution of racemates; 
and (ii) asymmetric synthesis. Presently asymmetric synthesis stands out as the most powerful 
method for chiral molecule preparation.3  
 
1.1.  ASYMMETRIC SYNTHESIS 
Asymmetric synthesis is a technique which involves the formation of a new chiral centre in 
a substrate under the influence of a chiral environment generated from a chiral compound. 
Depending on how this influence is exerted, this technique can be divided into four major 
classes.3  
 
1.1.1. Substrate-controlled approaches 
This is often referred to as the first generation of asymmetric synthesis. It is based on the 
presence and intramolecular effects of a chiral centre that already exists in the chiral 
substrate. New chiral centres may be formed by reacting a chiral substrate with an achiral 
reagent at a prochiral site, the stereoselectivity of the reaction being controlled by a nearby 
stereogenic centre.4 
 
1.1.2. Auxiliary-controlled approaches 
The auxiliary-controlled approach is called the second generation of asymmetric synthesis. 
The asymmetric control involves the influence of a nearby chiral centre within a complex of 
the substrate with a chiral auxiliary. The stereo-directing group (chiral auxiliary) is 
intentionally attached to the original achiral substrate via covalent bonds in order to achieve a 
stereoselective reaction. Once the stereoselective transformation is completed, the chiral 
auxiliary can be removed.4 
 
1.1.3. Reagent-controlled approaches 
This approach is termed the third generation of asymmetric synthesis. It involves the use of a 
chiral reagent to both convert and confer chirality on an achiral substrate. In contrast to the 
first- and second-generation techniques, the stereocontrol is now achieved intermolecularly.4 
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1.1.4. Catalyst-controlled approaches 
Owing to the common disadvantage of the above three techniques where at least 
stoichiometric amounts of enantiomerically pure compounds are required, a significant 
advancement in asymmetric synthesis came with the invention of chiral catalysts. In this 
approach only a small amount of a chiral compound may be needed to generate large 
quantities of a chiral product. This approach continues to be extensively explored.4 
 
1.2.    ASYMMETRIC CATALYSIS 
Chiral catalysts have the greatest potential in asymmetric synthesis since there are almost 
no limits to their application.6 The use of a cinchona alkaloid can be considered as the earliest 
chiral organic molecule used as catalyst for cyanohydrin formation.7 Enzymes and chiral metal 
complexes were also introduced as far back as the 1950’s,8-11 and several developments continue 
to be reported. 
 
1.2.1. Chiral organic molecules 
Recently, there has been renewed interest in developing small, chiral organic molecules as 
catalysts for asymmetric transformations. This can be attributed to the pioneering work of 
Eder et al.12 and Hajosh-Parish13 on the intramolecular aldol reactions of triketones 
employing L-proline as catalyst. Subsequent publications reporting the use of chiral organic 
molecules such as those shown in Figure 2, appear to be promising.14,15  
L-Proline Imidazolidinone Thiourea
Figure  2. Some chiral organocatalysts
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L-proline, for example, has been extensively reported to be an efficient catalyst in a wide 
range of asymmetric transformations, such as aldol condensations, Mannich reactions, -
amination, -aminooxylation of aldehydes and ketones, conjugate addition, alkylation, [4+2] 
and [2+2] cycloadditions, and the Baylis-Hillman reaction.16  
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Work on the use of imidazolidinones as chiral catalysts have mostly been pioneered by 
McMillan et al., where  new strategies were developed for asymmetric 1,3-dipolar 
cycloaddition,17 Mukaiyama-Michael reaction,18 and a number of cascade reactions.19 
Thiourea derivatives have also been demonstrated to effect asymmetric Strecker, Mannich, 
reductive amination, and oxocarbenium addition reactions.20   
The major limitation associated with the use of chiral organic catalysts is the fact that they are 
usually required in high percentage loadings, sometimes as high as 20%.14,15 
 
1.2.2. Enzymes 
Asymmetric reactions using isolated enzymes, cell cultures, or whole microorganisms are 
also practical and provide access to enantiomerically pure compounds from prochiral 
precursors. Based on their applications, enzymes can be grouped into: oxidoreductases; 
transferases; hydrolases; lyases; and isomerases. However, the highly specific action and 
instability of enzymes can be major drawbacks to their use.11 
1.2.3. Chiral metal complexes 
The seminal discovery of tris(triphenylphosphine)rhodium chloride as a catalyst for  
hydrogenation by Wilkinson and co-workers in 1966 paved the way for the development of 
metal-mediated asymmetric catalysis. Knowles and co-workers21 developed the novel 
monodentate phosphine CAMP (Figure 3), and used it in the asymmetric hydrogenation of -
acylaminoacrylic acids, achieving poor to good enantioselectivity. The limited success of the 
monodentate phosphines led to the design of bidentate ligands, which restrict the degrees of 
freedom, in the hope of enhancing enantioselectivity. Kagan and Dang22 proved the validity 
of this idea by developing DIOP (Figure 3) and obtained improved enantioselectivity. 
Knowles and co-workers23 also reported improved selectivity using DIPAMP (Figure 3), 
which is a bis-phosphine analogue of CAMP. The potential of asymmetric hydrogenation, 
however, was only realised with the introduction of BINAP, a ligand derived from BINOL 
(Figure 3) by Noyori and co-workers in 1980.24 Subsequently other catalytic systems based 
on DUPHOS25 and XYLIPHOS26 were also introduced (Figure 3).  
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Figure  3. Pioneering chiral ligands  
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Another breakthrough in metal-mediated asymmetric catalysis came in the 1990’s when 
Jacobsen27 and Katsuki28 independently developed the chiral SALEN complexes (Figure 4) 
for the asymmetric epoxidation of unsubstituted olefins. Extensive studies later showed that 
the Jacobsen-type complexes are the most efficient. Structurally, these tetradentate ligands 
are modelled on the framework of the porphyrin moiety in haeme-based oxidative enzymes. 
Their design was specifically inspired by cytochrome P-450, and its oxo-transfer mechanism. 
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Among the reactions catalysed by the Jacobsen-type catalysts and affording excellent 
selectivity are epoxidation, epoxide ring-opening, imine cyanation, and Diels-Alder 
reactions.10 
   
O
N N
O
But But
N
O
N N
O
But But
BOX PyBOX
Figure  5.  Bis(oxazoline) ligands.  
 
In 1991, another family of ligands was introduced into the realm of catalytic asymmetric 
synthesis by Evans et al.29 and Corey et al.30 These ligands contain two oxazoline rings, 
attached to methylene or pyridine linkers and are referred to as BOX and PyBOX ligands 
respectively (Figure 5). Metal complexes incorporating bis(oxazoline) ligands are effective 
for a wide range of asymmetric transformations which include aldol,31 Mannich,32 ene,33 
Michael,34 Nazarov35 and Diels-Alder reactions.36  
  
O
O
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Ph Ph
Ph Ph
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Ph Ph
Ph Ph
TiX2
 Figure  6. TADDOL and TADDOLate complexes
TADDOL X= Cl or  i-PrO
Ti -TADDOLate
 
Asymmetric catalysis has also been achieved with excellent results using TADDOLate 
complexes, which are derived from the TADDOL ligand and titanium (Figure 6).37 Numerous 
stereoselective reactions have been performed with this catalyst, which can be broadly 
categorised as follows:  
(a) Nucleophilic additions to aldehydes, ketones, ,-unsaturated carbonyl 
compounds, esters, anhydrides, and nitroolefins, as well as reactions of other 
nucleophiles with halogenating or oxidising agents, where the actual nucleophile may 
be an Nu-Ti TADDOLate complex. 
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(b) Lewis acid-catalysed transformations in which the electrophile is activated by an 
X2Ti-TADDOLate.  
Generally speaking, a large number of chiral-metal complexes has continued to emerge and prove 
efficient in catalysing such important reactions as C-C bond formation,38-73 and oxidation74-83 among 
others. In fact, in terms of substrate scope, chiral metal complex catalysis has the broadest activity of 
all types of catalysis. However, the major drawbacks of chiral metal complexes are the high cost and 
toxicity of the metals, which may be difficult to remove completely from the products.11 
 
1.3.      CAMPHOR AS A SOURCE OF CHIRALITY 
The chemistry of (+)- and (-)-camphor (Figure 7)84 and their derivatives has continued to receive much 
attention, especially in the field of asymmetric synthesis.85-94 This is largely due to the fact that camphor can 
easily undergo a number of  transformations, including several interesting rearrangement processes.95 The 
availability of methods  for the introduction of functionality at C(3), C(5), C(8), C(9) and C(10), as well as 
cleavage of the C(1)/C(2) and C(2)/C(3) bonds have been fully utilised in developing auxiliaries and catalysts 
for asymmetric transformations.96-149  
                           
O
 Figure  7.  Structure of (+)-camphor with numbering.
1 2
3
4
5
6
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1.3.1. Aldol Reactions 
Complementing their previous work on asymmetric aldol reactions, Oppolzer and co-
workers150 reported a successful N-acylsultam-mediated aldol reaction using three different 
metals (B, Li and Sn). Sultam 1 was acylated to provide acylsultams 2 which were then 
treated with an appropriate metal reagent to give the metal enolates. Subsequent addition of 
the various aldehydes furnished syn-aldols in ≥90% yield and 99% d.e. (Scheme 1).  
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The (Z)-enolate intermediates are considered to be in equilibrium with the electronically 
favoured N-SO2/C-OBR2 s-trans conformation 7I and the SnBu3 chelate-enforced s-cis 
conformation 7II (Scheme 2). The respective rate determining steps 7I     3 and 7II     4 most 
plausibly proceed via Zimmerman-Traxler-type151 transition states to give the respective 
products 3 and 4. 
9 
 
N
SO2
OMLn
H
R1
(Z)
N
SO2
H
O R
1
M
Ln
(Z)
7I 7
II
43
R2CHO
MLn = BR2
R2CHO
MLn = SnBu3
Scheme  2.
NSO
O
.. NSO
..
O
B
O
RR
H R1
H
R2

H R2
O
H
O R1
SnIV
O
Bu
Bu
Bu

 II
X'N R2
O
R1
OH
X'N R2
O
R1
OH
 
 
Boron and lithium enolates derived from camphor-based N-propionyloxazolidone have also 
been subjected to aldol reactions by Yan et al.,152 (Scheme 3). In all cases studied, the boron 
enolate exhibited complete erythro stereoselection (erythro/threo > 99:1) and absolute 
enantioselectivity. Optically active methyl esters were obtained by the removal of the chiral 
auxiliary via methanolysis. On the other hand, aldol reactions with the lithium enolate 10a 
afforded a mixture of erythro and threo products. However, the kinetically favoured mixture of 
erythro and threo aldols can be equilibrated to the thermodynamically favoured erythro 
adducts by quenching the reaction mixture with aqueous THF and stirring the resulting solution 
at -5oC for 0.5 h. 
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Bonner and Thornton153 synthesised the camphor-derived chiral auxiliary 20 (Scheme 4) and 
employed it in lithium- and titanium-mediated aldol reactions with a variety of aldehydes. 
What was remarkable about this procedure was the ability of the camphor nucleus to confer 
crystallinity on the resulting aldol products, which provided a practical means of improving 
optical purities of the crude products by recrystallization (Scheme 4). This yielded products 
of high enantiomeric purity (92-99% S1), in spite of the fact that the π-facial and syn/anti 
selectivity of the reaction are only moderate. Stereochemical analysis indicated chelation 
control for both the lithium and titanium enolates, which form chair-like transition structures 
to give syn products selectively. The syn isomers (2-13%; Scheme 4) which are also produced 
can be explained in terms of non-chelated transition-state structures. 
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Scheme  4.
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In order to improve on the above situation, Ahn and co-workers154 designed a new camphor-
derived auxiliary 26 such that the one enolate face was located closer to the camphor moiety 
and hence experienced an effective facial bias during an aldol reaction (Scheme 5). The 
titanium-mediated aldol reaction afforded one syn aldol product exclusively (≤ 99:1). The 
syn/anti and π-facial selectivities were remarkable in that only the S1 stereoisomer (Scheme 
6) was observed in the 1H NMR spectra of the crude aldol products. This can be explained by 
the chelated transition state (Figure 8) suggested by Bonner and Thornton.153 
Scheme  5.
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N
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OiPr
OiPr
MeMeMe
1
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11
 Figure  8.  Proposed transition-state for the aldol reaction illustrated in   
                     Scheme 6.  
 
            
Boeckman Jr. et al.155 reported two new camphor-derived lactams 27 and 28 (Figure 9) which 
were examined as chiral auxiliaries in the asymmetric aldol reactions of diethyl boron 
enolates. Preliminary investigation showed that imide 28 was the better candidate for further 
studies. Under optimal conditions, imide 28 was reacted with a representative series of 
aldehydes (Scheme 7).  
                       
N N
O
O
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O
Figure  9. Camphor-derived lactams
27 28
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 Scheme  7.
R =
 
 
The major product in each case was the syn-(2S) diastereoisomer 29 (˃ 80% d.e.). A series of 
MNDO and molecular mechanics calculations were conducted in an effort to understand the 
facial selectivity observed. However, the relative energies for the transition-states did not 
seemed to be reliable, although the geometries were considered qualitatively valid. The 
resulting model of the transition-state (Figure 10) suggests that due to the presence of a 
significant non-bonded interaction between an axial ethyl ligand on boron and the proximal 
methylene group in the two-carbon bridge of the lactam auxiliary, the E,Z-chair transition-
state which leads to the minor product (syn-2R), is less favourable.  
 
Figure  10.  Transition-state model for the aldol reaction illustrated in Scheme 7.
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The previously reported camphor-based oxazolidinone 33 was converted to the dibutylboryl 
and 9BBN enolates 35a and 35b (Scheme 8) by Wang and co-workers.156 Addition of TiCl4 
as cocatalyst and subsequent treatment of the complex with a series of unsaturated aliphatic 
aldehydes yielded aldol products with good anti selectivity (99:1). In contrast, aromatic 
aldehydes gave reduced stereoselectivity (~78:22). Switching the co-catalyst to SnCl4 
afforded higher anti selectivity for aromatic aldehydes (~88:12). In an attempt to improve the 
anti selection for aromatic aldehydes, the boron enolate 35b was examined with the hope that 
the enhanced Lewis character promoted by the rigid skeletal geometry of 9-BBN should 
increase the bonding energy between the boron and the carbonyl oxygen atoms. This in turn 
would result in transition-state compression which appears to enhance the π-facial selection. 
This led to dramatic enhancement of stereoselectivity in the aldol reaction of aromatic 
aldehydes (≥94:6). A logical explanation of the high levels of anti stereoselection achieved 
derives from consideration of the E and T transition states (Figure 11).  
O
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O
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N
O
O BLn
(i) NaH/THF
(ii) CH3CH2COCl
35a ; BLn = BBu2
35b; BLn = 9-BBN
Scheme   8.
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O
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O
O
N
O
R
O
HO
R
O
HO
36
37
1. TiCl4
    or
    SnCl4
2. RCHO
33 34
Bu2B-OTf
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9-BBN-TOf
EtN(i-Pr)2
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               Figure  11.  Transition-state model for the aldol reactions illustrated in Scheme 8.
CH2
O
H R
MeH
O
N O
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O
Cl4Ti or (SnCl4)
CH2
O
R H
MeH
O
N O
BLn
O
or (SnCl4)TiCl4
36 anti aldols
37 syn aldols
E
T
 
 
In the transition-state represented by E, the large group R projects toward the ring methylene 
group, resulting in a serious interaction. In transition state T, on the other hand, the ring 
methylene group interacts with the small hydrogen atom thus favouring formation of the anti-
aldol 36. Moreover, the presence of steric repulsion between the methyl group and the bulky 
OTiCl4 group further destabilises transition-state E, thereby preventing formation of syn 
aldols 37.  
 
Due to the insufficient stereoselectivity commonly attained in acetate aldol reactions, Palomo 
and co-workers157 designed a new camphor-based enolate 40 (Scheme 9) to address these 
limitations. Reactions between the lithium enolate of 40 and some representative aldehydes 
afforded the corresponding aldol products with strikingly high diastereoselectivity (95:5). In 
contrast, the metal enolate of 39 provided substantially lower levels of diastereoselectivity. 
However on addition of a 6-fold excess of lithium chloride, a fascinating improvement was 
achieved in the reaction with the enolate. The mechanism of this reaction is thought to have 
followed the Zimmerman-Traxler model.151 
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     Scheme   9.
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..
(2) PhCHO
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43 44 45
 Scheme 10.
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      Hunig's base
      CH2Cl2 , 0oC +
 
 
As a sequel to their studies on the use of imide lactam 28 for aldol reactions, Boeckman Jr. et 
al.158 anticipated that, by introducing unsaturation at the C(5)/C(6) bond of the lactam, 
diastereoselectivity could be enhanced. The assumption was that removal of the steric 
hindrance due to the endo-hydrogens would ease reagent approach distal to the geminal 
dimethyl bridge. The Z-boron enolate derived from 43 was thus reacted with benzaldehyde 
(Scheme 10). The reaction, however, proceeded with lower facial selectivity than observed 
for the saturated counterpart (1-1.5:1 versus 11.5:1).This deterioration in the facial selectivity 
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can be explained in terms of the geometric changes imposed upon the ring system as a whole 
by introduction of the unsaturation.  
The development of metal-free small organic molecules, which catalyse enantioselective 
reactions is an area that is actively being studied, and Tzeng and co-workers159 have 
synthesised a new class of bifunctional organocatalysts 47-51 (Scheme 11), which have 
proved to be effective in enhancing the aldol reaction of cyclohexanone with a variety of 
aromatic aldehydes in water (Scheme 12). Under optimal conditions, the workers employed 
dodecylbenzenesulfonic acid (DBSA) as a BrØnsted acid-surfactant combined catalyst to 
form a colloidal dispersion with the reacting species and, subsequently to accelerate the 
reaction rate.  Although the yield appeared to be low in some cases (26%), the diastereo- and 
enantioselectivities were high to excellent (up to >99:1 d.r. and >99% e.e.).159 
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1.3.2.    Baylis-Hillman reactions 
Brzezinski and co-workers160 reported that an acrylate-based Oppolzer’s sultam 56 could 
serve as an ideal auxiliary in the Baylis-Hillman reaction. This was established by subjecting 
the auxiliary to Baylis-Hillman reactions with a series of aldehydes to afford 1,3-dioxan-4-
ones 57a-h in greater than 99% e.e. in moderate to excellent yields (Scheme 13). 
N
S
O
O
O
O
O
O
RR
RCHO, DABCO
CH2Cl2, 0oC
>99% e.e.
56 57a-h
Scheme  13.
a  CH3
b  CH3CH2
c  CH3CH2CH2
d  (CH3)CH
e  PhCH2CH2
f  AcOCH2
g  (CH3)2CHCH2
h  Ph
R
 
     
Evans and Kaye161 prepared two novel bornyl acrylate esters from D-(+)-camphor and 
reacted them with a wide range of aldehydes to afford the corresponding Baylis-Hillman 
products in a moderate to good yields with fair diastereoselectivity of 34% d.e. (Scheme 14). 
Under comparable conditions they found that ester 59 provides marginally better 
stereocontrol (27% d.e.) than the diastereomeric ester 60 (18% d.e.).  
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Yang and Chen162 developed a chiral acryloylhydrazide for asymmetric Baylis-Hillman 
reactions, as an alternative to the Oppolzer’s sultam reported by Brzezinski and co-
workers.160 Thus, the chiral acryloylhydrazide 67 was synthesised from (+)-ketopinic acid in 
four steps (Scheme 15). When reacted with a series of aldehydes, the hydrazide 67 afforded 
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the Baylis-Hillman adducts of either diastereoisomer with excellent selectivity (up to 98% 
d.e.). Quite remarkable in their procedure was the fact that, changing the solvent permitted 
the generation of either diastereomer 68 or 69 from the same chiral auxiliary with high optical 
purity. 
 
1.3.3.   Epoxidation reactions 
Encouraged by recent interest in the synthesis of optically pure alkyl peroxides for use as 
stereoselective oxidising agents, Lattanzi and co-workers163 reported the synthesis of the 
tertiary furyl hydroperoxide 71 in two steps starting from (+)-(1R)-camphor (Scheme 16). The 
structure of 71 was confirmed by 2-D NMR (NOESY) to contain an exo hydroxyl group and 
this stereoisomer was obtained almost exclusively. Asymmetric epoxidation of various allylic 
alcohols was then conducted using Ti(Oi-Pr)4 as metal catalyst (Scheme 17) to furnish products 
with moderate enantioselectivity (46%). At the end of the reactions, exo-70 was usually 
recovered in 70-80% yields and could then be converted back into exo-71.  
Scheme  16.
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Scheme  17.
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Enantiomerically pure ,-epoxy ketones have been used as building blocks in organic 
synthesis and as intermediates for the production of pharmaceuticals. For example, natural 
products containing the epoxycyclohexenone core have been found to show antimicrobial and 
anticancer activity. Lattanzi et al.164 also employed their previously reported hydroperoxide 
74, derived from (+)-norcamphor, which is less hindered than 71, as oxidant in the 
asymmetric epoxidation of electron poor alkenes. One interesting feature about their oxidants 
is that the hydroperoxyl group is directly bound to a stereogenic centre. Substituted and 
unsubstituted trans-chalcones were epoxidised using the optimised conditions of Lattanzi’s 
methodology (Scheme 18)164 and, although it was observed that the enantioselectivity was 
moderate in all cases (51%), para-substituents on the -phenyl group (R1) were found to 
strongly enhance the reaction rate in the order: p-NO2  p-Cl  p-OMe. 
Scheme  18.
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The next class of alkenes studied was the -substituted naphthoquinones as cyclic enones. 
Their asymmetric epoxidation is more difficult because the enantioselectivity was found to be 
strongly dependent on the nature of the -side chain R (Scheme 19). Under the best reaction 
conditions utilised for chalcones, the (2S,3R)-epoxide was obtained in high yield and 51%  
e.e., which represented the best value, at the time of their reporting this work. It is noteworthy 
that at the end of each reaction, exo-77 was recovered in 95% yield and could thus be used 
effectively to regenerate 74 (Scheme 19).  
           Scheme  19.
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O
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+
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O
R O
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R
O
OH
O
77
+
78 79
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THF, -20oC
R = Me, i-Pr, n-Pr, Ph
(51% e.e.)
 
In an attempt to build on a rarely reported protocol for the asymmetric epoxidation of allylic 
alcohols using VO(acac)2 together with an optically pure hydroperoxide, Lattanzi et al. 165 
applied this approach to their previously reported tertiary alkyl hydroperoxides 71 and 74. 
Since hydroperoxide 74 was demonstrated to be more reactive and enantioselective than 71, 
various primary and secondary allylic alcohols were subjected to the epoxidation reaction 
using the former reagent 74 under optimised conditions. In general, the enantioselectivity was 
found to be good (up to 70%; Scheme 20). 
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Diastereoselective epoxidation of chiral auxiliary-derived enamides have been studied by Fan 
and co-workers.166 These authors investigated the influence of urea hydrogen 
peroxide/trifluoroacetic anhydride (UHP/TFAA) and methyl(trifluoromethyl)dioxirane as 
oxidants in the epoxidation of a series of camphor N-enoylpyrazolidinones (Scheme 21). In 
both cases, diastereoselectivities as high as 95% have been achieved. Remarkably however, it 
was observed that treatment of N-methacryloylpyrazolidinone 82a with UHP gave the major 
product (s-cis) with the epoxy group having an R configuration, while in the case of 
dioxirane, the epoxy group of the major product was found to have the opposite configuration 
(s-trans).  
            Scheme  21.
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In the same laboratory, Lee et al.167 sought to further study the scope of epoxidation with 
respect to substituent tolerance on chiral auxiliary-derived enones. Both camphor-derived N- 
and O-enones were explored to establish the impact of the change in linkage from amide to 
ester bond. They also explored for the first time the epoxidation of the N-enamide of 
Oppolzer’s sultam which is one of the most effective chiral auxiliaries presently available. 
Various camphor sultam derived N-enones 85a-i were epoxidised with 
methyl(trifluoromethyl)dioxirane, UHP/TFFA, and m-CPBA (Scheme 22). High to excellent 
selectivity for the α-substituted and α,β-disubstituted substrates was found, and, in agreement 
with their earlier work, reversal of diastereoselectivity was also observed with a change in 
conditions. 
          Scheme  22.
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Reactions of exo-10,10-diphenyl-2,10-camphanediol derivatives 88a-h and exo-10,10-
diphenyl-10-methoxy-2-camphanol derivatives 89a-b with methyl(trifluoromethyl)dioxirane, 
UHP/TFFA, and m-CPBA were also explored, but only the  β,β-dimethyl substituted O-enone 
derivatives were found to furnish products with high selectivity (Scheme 23). In general, the 
dioxirane appeared to be most efficient oxidant. 
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1.3.4.    Reduction reactions 
New chiral 1,3-amino alcohols derived from ketopinic acid were synthesised by Li et al. 
following Scheme 24.168 The exo-isomer of the amino alcohol was treated with a borane 
complex to form an oxaborolidine catalyst in situ to which various prochiral ketones were 
added to yield chiral alcohols as products (Scheme 25). Good enantiomeric excesses were 
obtained (up to 86%) and the configurations of the resulting alcohols were determined to be S. 
This procedure complements the standard method of using amino acid-derived ligands which 
furnish products with an R configuration.75 
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Santhi and Rao169 explored the catalytic utility of a series of chiral oxazoborolidines 
generated in situ from D-(+)-camphor 2,3-amino alcohol derivatives. In order to study the 
effect of substituents on the nitrogen at position 2 with regard to enantioselectivity, the 
substituted amino alcohol auxiliaries 98a and 98b were prepared as shown in Scheme 26. 
Reduction of different ketones using boron-dimethyl sulfide in the presence of each of the 
chiral auxiliaries showed that the endo,endo-amino alcohol derivative 98b gave the best 
enantioselectivity (76% e.e.) as shown in Scheme 27.  
 
         Scheme  26.
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A series of novel, chiral, squaric amino alcohol ligands 105 and 106 derived from D-(+)-
camphor and squaric acid were synthesised by Zou and co-workers for the asymmetric 
reduction of ketones (Scheme 28).170 The authors expected that the rigidity of the squaric acid 
structure would provide an efficient environment for coordination of the substrates and the 
reagents and that their proximity to the camphor moiety would enhance stereocontrol. 
Preliminary observations revealed good enantiocontrol and that the cis-endo-endo 105 and cis-
exo-exo 106 ligands gave products with S and R configurations, respectively. Ligand 105b 
appeared to give the best enantioselectivity of up to 99% e.e. Under optimised conditions, 
various aromatic ketones were subjected to the reduction procedure using borane dimethyl 
sulfide (Scheme 29), and the results showed that excellent stereoselectivities (99% e.e.) had 
been achieved. 
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Scheme  29.
RL RS
O
105b (0.1 equiv.), BH3. Me2S (1.2 equiv.)
THF, 50oC
RL
HHO
RS
Ketone = tetralone, -acetophenone, p-chloroacetophenone,
p-trifluoromethylacetophenone, -bromoacetophenone, -chloroacetophenone,
propiophenoneacetophenone,
107 108
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In an attempt to develop a more benign catalytic method of asymmetric ketone reduction 
utilising an in situ generated borane from NaBH4/BF3, Zhou and Guo171 synthesised novel N-
sulfonated amino alcohols from L-amino acids in the presence of D-(+)-camphor (Scheme 
30). To ascertain the role of camphor in the reaction, p-toluenesulfonated amino alcohols 
112a-f were tested in the reduction of acetophenone as model substrate. Catalyst 112e gave 
the highest selectivity (17% e.e.). Expecting an improvement in the selectivity, the 
camphorsulfonated amino alcohols 112g-l and 113g-h were then investigated again using 
acetophenone as the substrate. Unfortunately, the highest stereoselectivity was obtained using 
catalyst 113g (12.6% e.e.). The only notable difference between 112e and 113g was that the 
former required reaction at reflux temperature while the latter worked at a mild 50oC. Various 
ketones 114a-g were subsequently reduced using 113g (Scheme 31). Reduction of -
haloketones gave a higher enantioselectivity (33% e.e.). Moreover, -haloketones appeared 
to give the corresponding alcohol with an S configuration, whereas other ketones furnished 
alcohols with an R configuration. 
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Yang and co-workers172 reported the selective reaction of the camphor-derived aldol 116 with 
primary amines (Scheme 32). In each case, the reaction afforded the ring-expanded bicyclic 
-amino ketones 117a-j exclusively, with the endo- amino group at C-2. The bicyclic ketone 
117i was then used as the precursor for the preparation of the new oxazaborolidines 120 and 
121 (Scheme 33). Compounds 120 and 121 were subsequently employed as chiral catalysts in 
the asymmetric reduction of prochiral ketones. Preliminary tests showed that catalyst 121 is 
more active and stable and was therefore used to reduce a series of prochiral aryl ketones at 
room temperature in THF (Scheme 34) with excellent enantioselectivity (99% e.e.). The 
configuration of the products was determined to be S.  
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      Scheme  34.
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1.4.   MODEL CATALYST   
 
The Jacobsen27 and Katsuki28 catalysts (Section 1.2, Figure 4) were an important discovery 
made in the 1990’s. The fundamental features of the Jacobsen catalyst may be summarised as 
follows: (i) it is based on the salicylaldehyde ethylene diimine ligand (SALEN), where the chirality is 
incorporated in the diimine moiety; (ii) it is C2 symmetric; (iii) it incorporates cationic manganese 
(III); and (iv) it possesses a chloride counter-ion. 
 
  
O
M
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PhPh
O
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 Figure  4.  Jacobsen and Katsuki Systems
M= MnCl M= MnPF6
JACOBSEN  SYSTEM KATSUKI  SYSTEM
 
Prominently, Jacobsen catalyst has been widely applied in the asymmetric epoxidation of 
unfunctionalised alkenes with excellent selectivity.10 The simplicity in the synthesis and the activity 
of the Jacobsen catalyst provides an inspiration for the synthesis of different chiral metal 
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complexes.27 However, the fact that it had not been fully developed as a broad-spectrum catalyst 
continued to provide new research opportunities.  
 
1.5.   PREVIOUS WORK IN THE GROUP 
A variety of applications of camphor as a source of chirality have previously been explored in 
our research group. Sabbagh173 conducted an in-depth DFT calculation to find that the putative 
catalyst 124 (Figure 12) showed very similar coordination geometry to the Grubbs and Hoveyda-type 
catalysts used for methathesis reactions. Although the complete synthesis proved to be elusive, some 
of the synthetic intermediates provided an opportunity to carry out further computational studies. 
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Figure  12.  Camphor-based Grubbs-catalysts.
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In 2007 Magqi174 used DFT calculation to model a structurally related catalyst 126 which 
could be obtained from ligand 125 (Figure 13). He succeeded in accessing 125 and 
completion of this study is now in hand.  
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Figure  13.  Camphor-derived phosphine ligand in a 1st generation Grubbs' Catalyst  
 
Ravindran175 worked on the synthesis of acetals as chiral auxiliaries and, in the process, 
isolated novel camphor ethers 127 and 128. Matjila176 confirmed the reproducibility of these 
compounds and isolated an additional new dimer, 129 (Figure 14). 
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 Figure  14.  Camphor-derived dimers
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The potential of compounds 127 and 128 as scaffolds for the building of ligands analogous to 
BINOL (refer to Figure 2) led Duggan177 to reduce compounds 127 and 128 to furnish 130- 
134 (Figure 15). Although they were not tested, the intention was to develop novel 
hydroboration reagents. 
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1.6. AIMS OF THE PRESENT WORK 
The literature review and previous work done in our group indicated that opportunities 
exist with regard to the development and use of camphor-based catalysts in asymmetric 
transformations. In particular, there are challenges to develop catalysts that have broad 
substrate scope. This is because, irrespective of the beauty of a chiral auxiliary, it is always 
required in a stoichiometric amount, thus rendering it chemically and economically less 
desirable. With this in mind, we therefore intended to carry out the following tasks. 
1. The synthesis of novel ketopinic acid-based Mn(III) complexes as chiral catalysts. 
2.  Evaluation of these catalysts in various asymmetric reactions,viz., 
(i) aldol reaction 
(ii) the formation and subsequent aza-Michael reaction of Baylis-Hillman adducts 
(iii) epoxidation reaction 
(iv) reduction reactions. 
3.   To establish a method of immobilising the catalysts on a solid support 
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2. RESULTS AND DISCUSSION 
 
2.1.     CATALYST SYNTHESIS 
The procedure reported by Yang and co-workers127 was followed to obtain four (+)-ketopinic 
acid-derived ligands 135-138 (Scheme 35). This was then followed by the complexation step to 
obtain the novel chiral-Mn(III) complexes 139-142.185 
  
2.1.1.  Ligand synthesis 
 The synthesis began by refluxing (+)-ketopinic acid 10 with the appropriate diamine in the 
presence of a catalytic amount of glacial acetic acid, using chloroform as solvent (Scheme 35). The 
rigidity of the bicyclic moiety in the resulting ligands was expected to result in complexes which 
could be more effective than Jacobsen’s SALEN catalysts. This is an important factor considering 
the fact that the incoming substrate(s) will have to be directed to approach the catalytic centre located 
within the chiral framework. 
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O
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The first ligand 135,127 derived from ethane-1,2-diamine, was obtained as a white solid in 52% 
yield following chromatography. The imine carbon (C2, 2’) signal can be seen at 173 ppm in the 13C 
NMR spectrum (Figure 16) next to the carboxylic acid carbonyl carbon signal at 185 ppm. The 
remaining 9 carbons are also accounted for. As a result of the C2 symmetry (illustrated for compound 
135), only eleven carbon signals are observed in the 13C NMR spectrum. The presence of this 
element of symmetry within the chiral ligand is of substantial importance, because it serves the 
purpose of reducing the number of possible competing diastereomeric transition states.  Most of the 
catalysts listed in section 1.2.1 were carefully designed to incorporate C2 symmetry for this reason— 
a factor which has indeed contributed to their high stereo-induction capacity. 
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Figure  16.  100 MHz 13C NMR spectrum of ligand 135 in CDCl3. 
 
The IR spectrum (Figure 17) of ligand 135 provides further information on the presence and 
orientation of the imine and the carboxylic acid hydroxyl groups. The carboxylic acid O-H stretching 
band typically appears as broad, ragged band between approximately 3300-2500 cm‒1 due to 
intermolecular hydrogen bonding between a pair of carboxylic acid groups. In this case however, this 
band seems to be shifted to much lower frequency due to the presence of a strong 6-membered, 
intramolecular hydrogen bond (OHN=C).178 The carbonyl (C=O) and imine (C=N) bands 
appear as expected at 1740 and 1504 cm‒1, respectively.179 
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Figure  17.  IR Spectrum of Ligand 135. 
 
       Table 1. Attempted optimisation of the synthesis of ligand 135 
Entry Conditions Yield (%)a 
1 Benzene, reflux, 48h, Dean-Stark trace 
2 Benzene, reflux, molecular 
sieves, 48h, Dean-Stark 
trace 
3 Toluene, PCl5, reflux, 48h, Dean-
Stark 
trace 
4 Dichloromethane, MgSO4, 
µwave, 5h 
trace 
  a As determined from the 1H NMR spectroscopic analysis of the crude mixture  
 
 Due to the moderate yield of the ligand 135 (52%) obtained using this procedure, various 
attempts were made to optimise the reaction conditions as shown in Table 1. It is known that Schiff 
base formation typically involves a reversible reaction which is facilitated by the water, normally 
present in the reaction as a by-product. Consequently, removing traces of water would be expected to 
favour the formation of the desired product;180  entries 1, 2, and 3 in Table 1 reflect attempts to effect 
this. Benzene and toluene are high boiling solvents which form azeotropic mixtures with water. 
Water is denser than both of these solvents, and could thus be azeotropically removed and physically 
C=O 
C=N 
N N
O
O
O
O
135
H H
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trapped in a Dean-Stark apparatus thus driving the reaction. Additionally, it was thought that 
incorporating drying agents would enhance the drying process and improve the yield. Hence, 
molecular sieves or PCl5 were added in two cases (entries 2 and 3, respectively). However, in all 
three attempts, the results were disappointing with only trace of amounts of the products being 
obtained as determined by 1H NMR spectroscopic analysis of the crude mixtures. The reaction was 
then performed under microwave conditions in the presence of anhydrous MgSO4 (entry 4). The 
microwave radiation was expected to provide an alternative to the normal heating, but only traces of 
the product were again obtained.  
The second and third ligands 136127 and 137127 are derivatives of (R,R)- and (S,S)-trans-
diaminocyclohexane, respectively. One interesting feature about these diamines is the presence of 
two additional stereogenic centres at carbons 1 and 2 of the diaminocyclohexane moiety. We 
expected that linking two (+)-ketopinic acid units next to these chiral centres would increase the 
stereo-induction capability of these ligands. Another important hypothesis was that one of the 
diamine enantiomers might enhance the stereochemical bias of the (+)-ketopinic acid moieties being 
used, while the other might counteract that selectivity. The synthesis was conducted by condensing 
(+)-ketopinic acid with racemic trans-1, 2-diaminocyclohexane under the conditions illustrated in 
Scheme 35. The 13C NMR spectrum of the crude mixture (Figure 18) indicates the presence of the 
two diastereomers as evidenced by 26 carbon signals. The carbonyl and imine carbons for the two 
diastereomers resonate at 183.5 and 183.4 (C=O), and at 173.3 ppm and 173.2 ppm (C=N). The 
expanded region is inserted for clarity. Comparison of the relative intensities of these signals 
suggests a 70:30 diastereomeric ratio ‒ assuming diastereotopic nuclei exhibit comparable relaxation 
times. 
 
Figure  18. 100 MHz 13C NMR spectrum of the crude mixture of ligands 136 and 137 in CDCl3. 
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After careful flash chromatography on silica the two diastereomers were finally separated. The 
difficulty in separating the diastereomeric ligands coupled with the low recovery of the S,S-
diastereomer (18% yield) indicated the need to resolve the racemic mixture of the trans-diamines 
prior to the condensation reactions. This resulted in an improvement in the yield of the S,S-
diastereomer to 29%. 
2.1.1.1.  Resolution of (±)-trans-diaminocyclohexane 
 Scheme 36 shows the use of L- and D-tartaric acids to form the diastereomeric salts and thus 
resolve (±)-trans-1,2-diaminocyclohexane.181 The appropriate tartaric acid was dissolved in distilled 
water and stirred to obtain a homogenous solution. This was followed by the addition of the racemic 
mixture, followed by heating to ensure the temperature reached 70oC.  
Glacial acetic acid serves as a catalyst facilitating proton transfer and results in immediate 
formation of the respective salts as white precipitates. After thorough washing with water and 
methanol, both (R,R)-1,2-diammoniumcyclohexane mono-(+)-tartarate and (S,S)-1,2-
diammoniumcyclohexane mono-(‒)-tartarate salts were obtained in excellent yields of 90%. 
Characterisation was performed using polarimetry to ascertain the optical purity of each salt, and the 
results showed that at 2M concentration in water and 20oC in the presence of sodium light, the salts 
possessed equal and opposite specific rotations of +12.3° and ‒12.3°, which agreed with the 
literature value of 12.4° corresponding to 99% e.e. Elemental analysis was also conducted to confirm 
the presence of nitrogen in the salts. In both case 10.59% nitrogen was found close to the calculated 
value of 10.62%. 
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Scheme 36. 
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The next step involved the condensation of the chiral diaminocyclohexanes with two 
equivalents of (+)-ketopinic acid (Scheme 35). Liberation of the free amines from the ammonium 
salts was necessary for the reaction to take place and, consequently, each salt was suspended in 
dichloromethane and then treated with 4M-NaOH (Scheme 36). Stirring and extraction with ether 
afforded the R,R- and S,S-diaminocyclohexanes as colourless oils. The 13C NMR spectrum of both of 
the enantiomers are of course identical (Figure 19). The resolved neutral diamines were then refluxed 
with (+)-ketopinic acid in chloroform in the presence of a catalytic amount of glacial acetic acid for 
36 h to afford the respective ligands R,R-136 and S,S,-137 (Scheme 35). 
 
Figure 19. 100 MHz 13C NMR spectrum of either R,R- or S,S-diaminocyclohexane in CDCl3. 
 
The last ligand 138 has not been reported previously and was designed with the expectation 
that the planarity of benzene ring would render the manganese atom in the subsequent metal complex 
142 more accessible to the substrates. 1,2-diaminobenzene was boiled under reflux with 2 
equivalents of (+)-ketopinic acid in CHCl3 for 36 h. After cooling, the ligand precipitated from the 
reaction mixture as a dark brown solid which was purified by successive washing with clean cold 
CHCl3. The 13C NMR spectrum of this ligand (Figure 20) shows the presence of 26 signals instead of 
the expected 13 signals suggesting that, the two ketopinic acid moieties are not magnetically 
equivalent. This is clearly shown by the two distinct carbonyl signals at 179.2 and 177.5 ppm and the 
doubling of other signals indicating the disruption of the symmetry of this molecule. The 1H NMR 
spectrum shows the four methyl signals in the range 0.84-1.18 ppm, and the aromatic protons are 
also accounted for at 7.18 and 7.53 ppm (Figure 21). These assignments were all confirmed from the 
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DEPT NMR spectrum (Figure 22). Further elucidation of the structure was done using 2-D NMR 
(COSY, HSQC and HMBC) spectroscopic analysis. 
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Figure  20.  100 MHz 13C NMR Spectrum of ligand 138 in CD3OD. 
 
 
Figure 21. 400 MHz 1H NMR spectrum of ligand 138 in CD3OD. 
 
C=O C=O 
2C=N 
C11, 11’ 
C12, 12’ C13, 13’ 
Methyl, methylene, methine, 
and quaternary aliphatic carbons 
Aromatics 
4CH3 
N N
HO
O
O
OH
1
2
3
4
5
6
7
8
9
10
11
12
13
1'
2'
3' 4' 5'
6'
7'
8'
9'
10'
13'
12'
11'
138  
N N
HO
O
O
OH
1
2
3
4
5
6
7
8
9
10
11
12
13
1'
2'
3' 4' 5'
6'
7'
8'
9'
10'
13'
12'
11'
138  
44 
 
 
Figure  22. 400 MHz DEPT-135 NMR spectrum of ligand 138 in CD3OD. 
 
The COSY NMR spectrum (Figure 23) was run to identify the protons that couple with each 
other, and shows the coupling interactions between the aromatic protons 12, 12’ and 13, 13’. The 
HSQC NMR spectrum (Figure 24) clearly shows the aromatic methine carbons. These are labelled as 
12, 12’ and 13, 13’. 
 
 
                Figure  23. COSY NMR spectrum of ligand 138 in CD3OD. 
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Figure  24.  HSQC NMR Spectrum of ligand 138 in CD3OD. 
 
In the HMBC NMR spectrum (Figure 25), a two bond correlation is apparent between the 11, 
11’ carbons and 12, 12’ protons while a three bond correlation was observed between 11, 11’ and the 
13, 13’ protons. The diastereomeric 3- and 3’-protons correlate with the 2- and 2’- carbons via a two- 
bond linkage and, although sometimes difficult to locate, the hydroxy protons show a two-bond 
correlation with the carbonyl carbons 10 and 10’ respectively. 
 
 
Figure  25.  HMBC NMR Spectrum of ligand 138 in CD3OD. 
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2.1.1.2.  Conformational search 
The apparent magnetic non-equivalence of the ketopinic moieties in ligand 138 as observed in 
the 13C spectrum (Figure 20) prompted the search for a possible existence of dynamic conformers to 
account for the phenomenon. An in silico Boltzman jump method involving 1000 steps was 
implemented using the VEGA ZZ 3.0.5.12 programme,182 the resulting energy graph (Figure 26a) 
revealed the presence of five lowest energy conformers (Figure 26a). Each of those conformers was 
further minimised and the resulting lowest energy conformer pointed to a similar structure (Figure 
26b), in which both the ketopinic moieties appeared to be syn. It was thus, decided to perform a 
variable temperature NMR studies, in the hope that at elevated temperature, the equilibrium of the 
dynamic conformers might be established. 
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(a) Energy graph of conformers of ligand 138 calculated using VEGAZZ 3.0.5.12 
programme.182 
 
 
 
 
 
 
 
 
 
 (b) 
          Figure 26. Lowest energy conformer calculated using the VEGAZZ 3.0.5.12 programme.182 
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2.1.1.3.  Variable temperature studies 
The variable temperature studies183 of ligand 138 were performed in DMSO-d6 at 305, 321, 
348, and 356 K. The spectra obtained, however, did not support the existence of a dynamic 
conformational equilibrium of ligand 138 (Figure 27), because in each case a total number of 26 
signals was observed. 
-20-100102030405060708090100110120130140150160170180190200210
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   Figure 27. 100 MHz 13C NMR spectra for variable temperature studies of ligand 138 in DMSO-d6.  
   
Based on the information obtained from the conformational search and variable temperature 
studies, it was thus concluded that the ketopinic acid moieties in ligand 138 are diastereotopic due to 
the presence of syn- and anti- configurations about the imine bonds in the same molecule, as 
indicated by its simplified 2-D structure (Figure 28a). This could also be viewed in the 3-D structure 
(Figure 28b) generated from the DFT calculation using the B3LYP/LanL2D2184 method as 
implemented in Gaussian 03 (the method used is described later under section 2.1.2.2). It is further 
believed that the presence of a rotatable single bond between the aromatic ring and the ketopinic 
356K 
348K 
321K 
305K 
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moieties via ArC-N bonds permits the coordination of the carboxylate groups to the manganese atom 
during complexation. 
 
CO2H
N N
HO2C
 
 Figure 28. Proposed structure of ligand 138. 
 
2.1.2.   Preparation of manganese complexes 
 Following a literature method, each of the ligands 135-138 was reacted with two equivalents 
of Mn(OAc)24H2O in an alkaline medium as indicated in Scheme 35.185 After stirring the respective 
ligands with 2 equivalent Mn(OAc)2.4H2O for 12h, the complexes were obtained as amorphous 
brown powders typical of Mn(III).186 The +3 oxidation state of the paramagnetic manganese cation is 
supported by the broadening of signals in the 1H NMR spectra of the complexes. A representative 1H 
NMR spectrum is illustrated in Figure 29. 
 
 
           
Figure 29.  400 MHz 1H NMR spectrum of complex 139 in CDCl3. 
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The strong bands at 1740 cm-1 (C=O) and 1504 cm-1 (C=N) in the IR spectrum of ligand 135  
(Figure 17) reflect significant shifts in wave numbers after the insertion of the manganese metal 
(Figure 30) to 1598 and 1404 cm-1. This provides further evidence of the success of the 
complexation.183 Weak bands at 1739 and 1687 cm-1 indicate the presence of a small quantities of the 
free ligand. 
 
        Figure 30.  IR spectrum of complex 139. 
2.1.2.1.  Elemental composition 
The carbon, nitrogen, and hydrogen composition of the complexes was confirmed by the 
excellent correlations between the experimental and calculated combustion analysis data (Table 2). 
Complexometric titration using ethylenediaminetetraacetic acid (EDTA) was also employed to 
determine the manganese content of the complexes. 
 
           Table 2. Carbon, nitrogen, and hydrogen composition of complexes 139-142. 
                                                                    Calculated (%)                    Found (%) 
Complex      Empirical formula              C           H            N               C         H        N 
   139             C22H30ClMnN2O4            55.41     5.87        6.34          55.35    5.88     6.35 
   140             C26H36ClMnN2O4            60.75     4.72        8.50          60.73    4.74     8.51 
              141             C26H36ClMnN2O4            60.75     4.72        8.50          60.71    4.73     8.52 
              142             C26H30ClMnN2O4                60.75     4.77        7.55          60.75    4.79      7.53 
C=N 
C=O 
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EDTA (Figure 31) most often symbolised by H4Y is an excellent chelating agent capable of 
complexing with almost every divalent and trivalent metal ion in a 1:1 ratio depending on solution 
conditions. Structurally, EDTA is a tetraprotic acid having four ionisable protons to form various 
species often abbreviated as H3Y-, H2Y2-, HY3-, and Y4-. Together with the lone pairs on the two 
nitrogens, these make it hexadentate ligand that wraps itself very tightly around a metal ion. Usually, 
titrations are performed in basic solution, (pH 8-11) except for tri- and tetravalent metal ions which 
form highly stable complexes in acid medium (pH 1-3).187  
 
    
NCH2CH2N
HO2CH2C
HO2CH2C
CH2CO2H
CH2CO2H
Figure  31. Structure of EDTA  
Prior to the titration, each of complexes 139-142 was digested in a mixture of concentrated 
nitric and sulphuric acids (1:1) at 100oC until the mixture became clear signifying the removal of the 
organic matrix. The mixture was diluted with 0.1M nitric acid, filtered and the volume made up to 
25ml with more 0.1M nitric acid. Little portions of the resulting solution were titrated with 0.01M 
EDTA solution. After calculations, the % manganese contents were found to be in excellent 
agreement with the expected values (Table 3). 
Table 3. Manganese content of complexes 139-142. 
Complex Empirical formula Calculated Mn (%) Found Mn (%) 
139 
140 
141 
142 
C22H30ClMnN2O4 
C26H36ClMnN2O4 
C26H36ClMnN2O4 
C26H30ClMnN2O4 
11.52 
10.35 
10.35 
10.47 
 
11.54 
10.33 
10.33 
10.50 
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To fully understand the geometry of the complexes, several attempts were made to grow 
crystals for x-ray crystallographic analysis. Unfortunately none of the complexes yielded suitable 
crystals (see experimental).188,189 This encouraged the use of density functional theory (DTF) to 
explore the likely geometry of these complexes. 
2.1.2.2.  Computational methods  
The B3LYP/LanL2DZ method implemented in Gaussian 03 has been found to be successful in 
predicting structures of various transition metal complexes including manganese.184 The method was 
therefore used with the Dunning and Huzinaga valence double-ζ basis functions for first-row 
elements, while efficient core-potential functions were employed for chlorine and manganese.190-193 
The stable structures for each complex are shown in Figure 32. Complex 139 exhibits a trigonal 
bipyramidal structure about the metal centre. The R,R-140 and S,S-141 complexes  both appear to 
favour square pyramidal structures about the metal centre, while complex 142 appear to adopt a 
trigonal bipyramidal structure as the most stable geometry. 
 
 
 
139 140 
141 142 
Figure  32. DFT optimised structures of Mn(III) complexes of 139-142 obtained using Gaussian 03. 
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2.1.3.   Reactions under investigation 
 With the complexes 139-142 in hand, attention could be given to their use in asymmetric 
versions of various reactions, viz., aldol, Baylis-Hillman, aza-Michael, epoxidation, and reduction 
reactions as illustrated in Scheme 37. 
 
Complexes 139-142
R1 R2
OH O
R1CHO + R2COR3
R
1 OO
CC
H=
CH
2 
    
  +
 R
2 CH
O
R1O R2
O OH
R1O R2
O OH
N
R1O R2
O OH
N
+
Piperidine
R1
R2
O
R1 R2
R1COR2
R1
OH
R2
R2
NH2
R1
I
II
III
IV V VI
I= Asymmetric aldol reaction;        II= Asymmetric Baylis-Hillman reaction;    
III= Asymmetric aza-Michael reaction;  IV= Asymmetric epoxidation reaction;
V= Asymmetric reduction of ketone;   VI= Asymmetric reduction of imines.
Scheme  37.
R
1CO
R
2 + RN
H
2
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2.2.  ASYMMETRIC ALDOL REACTIONS 
 
In the synthesis of complex molecules, which includes both natural products and commodity 
chemicals, asymmetric C-C bond formation is one of the most important reactions employed. Of 
those reactions available as asymmetric versions, very few have reached the standard of the aldol 
reaction — a reaction that is normally performed using a latent enolate, most notably the Mukaiyama 
reagent which is a modified ketone in a form of a silyl enol ether (Figure 33).194 Thanks to recent 
work from Yoshikawa’s195 and Trost's groups,68 aldol reactions can be now successfully conducted 
using an unmodified ketone in the presence of chiral-metal complexes — an approach illustrated by 
the direct asymmetric aldol reactions of various aldehydes with acetophenone promoted by a barium 
complex of BINOL. Following critical analysis of Yoshikawa et al.,195 and Trost et al.,68 procedures, 
it was observed that both systems require excessive equivalents of the ketone (up to 50 equiv.) and, 
in some cases, a long reaction period of up to 10 days! This implies that these catalysts are far from 
being useful beyond academia, and indicate an opportunity to test catalysts 139-142 by modifying 
the procedure reported by Yoshikawa and co-workers,195 which employed a lanthanum-lithium 
complex of BINOL as catalyst. 
 
   
R1
O
R3
R2
Bu2BO R2
R1 R3
Bu2BOTf
iPr2EtN, -78oC
Figure  33. Formation of Mukaiyama reagent  
The hypothesis, in our approach, as illustrated in Scheme 38, was that the the potassium 
hydroxide [generated in an organic solvent by the reaction of KHMDS (2 equiv.) and H2O (1 equiv.)] 
would remove the -proton of the ketone I to generate the enolate II. In the pre-mixed solution of 
the chiral catalyst with the aldehyde, the manganese would serve as a Lewis acid to coordinate to the 
carbonyl group forming III, resulting in activation of the carbonyl group making it more eletrophilic. 
The enolate II would approach the coordination sphere of complex III to form a stable transition-
state complex in accordance with the Zimmerman-Traxler model IV.151 Quenching the reaction with 
HCl would release the catalyst and the product V. 
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 Scheme  38.
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
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2.2.1.  Method development 
 The first step in developing this method was to establish the activity of the catalysts using 
benzaldehyde and acetophenone as model reactants. Solvent choice was the first factor to be 
considered. The uncatalysed version of this reaction is normally conducted in ethanol at low 
temperature.196 A method reported by Yoshikawa et al.195 and Trost et al.,68 using ethereal solvents 
(diethyl ether, tetrahydrofuran, and dioxane) seemed more appropriate, considering the use of a 
potassium enolate and Lewis acid catalyst. The method development was approached starting with a 
high ketone concentration (20 equiv.), KHMDS and H2O (2: 1 equiv.) dissolved in the ethereal 
solvents to generate the KOH in situ since the solubility of solid KOH was insufficient for the 
reaction. Each catalyst was tested under the conditions listed in Table 4 and the reaction mixture 
assessed at hourly intervals by 1H NMR spectroscopic analysis.  
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Ph H
O
+
Ph
O
Ph Ph
OH O
20 equiv.
catalyst (20 mole %) 
            1-24 h
Table  4.  Aldol reaction of benzaldehyde with acetophenone in ethereal solvents  
                 at different temperatures.
KHMDS (2 equiv.) 
+ H2O (1 equiv.)
143 144
Ph Ph
O
145 146
+
1 equiv.
 
 
Catalyst 
 
Solvent 
 
Temperature (oC)           
    Yield (%) 
145            146 
none 
139 
140 
141 
142 
Et2O 
Et2O 
Et2O 
Et2O 
Et2O 
0-rt 
0-rt 
0-rt 
0-rt 
0-rt 
0                  0 
Tracea            100 
Tracea            100 
Tracea            100 
Tracea            100 
none 
139 
140 
141 
142 
THF 
THF 
THF 
THF 
THF 
0-rt 
0-rt 
0-rt 
0-rt 
0-rt 
0                  0 
Tracea            100 
Tracea            100 
Tracea            100 
Tracea            100 
none 
139 
140 
141 
142 
THF 
THF 
THF 
THF 
THF 
‒20 
‒20 
‒20 
‒20 
‒20 
0                  0 
41b              19 
35b              13 
33b              14 
28b                9 
none 
139 
140 
141 
142 
Dioxane 
Dioxane 
Dioxane 
Dioxane 
Dioxane 
‒20 
‒20 
‒20 
‒20 
‒20 
0                  0 
7c               tracea 
5c               tracea 
5c               tracea 
3c               tracea 
a Trace indicates yield 0.5%  unless indicated otherwise.  b Isolated product.  
c As determined by the 1H NMR spectroscopic analysis of the crude mixture. 
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Conducting the experiments in both Et2O and THF at 0oC to room temperature did not yield 
the desired aldol products (145); instead, the dehydrated products (146) were obtained exclusively. 
This was a promising result since it indicated that the aldol condensation was facile, and dependent 
on the presence of the catalyst. However, it appeared that the subsequent dehydration was also facile 
under these conditions resulting in the loss of the asymmetric induction. Although the change in 
solvent did not make much difference, the hourly 1H NMR spectra indicated that the appearance of 
aldol products began much earlier using THF than Et2O, especially at the lower temperature. This led 
to the reduction in temperature to ‒20oC so as to trap the aldol products. 
The reduction in temperature proved moderately effective in THF, but a change to the more 
polar dioxane resulted in reduced conversion. A possible explanation might be that to the higher 
Lewis basicity of dioxane with respect to THF interfering with the Lewis acid centre of the 
catalysts.197 This would hinder the approach of the substrates to the active sites and thus slow down 
reaction, resulting in lower yields. Therefore, the use of THF at ‒20oC was adopted.  
 
2.2.2.  Method optimisation 
 The most crucial factors to consider at this stage were the catalyst loading and the equivalents 
of ketone. At 20 mol % (Table 4), the four catalysts led to less than 40% conversion.  It was felt that 
increasing the loading would render the system sub-stoichiometric rather than genuinely catalytic. 
Furthermore, using 20 equivalents of ketone was considered wasteful.198 Thus it was decided to test 
10 % catalyst loading with fewer equivalents of ketone. Interestingly, the result showed that the 
yields of the aldol products (Table 5) was similar using both 10 and 1 equivalents of acetophenone, 
and were not significantly different to the use of 20 equivalent of acetophenone (Table 4). 
 
 
 
 
 
 
 
 
 
57 
 
 
Ph H
O
+
Ph
O
Ph Ph
OH O
catalyst (10 mole %)
THF, 20 oC, 1-24 h
KHMDS (2 equiv.) 
+ H2O (1 equiv.)
Table  5.  Aldol reaction of benzaldehyde with acetophenone (10 or 1 equiv.) and catalyst
                 (10 mole. %) in THF at 20oC.
143 144 145
  
             Catalyst 
         Yield (%)a 
10 eq.                  1 eq. 
              none 
              139 
              140 
              141 
              142 
0                          0 
41                       39 
35                       35 
33                       33 
28                       25 
  a Isolated yield 
 
Further reduction of the catalyst loading to 5 mole % resulted in very poor yields (Table 6), 
even when the duration of the reaction was extended to 48h. In fact, it could be said that from a 
practical point of view, that this system is far from ideal. 
 
Ph H
O
+
Ph
O
Ph Ph
OH O
catalyst (5 mole %)
THF, 20 oC, 1-24 h
KHMDS (2 equiv.) 
+ H2O (1 equiv.)
Table  6.  Aldol reaction of benzaldehyde (1 equiv.) with acetophenone (1 equiv.) and         
                   catalyst (5%) in THF.
144143 145
  
Entry  Catalyst  Yield (%)a 
1  none  0 
2  139  13 
3  140  10 
4  141  8 
5  142  6 
        a As determined by the 1H NMR spectroscopic analysis of the crude mixture. 
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It was therefore decided to investigate the effect of the catalysts 139-142 on the 
enantioselectivity of the reaction with 1 equivalent of acetophenone. The results (Table 7) 
encouraged the adoption of these reaction conditions as a model for the rest of the substrates. Thus, 
in a typical reaction, a solution of KHMDS/KOH in THF at 0oC was added to 1 equiv. of  
acetophenone and the mixture stirred for 10 min; then cooled to -20oC, and a solution of catalyst and 
10 equivalents benzaldehyde in THF was followed by stirring for 24h. The crude mixture was 
purified by preparatory TLC (silica; hexane:EtOAc, 3:1) to afford the aldol product.  Chiral HPLC 
analysis of the products showed excellent enantioselectivity of up to 99 % e.e. for catalyst 139. This 
represented the first direct aldol reaction between acetophenone and benzaldehyde with such 
magnificent selectivity.199 The 1H NMR spectrum of the aldol product is shown in Figure 34. The 
enantioselectivity was determined by exporting the HPLC data into SigmaPlot (2001); the peaks 
were deconvoluted to facilitate the quantification of each enantiomer, thus affording the 
enantioselectivity.200 This can be illustrated using the aldol product of benzaldehyde and 
acetophenone.  
A racemic mixture obtained from an uncatalysed reaction was first analysed as a control to 
check the retention time(s) for the enantiomers and the intensities of the peaks. This was then 
followed by the HPLC analysis of the product obtained using catalyst 139. Both the chromatograms 
are shown in Figures 35 and 36. Significant stereocontrol was achieved using catalysts 139 and 142, 
both of which have an achiral diamine linker. The complexes incorporating R,R- and S,S- 
diaminocyclohexane were completely ineffective. 
 
Ph H
O
+
Ph
O
Ph Ph
OH O
catalyst (10 mole %)
THF, 20 oC, 1-24 h
KHMDS + H2O
Table  7. Enantioselectivity of the aldol reaction of benzaldehyde with acetophenone  and   
                catalyst (10 %) in THF at -20oC.
143 144 145  
 
Entry  Catalyst  Yield (%)a  E.e. (%)b 
1  139  39  99 
2  140  35  0 
3  141  33  0 
4  142  25  60 
     a Isolated    b Determined by chiral HPLC (Lux 5u Cellulose-2, Phenomenex)  
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Figure  34. Representative 600 MHz 1H NMR spectrum of the aldol product, obtained  
       in the reaction between benzaldehyde and acetophenone in the presence of  
       catalysts 139-142 in CDCl3. 
 
  
Figure 35. HPLC chromatogram of the racemic mixture obtained from the uncatalysed  
                   aldol reaction between benzaldehyde and acetophenone.   
 
 
 
 
 
 
 
 
Ph Ph
OH O
 
Ph Ph
OH O
 
-CH2 + OH 
-CH
2Ph 
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Figure 36. HPLC chromatogram of the product obtained from the aldol reaction 
      between benzaldehyde and acetophenone catalysed by 139.   
 
                                                                       
2.2.3.   Exploration of substrate scope 
 A broad substrate scope is one of the measures of catalyst efficiency201 and, in this study, 
extension of the methodology to the aldol reaction of benzaldehyde with different aryl ketones was 
explored. Thus, the aryl ketones, acetophenone, propiophenone, -tetralone, 4-nitroacetophenone, 
and 4-methoxyacetophenone were all selected, based on both steric and electronic factors and reacted 
with benzaldehyde with the four catalysts to afford the aldol products (Scheme 39). 
 
Ph H
O
+
Ph R
OH O
 139-142 (10 mole %)
THF, 20 oC, 1-24 h
KHMDS + H2O
Aryl
ketone
Aryl ketone
a  Acetophenone
b  Propiophenone
c  -tetralone
d  4-nitroacetophenone
e  4-methoxyacetophenone
143 145a-e
Scheme  39.
144a-b
 
 
 
Solvent front 
1st enantiomer
2nd enantiomer
Ph Ph
OH O
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Examination of the results summarised in Table 8 reveals that enantio-enriched products were 
only obtained using catalysts 139 and 142. These catalysts proved to be effective, yielding the aldol  
products from propiophenone and -tetralone in good selectivity (82-85% e.e.), albeit in 
disappointing yield. The enantioselectivities observed in the reaction of 4-methoxyacetophenone 
were somewhat lower (53 and 78% e.e.), but 4-nitroacetophenone failed to react altogether. 
In principle the aldol reactions of propiophenone and -tetralone might be expected to result in 
the formation of both syn and anti adducts. In this study, however, a single distereoisomer was 
obtained exclusively in each case; and the stereochemistry is predicted to be on the basis of the 
favoured geometry of the enolates. Alkali metal-based base deprotonation of such ketones has 
generally been observed to provide Z-enolates as the major product, which typically afford syn-aldol 
products by minimising unfavourable 1,3-diaxial interactions between the substituents  in the chair-
like transition state, as illustrated in Figure 37.202  
 
 
   
O
Mn
O
H
R3
R1

R2

Figure  37. Favoured Z-enolate transition-state  
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Table 8.  Results of aldol reactions of benzaldehyde with different aryl ketones in the  
    presence of catalysts 139-142. 
Aryl ketone Catalyst Aldol product Yield (%)a E.e. (%)b 
Ph
O
144a  
 
139 
140 
141 
142 
 
Ph
OH O
Ph
145a
 
39 
35 
33 
25 
 
99 
0 
0 
60 
144b
O
Ph
 
 
139 
140 
141 
142 
 
145b
Ph
OH O
Ph
 
32 
30 
30 
31 
 
83c 
0 
0 
82c 
144c
O
 
 
139 
140 
141 
142 
 
145c
Ph
HO O
 
23 
23 
23 
27 
 
85c 
0 
0 
85c 
O
NO2
144d  
 
139 
140 
141 
142 
 
Ph
OH O
NO2145d  
 
0 
0 
0 
0 
 
- 
- 
- 
- 
O
OCH3
144e  
 
139 
140 
141 
142 
 
Ph
OH O
OCH3
145e  
 
26 
23 
22 
50 
 
78 
0 
0 
53 
 a  Isolated yield.   b Determined by chiral HPLC (Lux 5u Cellulose-2, Phenomenex). 
c % D.e as determined by the 13C NMR spectroscopic analysis of the crude mixture. 
 
4-nitroacetophenone and 4-methoxyacetophenone were used as substrates in order to 
investigate the influence of activating and substrates substituents on the reactivity and 
stereoselectivity in these chiral aldol reactions. It was envisaged that the presence of the  para nitro 
group in  4-nitroacetophenone would enhance the acidity of the enolisable proton which would thus 
become more susceptible to deprotonation. However, the non-reactivity of this substrate suggested 
that there might be a strong coordination between the two oxygens of the nitro group and the 
manganese centre in the catalyts, thus decreasing the likelihood of the preferred coordination 
between the Mn and the aldehyde carbonyl group leading to the aldol reaction. On the other hand, 4- 
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methoxyacetophenone was chosen, to illustrate electron releasing effect of the para methoxy group. 
Although the yields were generally low, the performance of catalyst 142 appeared to show the best 
activity (up to 50% yield) ‒ albeit the lower stereoselectivity (53% e.e.).   
Interestingly, catalysts 140 and 141, which are diastereomers of each other did not provide any 
stereoselection. Considering the link beween the two ketopinic acid units, it might be suggested that 
the conformational constraints associated with the cyclohexane ring hinder effective coordination of 
the substrates with the manganese centre of the catalyst. 
The next set of substrates investigated were the aliphatic ketones. Under the  optimised 
conditions used for the aryl ketones, the following aliphatic ketones were studied: cyclohexanone; 2-
methylcyclohexanone; 4-methylcyclohexanone; 2-hexanone, and pinacolone (Scheme 40). In order 
to explore the reactivity of the aliphatic ketones, it was decided to use 10 and 20 equiv. instead of the 
1 equiv. used for the aromatic ketones. The results indicated in Scheme 40 appeared to be very 
disappointing, as none of the catalysts yielded any aldol product at 20oC. However, when the 
reaction mixture warm up to room temperature, excellent conversion to the dehydrated products was 
observed. The same phenomenon was observed when isobutylraldehyde was reacted with aryl 
ketones under similar reaction conditions (Scheme 41). At the lower temperature it seems that the 
aliphatic substrates are less reactive. 
 
Ph H
O
Ph R
OH O139-142 (10 mole %)
THF, 20 oC, 1-24 h
KHMDS + H2O
10 equiv. aliphatic ketone
Aliphatic ketone
a  Cyclohexanone
b  2-Methylcyclohexanone
c  Methylcyclohexanone
d  2-Hexanone
e  Pinacolone
143
147a-e
Scheme  40.
139-142 (10 mole %)
THF, 20oC, 1-24h
KHMDS + H2O
20 equiv. aliphatic ketone
Ph R
O
148a-e
Ph R
O
148a-e
Ph R
OH O
147a-e
+
+
100%
100%
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CHO
R
OH O139-142 (10 mole %)
THF, 20 oC, 1-24 h
KHMDS + H2O
10 equiv. aryl ketone
149
150a-e
Scheme  41.
139-142 (10 mole %)
THF, 20 oC, 1-24 h
KHMDS + H2O
20 equiv. aryl ketone
Ph R
O
151a-e
Ph R
O
151a-e
R
OH O
150a-e
+
+
100%
100%
Aryl ketone
a  Acetophenone
b  Propiophenone
c  -Tetralone
d  4-Nitroacetophenone
e  4-Methoxyacetophenone
 
2.3.   ASYMMETRIC BAYLIS-HILLMAN REACTIONS 
The Baylis-Hillman (BH) reaction is another important carbon-carbon bond forming reaction 
involving electron-deficient alkenes, such as ,-unsaturated ketones. It comprises the reaction of 
,-unsaturated carbonyl compounds with aldehydes catalyzed by nucleophilic amines or 
phosphines (Scheme 42).203 The products of this reaction are highly functionalised allylic alcohols, 
which have proven to be valuable building blocks for biologically important compounds and natural 
products.203 This has led our group to explore applications of the BH reaction in the construction of 
anti-HIV drug candidates.204-207  
  
R
O
+
H R'
O
R R'
O OHLB : Lewis Base
     (PR3, NR3)
Electron-deficient 
       alkenes Aldehyde Allylic alcohol
Scheme  42.  
 
65 
 
One of the most common nucleophilic bases employed in the BH reaction is 1,4-diazabicyclo-
[2.2.2]octane (DABCO). Taking DABCO as an example, the mechanism of the BH reaction is 
understood to proceed through the conjugate addition of DABCO to an electron-deficient alkene to 
form a key zwitterionic intermediate (I), which attacks an aldehyde in an aldol fashion to generate a 
second intermediate (II). Subsequent proton transfer and elimination of the DABCO yields the BH 
adduct (Scheme 43).208 The fact that the BH reaction is typically accompanied by the generation of a 
new chiral centre has inspired the development of new methodologies that would lead to the 
enantioselective synthesis of the BH adducts. Several efforts in this direction have involved the 
development of a catalyst that could play a two-fold role; firstly, the acceleration of the reaction rate 
because the BH reaction is characterised by very slow rates (often with low yield) and, secondly, to 
impart chiral induction.208 While some success has been achieved in terms of both rate acceleration 
and selectivity, the applicability of the known catalysts has been limited to particular substrates.203  
 
N
N R
O
N
N
O
R
+
-
N
N
O
RR'
O
H
R R'
O OH
(I)
(II)
H R'
O
Scheme  43.  
Encouraged by the performance of catalyst 139 in the aldol reaction, it was decided to further 
test its stereoselective efficiency in two of the steps  previously used in our group in the construction 
of potential HIV-1 enzyme inhibitors.204-207 These involve the initial BH reaction, with the formation 
of a new stereogenic centre, and the conjugate addition of amines to the BH adducts, with the 
formation of the second stereogenic centre and, hence, the formation of diastereomers. (Scheme 44). 
The current study thus focussed on exploring using catalyst 139 to effect enantioselectivity in the 
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first step (the BH reaction) and diastereoselectivity in the second, conjugate addition step (Scheme 
44). 
 
R
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+
H R'
O
R R'
O OH
*
A: DABCO, CHCl3
B:139, DABCO, CHCl3
A: Piperidine, THF
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using racemic BH adducts
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N
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+
R= OMe,
      OBut N CHO
N CHO
CHOCl
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CHO
CHO
Cl CHO
NO2
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Scheme  44.
Syn Anti
 
 
2.3.1.  Synthesis of the Baylis-Hillman adducts 
Baylis-Hillman reactions were initially conducted using methyl- and tert-butylacrylates, in the 
presence of DABCO but in the absence of catalyst 139 (Scheme 44; Method A).The known BH 
adducts, were all isolated and characterised. Exploration of Method B (Scheme 44) began with 
investigating the rate acceleration of methyl acrylate with benzaldehyde by catalyst 139. It was 
assumed that the Lewis acidity of the manganese in the catalyst would activate the benzaldehyde 
towards nucleophilic attack — the step which had been proposed to be the rate determining step of 
the reaction,209 although subsequent studies have proposed that the final, elimination step is rate-
determining. 
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Aggarwal and co-workers210 had established the efficacy of lanthanum triflate as a Lewis acid 
catalyst in the presence of DABCO in accelerating the BH reaction, inspiring Yang et al.,127 to utilise 
ligands 135-137 to develop an asymmetric version with relative success. In general, however, the use 
of lanthanum metal results in the formation of DABCO-lanthanum complexes which, in effect, 
reduce the activity of the metal.209 We therefore assumed that a pre-formed complex such as 139 
would avoid some of the issues associated with the aforementioned systems. Additionally manganese 
is cheaper and less toxic than lanthanum.211  
 Thus, a reaction between methyl acrylate and benzaldehyde was conducted using both 139 (5 
mole %) and DABCO with regular  monitoring by 1H NMR spectroscopy over 24 h. 
Disappointingly, no product formation was observed. Increasing the amount of 139 to 10 and 20 mol. 
% did not yield a better result. However, when the reaction was allowed to proceed for 48 h, it was 
observed that in the presence of 5 mole % 139 and 30 mole % DABCO some product began to 
appear even though not substantial. At this stage it was decided to allow the reaction to proceed for a 
longer time as Matsui and co-workers had reported.212 Interestingly, after 21 days, excellent 
conversion was observed by 1H NMR spectroscopic analysis of the reaction mixture. Upon 
completion, the solvent was removed in vacuo and the crude product purified by preparative TLC on 
silica to obtain the pure Baylis-Hillman adducts. The subsequent BH reactions between methyl- and 
tert-butyl acrylates and the appropriate aldehyde as shown in Scheme 44, were conducted using 139 
(10 mole %) and DABCO (30 mole %). 
 
Figure  38. 600 MHz 1H NMR spectrum of the BH product 157, obtained in the reaction 
between benzaldehyde and methyl acrylate in CDCl3 in the presence of catalyst 139 and 
DABCO. 
 
 
OH
OCH3 
ArH CH=CH2 
HOCH O
OH O
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The enantioselectivities of the catalysed reactions were determined by recording the 1H NMR 
spectra of the isolated BH adducts in the presence of Eu(hfc)3 as chiral shift reagent and CDCl3 as 
solvent. This was possible due to the availability of nucleophilic sites in the BH adduct capable of 
complexing with the Eu centre. The 1H NMR spectrum  of each adduct was recorded prior to the 
addition of the chiral shift reagent to facilitate assignment of the relevant signals and their likelihood 
of overlapping with the Eu(hfc)3 signals (Figure 39). 
 
Figure  39. 600 MHz 1H NMR spectrum of Eu(hfc)3 in CDCl3. 
The 1H NMR spectra of the racemic samples, which were produced in the absence of the 
catalyst, were used as control to compare with the spectra of the catalysed products. Thus, the 1H 
NMR spectrum of the BH adduct of 6-methylpyridine-2-carbaldehyde (Figure 40) confirmed the 
structure of the molecule prior to the addition of the chiral shift reagent. This can then be compared 
with the 1H NMR spectra (Figures 41 & 42) of the racemic adducts and the stereo-enriched adducts 
obtained from the catalysed reaction in the presence of Eu(hfc)3. 
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Figure  40. 600 MHz 1H NMR spectrum of the racemic BH product 155, obtained in the 
       reaction between 6-methyl pyridine-2-carbaldehyde and methylacrylate in the 
       absence of Eu(hfc)3 in CDCl3.             
 
Figure  41. 600 MHz 1H NMR spectrum of the racemic BH product 155, obtained in the  
        reaction between 6-methyl pyridine-2-carbaldehyde and methylacrylate in the 
        presence of Eu(hfc)3 in CDCl3.  
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Figure  42. 600 MHz 1H NMR spectrum of the enantiomerically enriched BH product 155, obtained 
in the reaction between 6-methyl pyridine-2-carbaldehyde and methylacrylate in the presence of 
Eu(hfc)3 in CDCl3.  
    
The 1H NMR spectrum of the racemic product 155 in the presence of Eu(hfc)3 shows a clear 
splitting of the methoxy proton singlet  into separate signals. Integration of each singlet confirmed 
the presence of equimolar amounts of the R and S enantiomers. On the other hand, the product 
obtained with the chiral catalyst 139 in the presence of the chiral shift reagent (Figure 42) reveals 
that the methoxy signals for the enantiomeric adducts had very different intensities. Comparison of 
the integrals (I) of these two signals, and applying the relation; % e.e. = I1-I2/I1+I2100 (where the 
signal integrals I1I2) indicated an enantioselectivity of 45% e.e. Enantioselectivities were similarly 
determined for all of the BH adducts produced in the presence of catalyst 139. The results are 
summarised in Table 9. 
 
 
 
 
N
O
OH O
Catalysed  
2xOCH3 
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Table 9. Results of the Baylis-Hillman reactions of methyl- and tert-butyl acrylate with different         
aldehydes in the absence and presence of catalysts 139. 
 
Compd. No. 
 
BH  adduct 
Uncatalysed 
Yield (%)a 
     Catalysed 
Yield (%)b 
 
E.e. (%)c 
152 
 
N
O
OH O
 
65f 90 26d 
153 
 
N
O
OH O
 
77f 93 44e 
154 
 
N
O
OH O 85f 91 25 
155 
 
N
O
OH O
 
52f 90 45 
156 
 
Cl
OH O
O
OH  
44 55 10 
157 
 
OH O
O
 
31 85 0 
158 
 
OH O
O
Cl
42 90 7 
159 
 
OH O
O
Cl
55 91 10 
160 
 
OH O
O
NO2  
59 77 13 
161 
 
OH O
O
NO2  
66 80 15 
a Isolated yield after 21 days. b Isolated yield using catalyst 139 (5 mole %), DABCO (30 mole %), CHCl3, rt, 
21 days c Determined by the analysis of the  1H NMR spectrum of the isolated products in the presence of 
Eu(hfc)3 d From comparison of the tert-butyl singlets. e From the comparison of the methoxy singlets. f 
Isolated after24 h for uncatalysed and 6 h for catalysed conditions. 
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The chiral influence of the catalyst is proposed to be exerted via the generalised transition-state 
complex illustrated in Figure 43. It is proposed that the manganese centre in the catalyst coordinates 
simultaneously with the aldehyde and DABCO-acrylate enolate oxygens to form a six-membered 
ring incorporating the metal.  
 
N
N
O
O
R''
R'
O
Mn
+
* 
Figure  43. Generalised transition-state complex of catalyst 139 with
                    DABCO-acrylate enolate complex.  
 
Examination of the enantioselectivity data in Table 9 reveals that the pyridine-2-carbaldehyde 
adduct 152 was obtained in excellent yield (90 % yield) and the best selectivity (45% e.e.). The 
generally high yields (relative to the uncatalysed reaction) may be attributed to the enhancement of 
the electrophilicity of the aldehydic carbonyl carbon and/or stabilisation of the zwitterionic enolate 
by coordination with the metal complex. The higher enantioselectivities observed for adducts 152-
155 (25 and 45 % e.e.) may reflect enhanced diastereofacial selectivity due to prior coordination 
between the chiral catalyst and the pyridine nitrogen and aldehydic oxygen in the pyridine-2-
carbaldehydes. Similar effects involving the ortho- nitro group may account for the marginally 
higher (13-15% e.e.) enantioselectivities observed for these adducts 160 and 161 compared to the 
salicylaldehyde-derived systems. 
2.3.2.   Aza-Michael addition of piperidine to the Baylis-Hillman adducts 
The second step as illustrated in Scheme 44 is the conjugate addition of piperidine to each of 
the Baylis-Hillman adducts. Over the past decade, an attractive area of asymmetric synthesis is the 
stereocontrolled addition of nucleophiles to activated alkenes.213 This can be enantioselective when 
one or more chiral centres are generated or diastereoselective where the substrate has an existing 
chiral centre (Scheme 45). In comparison with other areas of asymmetric synthesis, such as 
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hydrogenation, epoxidation, and the aldol/Mannich-type reaction, asymmetric conjugate addition can 
be said to be less well developed. This is even more apparent in the case of ‘diastereoselective’ 
conjugate addition described by the general mechanism shown in Scheme 45.213  
XR1
R3R2
R2
R3
NuH
X
R1
YY
I II IIIa
NuH
Scheme  45.
X/Y = carbonyl, sulphonyl, nitro etc.
R1, R2, R3 = H, alkyl, aryl
R1*   contains chiral centre(s)
..

IIIb
Syn Anti
X
Y
R1*
Nu
R3
R2
H
X
Y
R1*
Nu
R3
R2
H
+
 
 
The essence of this section, therefore, was to explore the applicability of catalyst 139 as chiral 
Lewis acid in the diastereoselective conjugate addition of piperidine to the racemic BH adducts 
obtained from step one (Method A; Scheme 44). It was expected that the manganese centre in 
catalyst 139 would provide an alternative to some of the hazardous metals reported in the 
literature.213 Thus the racemic Baylis-Hillman adducts obtained using Method A; (Scheme 44) were 
reacted with and without catalyst 139 in THF, at room temperature. In order to remove the 
paramagnetic manganese, the crude mixtures were eluted through celite and the solvent evaporated 
in vacuo to afford material for spectroscopic analysis. Interestingly, in the presence of catalyst 139 
the adducts were not only formed in 24 h, as opposed to the 3 days duration under uncatalysed 
conditions, but also in good to excellent overall yields (77-100%).204-207 The diastereoselectivity was 
determined by 13C NMR spectroscopic analysis of the diastereomeric mixtures. The resolution of 
some of the 13C signals in the 13C provided an opportunity to calculate the % d.e. by considering the 
relative intensities of the signals corresponding to each diastereomer. Since chirality in the enantio-
enriched Baylis-Hillman adducts might impart some degree of selectivity in the conjugate addition 
reactions, the racemic BH adducts for each reaction was run both in the presence and absence of 
catalyst 139, permitting assignment of 13C signals in the spectra of the uncatalysed reactions and 
comparison of their intensities and those of the corresponding signals in the spectra of the catalysed 
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reactions. The 13C NMR spectra of the products of uncatalysed and catalysed reactions between 
pyridine-2-carbaldehyde and tert-butyl acrylate (Figures 44 and 47) illustrate the approach used in 
the determination of the diastereoselectivities. 
The 13C NMR spectrum (Figure 44) of the diastereomeric mixtures formed in the case of the 
uncatalysed reaction clearly shows doubling of the signals and in particular the C=O, C-2, C-6, and 
(CH3)3 signals. Assignment of these signals was supported by the DEPT-135 NMR spectrum (Figure 
45) which shows the two diastereotopic C-6 methine signal pointing upward at 148.78 and 148.33 
ppm, and the two diastereotopic CH3 signals at 27.81 and 28.05 ppm. Further support is provided the 
HSQC NMR spectrum (Figure 46) which confirms C-6 coupling with the aromatic proton resonating 
at 8.50 ppm and (CH3)3 carbon nuclei coupling with protons resonating at 1.20 ppm. 
 
 
Figure  44. 100 MHz 13C NMR spectrum of the conjugate addition product 162 in CDCl3 obtained in 
                    the uncatalysed reaction between racemic BH adduct 152 and piperidine. 
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Figure  45. DEPT-135 NMR spectrum of the conjugate addition product 162 in CDCl3 obtained in 
                   the uncatalysed reaction between racemic BH adduct 152 and piperidine. 
          
     
       
   
Figure  46. HSQC NMR spectrum of the conjugate adduct product 162 in CDCl3 obtained 
         in the uncatalysed reaction between BH adduct 152 and piperidine.  
 
 C-6 
 (CH3)3 
  (CH3)3 
 
N
O
OH O
N
1
2
3
4
5
6
   
N
O
OH O
N
1
2
3
4
5
6
 
2(CH3)3 
2(CH3)3 
C-6 
76 
 
The 13C NMR spectrum (Figure 47) of the diastereomeric products obtained from the catalysed 
version (Method B; Scheme 44) similarly revealed the pairs of carbon signals corresponding to C=O, 
C-2, C-6, and (CH3)3 at: 171.65 and 171.32; 161.83 and 161.15; 148.82 and 148.34; 27.98 and 27.85, 
ppm, respectively. The two 13C NMR spectra (Figures 44 and 47) provided the signal intensities of 
the relevant signals considered for the determination of the diastereoselectivity.  
 
 
 
Figure  47. 100 MHz 13C NMR spectrum of the catalysed conjugate product 162 in CDCl3 
                   obtained in the reaction between racemic BH adduct 152 and piperidine in the 
                   presence of catalyst 139. 
        
    
Table 10. Selected 13C NMR signals of uncatalysed and catalysed products of the  
  conjugate addition of BH adduct 152. 
                  Uncatalysed reaction 
Signal                    ppm                    Intensity 
                  Catalysed reaction 
            ppm                    Intensity 
 
C=O                     171.69                  0.1185 
C=O                     171.28                  0.1007 
C-2                      161.88                   0.1437 
C-2                      161.11                   0.1242  
C-6                      148.77                   0.2403 
C-6                      148.32                   0.2287 
(CH3)3                          27.96                     1.0000 
(CH3)3                          27.81                     0.8164 
 
 
          171.69                   0.0147 
          171.28                   0.0972 
          161.88                   0.0097 
          161.11                   0.2526 
          148.77                   0.0229 
          148.32                   0.2414 
          27.96                     0.0802 
          27.81                     1.0000 
C=O 
C-2 C-6 
(CH3)3 
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Thus, the intensity ratio was calculated for each pair of signals and the average ratio was taken. The 
uncatalysed reaction thus gave an average of 7% d.e.,while the average ratio for the catalysed 
reaction, on the other hand, gives an average of 91 % d.e. The 13C T1 spin-lattice relaxation times for 
specific nuclei in diastereomeric compounds may be assumed to be comparable215and, thus, the 
results for each of the catalysed conjugate additions were treated in a similar way to provide the % 
d.e. data summarised in Table 12. From examination of the relative intensities of the selected signals 
in Table 11, it is clear that the uncatalysed reaction proceeds with some diastereoselectivity due to 
the presence of the chiral centre in the BH adduct substrate. However examination of each pair of 
signals in Table 10 reveals that lower field signal is more intense for the product of the uncatalysed 
reaction but less intense for the catalysed reaction. This means that the diastereoselectivity resulting 
from asymmetric induction in the uncatalysed reaction is in the opposite direction to that induced by 
the chiral catalyst. 
              
       Table 11. Average diastereoselectivity of uncatalysed and catalysed conjugate 
   Addition of piperidine to BH adduct 152. 
Signal Uncatalysed d.e. (%) Catalysed d.e. (%) 
C=O 
C-2 
C-6 
(CH3)3 
8 
7 
2.5 
10 
87 
96 
99 
83 
Average % d.e. 7 91 
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     Table 12. Results of conjugate addition of piperidine with different BH adduct substrates in the  
    absence and presence of catalysts 139. 
 
Compd. No. 
 
Conjugate adduct 
Uncatalyseda 
Yield (%) 
 
Time (h)b 
Catalysed 
Yield (%)c 
 
D.e. (%)d 
 
162 N O
N
OOH
  
53 5 100 91 
 
163 N O
N
OOH
  
60 5 100 85 
 
164 N O
N
OOH
  
51 5 100 77 
 
165 N O
N
OOH
 
53 5 100 75 
 
166 Cl
OH
N
O
O
OH
 
44 7 83 52 
 
167 
 
OH
N
O
O
 
52 20 80 56 
 
168 
OH
N
O
O
Cl
 
56 14 81 52 
 
169 
OH
N
O
O
Cl
 
59 18 78 49 
 
170 
OH O
O
NO2 N
 
35 22 82 21 
 
171 
OH O
O
NO2 N
 
44 22 77 14 
 a Isolated yield after 3 days  b Duration for the catalysed reactions  c In the case of 100 % yield , no 
starting material or unwanted product was evident in the 1H NMR spectrum of the crude product, 
otherwise all yields are isolated. dDetermined by the 13C NMR spectrum of the diastereomeric mixture. 
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2.3.3.1.   Configurational assignment of syn and anti diastereomers 
The hydroxyl methine proton (HCOH) signals for the syn and anti diastereomers are 
conveniently identified in the 1H NMR spectra of the crude mixtures of the conjugate addition 
products. The representative 1H NMR spectrum of conjugate adduct 162 (Figure 49) shows two 
doublets at 5.19 and 5.07 ppm for the hydroxyl methine proton of the diastereomers. The splitting is 
due to the 3-bond coupling between the vicinal hydroxyl methine and 2-methine protons. This 
provides an opportunity to assign the structures to the respective diastereomers based on the Karplus 
relationship.216 The Karplus relationship was developed based on the observation, backed by 
theoretical considerations, that vicinal H-H couplings will be maximal with protons having 0° or 
180° dihedral angles which correspond to the eclipsed or anti arrangements, respectively. Also, 
coupling will be minimal for vicinal protons that are separated by dihedral angles of 60o or 90° 
relative to each other.216 To address this aspect, a computational study was carried out to determine 
the most stable staggered conformation of each diastereomer. The relative geometries of the two 
vicinal hydrogens were set at 60o, 180o, and 300o and then complete systematic conformational 
searches were performed (allowing the rest of the molecule to be geometry optimised in each case) 
using a conformational search module within VEGAZZ 3.0.5.12. programme.182 The lowest energy 
conformation of each staggered arrangement was then optimised (with frequency analysis) at the 
B3LYP/6-31G(d) to identify the conformation with the lowest energy. This can be illustrated with 
the models of the syn and anti diastereomers of conjugate adduct 162 (Figure 48). The 3-bond 
coupling constants of the doublets at 5.07 and 5.19 ppm in the 1H NMR spectrum (Figure 49) of 162, 
were found to be 8.4 and 3.6 Hz respectively, signifying that, the signals at 5.07 and 5.19 ppm 
corresponds to the anti- and syn- diastereomers respectively.  
 
 
 
 
 
 
 
Figure  48. Optimised models of the syn and anti diastereomers of 162 showing dihedral angles. 
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Figure  49. 600 MHz 1H NMR of the catalysed conjugate product 162 in CDCl3 obtained in the 
                    reaction between racemic BH adduct 152 and piperidine. 
   
The proposed mechanism of the catalysed conjugate addition can be illustrated using the BH 
adduct 153. It is suggested that the manganese atom in the catalyst coordinates to the C=O and OH 
groups of the BH adduct thereby activating the ,-unsaturated carbonyl moiety towards conjugate 
addition and thus accounting for the rate enhancement observed for the catalysed reaction. Moreover, 
such coordination may be expected to induce diastereofacial selectivity during conjugate addition 
and/or during the subsequent and stereochemically critical proton transfer (II-III; Scheme 46) 
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The results in Table 12 present some interesting information about the behaviour of each 
substrate during the conjugate addition. The conjugate addition products 162-165 of the pyridine 
derivatives were produced in high yield within 5h, and the best diastereoselectivity for this step was 
91% d.e. This might be attributed to the fact that the strategic position of the nitrogen atom in the 
ring close to the chiral centre could enhance the interaction between the catalyst and the BH adduct. 
The conjugate adduct 166 gave good conversion but only moderate diastereoselectivity of 50%. It is 
suspected that the ortho-hydroxyl group might coordinate competitively with the manganese atom in 
the catalyst thus reducing its efficiency. The benzaldehyde-derived BH adducts, 157-161 when 
subjected to conjugate addition exhibited some remarkable differences. For instance adduct 167, 
considered as the parent system appeared to give 80% yield and 53% d.e. within 20 h. On the other 
hand, the chloro-substituted adducts 168 and 169 reacted in a shorter time but exhibited lower 
diastereoselectivities of 48 and 46 % d.e., respectively. The most striking result was found in the case 
of adducts 170 and 171 with the reactions taking 22h to yield products with poor 
diastereoselectivities of 16 and 11 % d.e., respectively. This could be due to the fact that the ortho- 
nitro group might compete strongly for coordination with the catalyst, thus decreasing both reactivity 
and stereocontrol during the course of the conjugate addition.  
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2.4.    ASYMMETRIC EPOXIDATION REACTIONS 
Enantiomerically pure epoxides are key intermediates in organic chemistry because they can 
undergo stereospecific ring-opening reactions to form 1,2-difunctional compounds. These contiguous 
chiral centres have been well utilised in the preparation of biologically and pharmaceutically active 
compounds.217 The first practical asymmetric epoxidation method was discovered by Sharpless in the 
1980s. It was based on a combination of (+)- or (-)-diethyl tartarate, titanium tetraisopropoxide, and 
tert-butyl hydroperoxide acting on allylic alcohols.218 However, for the non-functionalised alkenes, 
the method was found to be unsuitable. In subsequent years the Jacobsen catalyst27 (Figure 4) was 
developed and has been used successfully in the epoxidation of non-functionalised alkenes. Since 
then further chiral manganese catalysts have continued to be reported ‒ in particular SALEN 
catalysts.219 At present, a number of  SALEN-manganese complexes are relevant in the asymmetric 
epoxidation of non-functionalised alkenes.220 Notwithstanding these achievements, we realised that 
more work is still needed to address some limitations in the substrates which can be effectively 
reacted with such catalysts.197 
In view of the performance of catalysts 139-142 in aldol reactions, it was thought worthwhile 
to explore epoxidation of non-functionalised alkenes in the hope of extending the utility of these 
modified Jacobsen complexes.  
 
2.4.1.  Method development 
  Besides the steric and electronic effects of the organic ligand and the properties of the metal, 
the most important features that affect the action of a SALEN-based epoxidation catalysts are the 
nature of the axial ligand and the choice of the co-oxidant.221 Asymmetric epoxidations are generally 
carried out in the presence of a catalytic amount of the transition-metal complex (1-10 mole %) with 
1-2 equivalents of co-oxidant and an additive to serve as an axial ligand, at temperatures ranging 
from ‒20oC to room temperature. The catalytic cycle is believed to proceed as shown in Figure 50.221 
In some cases enantioselectivity is enhanced by reacting at lower temperatures (‒78oC).222 
Commonly used solvents are dichloromethane (CH2Cl2) and acetonitrile (CH3CN), while the 
oxidants, NaOCl, H2O2, PhIO, and m-CPBA have variously been reported to be efficient.221 In the 
present study, attention was given to the reaction of trans-methylstyrene with catalysts 139-142 
using NaOCl, H2O2, PhIO, and m-CPBA under various conditions. 
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Figure  50. Catalytic cycle of alkene epoxidation using SALEN-Mn complexes.
L
 
 
2.4.1.1.  Use of sodium hypochlorite, (NaOCl) as oxidant 
 Sodium hypochlorite is widely used in organic chemistry due to its low cost and availability. It 
is commonly used as an aqueous solution and is quite stable at alkaline pH.223 Mn(III)-salen 
complexes have been reported as catalysts in a biphasic asymmetric epoxidation procedure with an 
aqueous phase containing commercial bleach and a dichloromethane solution containing the 
substrate. The catalyst loading was reported as 1-10 mole %, and reactions have been conducted at 
‒20oC- 0oC for 4h.224  
The first attempt was to test the activities of the catalysts 139-142 using trans-methylstyrene as 
a model non-functionalised alkene at different temperatures. Upon conducting the experiments at ‒20 
oC, 0oC, and 25oC, all four of the catalysts seemed to be completely inactive (Table 13). However, 
slight but very weak activity was observed at room temperature (25 oC) after 4 h, resulting in the 
formation of trace amounts of product. The presence of trace quantities of the epoxide product(s) was 
supported by the appearance of a quartet signal at 3.05 ppm and a singlet at 3.58 ppm in the 1H NMR 
spectrum due to the methine protons of the epoxide.The first assumption was that the transfer of the 
hypochlorite anion from the aqueous to the organic phase was not effective. The consequence would 
of course be inefficient donation of monooxygen to the alkene substrate. Phase-transfer catalysis 
(PTC) has been shown to address this problem in some asymmetric catalytic reactions,225 and 
therefore the experiments were repeated in the presence of 2 mole % of tetrabutylammonium 
bromide as PTC; unfortunately, no improvement in the yield was observed.  
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Table   13.  Asymmetric epoxidation of trans-methylstyrene using NaOCl(aq)  
                    at different temperatures.
Ph
CH3
NaOCl(aq), catalyst (10 mol. %)
CH2Cl2 , 4h
Ph
CH3O
172a 173a  
Catalyst  Temperature oC  Yield (%)a 
none 
 ‒20 
0 
25 
 
0 
0 
0 
139 
 ‒20 
0 
25 
 
0 
traceb 
      trace 
140 
 ‒20 
0 
25 
 
0 
trace 
trace 
141 
 ‒20 
0 
25 
 
0 
trace 
trace 
142 
 ‒20 
0 
25 
 
0 
trace 
trace 
   a  1H NMR spectroscopic analysis of the crude mixture      b 0.5 
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Addition of an axial ligand as an additive in a transition-metal mediated asymmetric 
epoxidation has been shown to improve the reaction rate as well as the selectivity. Axial ligands that 
have been well studied are nitrogenous bases and amine-N-oxides. They are normally added in a 
stoichiometric amount.226 Nitrogenous bases improve the epoxide yield by lowering the Lewis 
acidity of the transition-metal in the chiral complex, and by suppressing the undesired reaction 
pathway or by decreasing the uncatalysed epoxidation pathways. The N-oxides were also found to 
participate in transporting the active oxidant HOCl into the organic layer in aqueous NaOCl/organic 
solvent bi-phasic systems.217 However our use of three nitrogenous bases and one amine-N-oxide in 
the presence of the PTC (Scheme 47) was disappointing as only traces of the products were again 
detected by 1H NMR analysis of the crude mixture. 
 
 
 
  
Ph
CH3
NaOCl(aq),  139-142 (10 mole %)
CH2Cl2 , 25 oC, 4 h
Ph
CH3O
Bu4NBr (2 mol. %), axial ligand (1 equiv.)
Scheme  47.
Axial ligands = pyridine, imidazole, triethylamine, 
                         N- methylmorpholine-N-oxide
0.5 yield
172a 173a
 
 
The most plausible hypothesis that could be made to describe the ineffectiveness of the trial 
reactions described above has to come from the perspective of Meunier and co-workers225 that the 
role of the phase-transfer catalyst is largely to increase the hypochlorite anion concentration in the 
organic phase so that the substitution of the axial anionic ligand X by OCl- is allowed leading to the 
formation of A or B (Figure 51). Although complex (B) is the generally accepted oxygen transfer 
species in the transition-metal catalysed epoxidation reaction, we suspect that in our reactions, 
complex (A) dominated the system. Heterolytic dissociation of the oxygen-chlorine bond leads to a 
manganese (V)-oxo species (B) with a sufficiently electrophilic oxygen atom to permit transfer to the 
alkene. Incomplete oxidation of the Mn centre would thus decrease the transfer of oxygen to the 
alkene substrate.  
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Figure  51.  Proposed mechanism for metal oxidation using NaOCl.225
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2.4.1.2. Use of hydrogen peroxide, (H2O2) and tert-butyl hydroperoxide, (t-BuOOH) as 
 oxidants. 
 
Hydrogen peroxide H2O2 is an attractive oxidant in the metal-complex epoxidation of alkenes. 
This is largely due to its stability, availability, low cost, and above all, to the fact that it promotes 
“green chemistry” because it generates only water as a by-product.227 There have been a number of 
achiral and chiral catalytic epoxidation reactions reported using hydrogen peroxide as oxidant with 
fair to good activity.217 This even led to the exploration of its alkyl derivatives, notably tert-butyl 
hydroperoxide, in the hope of addressing some of the limitations encountered with the parent 
hydrogen peroxide.228 
Normally, the successful catalytic reaction is conducted using 30% aqueous H2O2, a 
nitrogenous base (imidazole or pyridine) as additive, and a mixture of CH2Cl2/CH3CN (1:1) as 
solvent at room temperature.226 Consequently, these conditions were explored in conjuction with our 
catalysts 139-142. Initial studies involved the use of trans-methylstyrene, H2O2, a nitrogenous base, 
and the catalyst in a ratio of 1: 2: 1: 0.05. Running the experiments for 24 h with periodic analysis 
revealed that, in the absence of the catalyst, traces of the epoxides could be detected in the crude 
mixtures. On the other hand, no significant conversion was achieved in the presence of the catalysts 
for the same duration. The same situation has been encountered by Battioni and co-workers,228 who 
found that the main challenges in the transition metal complex catalysed epoxidation reaction were 
the cleavage of the weak O-O bond (formation of radicals), the relative ease of dissociation, and the 
destruction of  the catalysts by H2O2. To address these problems, Battioni and co-workers228 
increased the amount of H2O2 to as high as 30 equiv, and added it gradually over the course of 24 h 
to compensate for loss of the oxidant. Unfortunately, application of this approach did not improve the 
conversion in our case (Table 14).  
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Another factor that enhances activity is the nature of the additive. Pietikainen demonstrated 
that the use carboxylate salts as additives in manganese-SALEN complex catalysed epoxidation226 of 
alkenes surpasses the performance of nitrogenous bases in improving the yield and selectivity. 
Therefore, we decided to explore this by using ammonium acetate, ammonium oxalate, and sodium 
acetate with CH2Cl2/CH3OH as solvent to ensure proper solubility (Scheme 48).227 The results, 
however, showed that there was no significant difference compared to the use of a nitrogenous base. 
It seems that destruction of the catalysts due to the dissociation of H2O2 cannot be overcome.   
 
Table 14.  Asymmetric epoxidation of trans-methylstyrene using 30% H2O2 (30 equiv.)      
                   in the presence of additive.
Ph
CH3
30 % H2O2 (30 equiv.), catalyst (5 mole %)
CH2Cl2/CH3CN , 25 oC, 24 h
Ph
CH3O
 additive (1 equiv.)
172a 173a  
 
Catalyst Additive Yield (%)a 
none 
Pyridine 
Imidazole 
traceb 
trace 
139 
Pyridine 
Imidazole 
2 
2 
140 
Pyridine 
Imidazole 
1 
1 
141 
Pyridine 
Imidazole 
1 
1 
142 
Pyridine 
Imidazole 
1 
1 
              a  As determined by 1H NMR spectroscopic analysis of the crude mixture   
 b 0.5% 
  
 
 
 
 
88 
 
 
 
Ph
CH3
30% H2O2 (30 equiv.),  139-142 (5 mole %)
 CH2Cl2/CH3OH, 25 oC, 24 h
Ph
CH3O
 carboxylate additive (1 equiv.)
Scheme  48.
carboxylate additive =  ammonium acetate, ammonium oxalate,
                                       sodium acetate
0.5 yield
172a 173a
 
 
Since 100% H2O2 is not readily available and is dangerous to use, generating anhydrous 
hydrogen peroxide in situ was considered, so that the high concentration of the oxidant might 
suppress the effect of the apparently excessive loss of the H2O2. Urea-hydrogen peroxide adduct 
(UHP) has been widely used as a safer source of anhydrous hydrogen peroxide in many oxidation 
processes. The substance exists as white crystals, which can be prepared by heating a solution of urea 
in 30% hydrogen peroxide in the molar ratio 2:3 at about 60oC. It has been found to be a stable 
addition compound with composition CO(NH2)2H2O2.229,230 Highly polar solvents, such as 
methanol, have an important role in the dissociation of UHP thereby releasing the active H2O2 into 
the reaction medium.229 Thus, oxidation reactions conducted in non-polar solvents tend to give 
products in low yield. Bagherzadeh et al.229 studied the catalytic activity of two manganese (III) 
oxazoline complexes using UHP as oxidant, and achieved an epoxide yield as high as 95%, while 
enantioselective epoxidation of non-functionalised alkenes was achieved by Kureshy and co-
workers230 using Mn(III) complexes and UHP as oxidant. Selectivity of 100% e.e. was achieved 
using just 1 mol. % of the catalyst. The catalytic conditions employed by these workers have been 
reported to involve the use of 20 equiv. of UHP in the presence of a nitrogenous base as additive and 
CH2Cl2/CH3OH as solvent. It was therefore decided to examine use of these conditions in our study 
(Scheme 49). Disappointingly, only traces of products were observed in the 1H NMR spectra of the 
crude reaction mixtures.  
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Ph
CH3
UHP (20 equiv.), 139-142 (5 mole %)
 CH2Cl2/CH3OH, 25 oC, 24 h
Ph
CH3O
 additive (1equiv.)
Scheme  49.
Additive = pyridine, imidazole, ammonium acetate,
                  ammonium oxalate, sodium acetate
<0.5% yield
172a 173a
 
 
Achiral and chiral epoxidation of non-functionalised alkenes, catalysed by transition-metal 
complexes and using tert-butyl hydroperoxide (70 % wt. in water) as oxidant have also been 
reported. In these cases, the reactions were conducted without the need of additive.231,232 It was 
therefore decided to explore the use of tert-butyl hydroperoxide (t-BuOOH) as a last resort in the 
hydroperoxide series of oxidants (Scheme 50). The expectation was that the bulkiness of the tert-
butyl group might confer a measure of stability on the transition-state complex and thus prevent or 
minimise the effect of the dissociation of the oxidant. However, t-BuOOH did not prove to be an 
efficient oxidant either yielding only trace amounts of products, and we concluded that hydrogen 
peroxide and tert-butyl hydroperoxide were not suitable oxidants for use with the ketopinic acid-
Mn(III) complexes 139-142.  
 
Ph
CH3
t-BuOOH, 139-142 (5 mole %)
 CH2Cl2/CH3OH, 25 oC, 24 h
Ph
CH3O
Scheme  50.
<0.5% yield
172a 173a
 
 
2.4.1.3.  Use of iodosylbenzene (PhIO) as oxidant 
Structurally, iodosylbenzene is proposed to be a polymeric substance (174).233 A large number 
of related iodine(III) compounds of the forms PhI(X)Y (175) and O[(IPh(X)]2 (176) are also 
available. These compounds have shown promise in many organic reactions, with the iodine 
behaving as an electrophilic centre (Figure 52).233  
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174 175 176
Figure  52.  Iodine (III) oxidants.  
  
      
Since iodosylbenzene 174 has been shown to be a mild oxidant and less likely to destroy the 
catalysts, it was decided to explore its use with catalysts 139-142. Iodosylbenzene and other 
iodosylarenes were, in fact, the first oxidants reported to effect alkene epoxidation in the presence of 
achiral or chiral metal complexes.234 Although iodosylbenzene has the disadvantages of high cost, 
low oxygen content, low solubility, and instability, many excellent catalytic epoxidation reactions 
have been developed using it. Notable amongst them is the pioneering work of Jacobsen and co-
workers27 and Katsuki and co-workers.28 Generally, the reaction is conducted at room temperature in 
either dichloromethane or acetonitrile with a catalyst loading of 2-4 mole % for 1-58h.235,236 The 
choice of solvent affects the ratio of the substrate to the oxidant. When using dichloromethane, 
substrate:oxidant ratios of 32:1 and 10:1 have been reported.236 The ratio is lower when acetonitrile is 
used as the solvent (substrate:oxidant :: 2:1); this is apparently due to the coordinating property of 
acetonitrile. However, the use of additive was found to be of paramount importance in improving the 
epoxide yield.236 In order to explore the performance of catalysts 139-142 with PhIO, the conditions 
were used as indicated in Table 15.  
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Table 15.  Asymmetric epoxidation of trans-methylstyrene using 30 equiv.
                   PhIO
Ph
CH3
PhIO (1 equiv.), catalyst (5 mole %)
 CH2Cl2, 25 oC, 48 h
Ph
CH3O
172a 173a  
 
Catalyst Yield (%)a 
None traceb
139 2
140 2
141 2
142 2
             a  Determined by the 1H NMR spectroscopic analysis of the crude mixture.  
           b 0.5%  
 
As shown in Table 15, the yields were still very low, and it was decided to increase the catalyst 
loading to 10 mole %. Once more the yields were found to be around 2%. However catalysts 139 and 
142 exhibited a slight improvement in performance (Table 16). This could be due to better 
accessibility of the manganese centre in 139 and, in the case of 142, the phenyl linker might have 
experienced some π-π interaction with the phenyl group of the substrate. Attention was then turned to 
the use of acetonitrile which offered potential advantages in that a lower substrate:catalyst ratio is 
required and because PhIO shows improved solubility in this solvent. Using acetonitrile as solvent, 
the normal substrate:oxidant ratio (2:1) was used, and some improvements were observed with 
respect to catalysts 139 and 142 (Table 16). Since the use of additive (10 equiv.) is reported to 
improve the yield when acetonitrile is used as the solvent, the next attempt was to test the effect of 
the common additives viz., imidazole, pyridine and pyridine-N-oxide.235 The yields obtained showed 
that the use of additives did not improve the activity of the catalysts enough to make this a practical 
approach (Table 17). To account for all the failures encountered with PhIO as oxidant, it was 
necessary to examine the transition state of the catalytic cycle to establish why iodosylbenzene did 
not prove to be compatible with catalysts 139-142.  
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Table 16.  Asymmetric epoxidation of trans-methylstyrene using 2 equiv. PhIO
Ph
CH3
PhIO, catalyst (10 mole %)
 CH3CN, 25 oC, 48 h
Ph
CH3O
172a 173a  
Catalyst Yield (%)a  
None traceb  
139 5  
140 2  
141 2  
142 4  
      a Determined by the 1H NMR spectroscopic analysis of of the crude mixture.  b 0.5% 
 
Table 17.  Asymmetric epoxidation of trans-methylstyrene using 2 equiv. PhIO in  
                   the presence of an additive.
Ph
CH3
PhIO, catalyst (10 mole %)
additive (10 equiv.)
 CH3CN, 25 oC, 48 h
Ph
CH3O
172a 173a  
Catalyst Additive Yield (%)a 
None 
Imidazole 
Pyridine 
Pyridine-N-oxide 
1 
1 
1 
139 
Imidazole 
Pyridine 
Pyridine-N-oxide 
6 
8 
7 
140 
Imidazole 
Pyridine 
Pyridine-N-oxide 
3 
4 
6 
141 
Imidazole 
Pyridine 
Pyridine-N-oxide 
3 
3 
7 
142 
Imidazole 
Pyridine 
Pyridine-N-oxide 
5 
7 
5 
 a Determined by the 1H NMR spectroscopic analysis of the crude mixture. 
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It is generally agreed that in Mn(III)-SALEN catalysed epoxidation using an oxygen source, 
the reactive intermediate is an oxomanganese(V) species (Eq. 1; for PhIO), which is generated by the 
donation of oxygen to the catalyst. The oxygen atom thus becomes highly electrophilic and can 
easily be transferred to the approaching electron-rich alkene as shown in Eq. 2.234 However, the 
active oxomanganese(V) species is capable of readily coupling with Mn(III)-SALEN to afford the µ-
oxo-bismanganese(IV) complex (Eq. 3), which is  inactive towards the alkene. As illustrated in 
Equation 3, the process is reversible. Thus, if the alkene accepts an oxygen from oxomanganese(V), 
the µ-oxo-bismanganese(IV) can disproportionate, thereby producing more of the active 
intermediate. 
 
 
C CO=Mn(V)(SALEN)+ +
O
C C +
- (2)
(SALEN)Mn(III) + O=Mn
V(SALEN)+ - (1)
O=Mn(V)(SALEN)+ + (SALEN)Mn(IV)OMn(IV)(SALEN)
2+ - (3)
PhIO
(SALEN)Mn(III)
-PhI
(SALEN)Mn(III)
 
 
In the cases of our catalysts 139-142, it may be suggested that the equilibrium lies in favour of 
the corresponding inactive µ-oxo-bismanganese(IV) complex. This could result in the domination of 
the entire catalytic system by the unwanted and inactive species and consequently, the alkene cannot 
abstract sufficient oxygen for the epoxidation to take place to any significant extent. 
 
2.4.1.4.  meta-Chloroperbenzoic acid (m-CPBA) as oxidant 
Peroxyacids are commonly used in the laboratory to perform various oxidation reactions. 
Among these, m-chloroperbenzoic acid is often employed in the epoxidation of alkenes — a reaction 
named after Prileschajew,237 its discoverer. The availability, stability and ease of handling makes m-
chloroperbenzoic eminently suitable for this reaction.238 The epoxidation of alkenes with m-CPBA is 
usually carried out by mixing the reactants in CH2Cl2 or CHCl3 at room temperature.238 In solution, 
m-CPBA tends to adopt an intramolecularly hydrogen-bonded conformation. This results in a high 
degree of polarisation which leads to an electrophilic oxygen atom that is able to add to the alkenes. 
The uncatalysed reaction is considered likely to proceed via a transition-state known as the 
“Butterfly transition-state”, in which the electrophilic oxygen adds to the carbon-carbon double bond  
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and the proton simultaneously migrates to the carbonyl oxygen of the acid to afford the epoxide and 
m-chlorobenzoic acid (Scheme 51). 
 
Scheme  51.
Cl
O
O O
H
Cl
O
O H
+
O
Cl
O O
HO
"Butterfly transition state"
Alkene
m-CBA
Epoxide
m-CPBA
 
 
 Epoxidation of various non-functionalised alkenes using m-CPBA has been shown to proceed 
with higher enantioselectivity than those conducted in the presence of NaOCl.222 Thus, Jacobsen and 
co-workers have effected epoxidations at ‒78oC using m-CPBA and the additive, N-
methylmorpholine-N-oxide (NMO).222 It was therefore decided to use m-CPBA in the presence of 
catalysts 139-142 at 0oC to epoxidise trans-methylstyrene as a model substrate, and NMO as 
additive.222 The uncatalysed reaction furnished negligible epoxides within the longest duration (16 h) 
and 1H NMR spectroscopic analysis of the crude products showed no increase in the products beyond 
the times indicated for the catalysed reactions (Table 18). For the catalysed reactions, moderate to 
good yields were obtained, providing sufficient cause to assess the enantioselectivity of the reaction 
(Table 18). 
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Table 18.  Asymmetric epoxidation of trans-methylstyrene using m-CPBA        
                       in the presence of NMO as Additive.
Ph
CH3
m-CPBA, catalyst (5 mole %)
 CH2Cl2 , 0o C
Ph
CH3O
NMO (5 equiv.)
172a 173a  
Catalyst Time (h) Yield (%)a E.e. (%)b 
none 16 7 - 
139 3 30 32 
140 16 39 13 
141 11 40 15 
142 9 70 11 
                 a Isolated yields 
                 b Determined by the 1H NMR spectroscopic analysis of the isolated products 
       in the presence of Eu(hfc)3 
 
The values obtained by integrating selected proton signals for the respective enantiomers (I1-I2) 
in the presence the chiral shift reagent, europium tris[3-(heptafluoropropylhydroxymethylene)-(+)-
camphorate] abbreviated as Eu(hfc)3 were substituted into the following equation to calculate the % 
e.e.239  
    
   I1-I2   
    I1+I2 
    I1  I2 
As shown in Table 18, the enantioselectivity appears to be poor. Since low temperatures are 
reported to improve selectivity, the experiments were repeated at -78oC. Unfortunately, no significant 
change in the enantioselectivity was observed at the lower temperature. 
The method used to calculate the enantioselectivity can be illustrated using the 1H NMR data 
for the trans-methylstyrene epoxide obtained in the presence of catalyst 139. The 1H NMR spectrum 
(Figure 53) shows the relevant signals prior to the addition of the chiral shift reagent, i.e. Eu(hfc)3.  
× 100 
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The methyl protons resonate as a doublet (at 1.47 ppm) which reflects the coupling with the 
neighbouring proton (H-2), which resonates, in turn, as a quartet at 3.05 ppm. The H-1 proton 
resonates downfield (3.58 ppm) due its proximity to the phenyl group and does not appear to couple 
with H-1. The aromatic protons are responsible for the series of multiplets within the range 7.28-7.37 
ppm. 
Since a cluster of signals will arise from the presence of the chiral shift reagent, it was decided 
to record the 1H NMR spectrum of Eu(hfc)3 separately. This assisted in unambiguous identification 
of the relevant trans-methylstyrene epoxide signals. Consequently, three 1H NMR spectra were 
recorded as a means of establishing a method of evaluating the enantioselectivity of epoxide 
formation (Figures 54, 55 and 56).  
 
 
 
 Figure  53. 400 MHz 1H NMR spectrum of trans-methylstyrene oxide in CDCl3. 
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               Figure  54. 400 MHz 1H NMR spectrum of Eu(hfc)3 in CDCl3. 
 
    Figure  55. 400 MHz1H NMR spectrum of racemic trans-methylstyrene oxide  
            in the presence of Eu(hfc)3 in CDCl3. 
 
 
 
             Figure  56. 400 MHz1H NMR spectrum of a mixture of enantiomerically-enriched trans- 
          methylstyrene oxide, produced by the catalysed 139 in the presence of Eu(hfc)3  
          In CDCl3. 
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 Prior to the addition of the chiral shift reagent, the epoxide methyl signal appears as a well 
resolved doublet in the spectrum of racemic trans-methyl styrene oxide (Figure 53). In the presence 
of the chiral shift reagent, a separation of the methyl signals (corresponding to the two enantiomers) 
into two doublets was observed (Figure 55). However, the epoxide methyl signals overlap signals 
corresponding to the chiral shift reagent, whereas the epoxide methine signals appearing in the range 
4-5 ppm, do not. Consequently, the relative integrals of the pair of methine signals (a and b) were 
used to calculate % e.e. 
The next spectrum (Figure 56) is that of the trans-methylstyrene epoxide obtained following 
m-CPBA oxidation in the presence of catalyst 139. The two pair of methine signals corresponding to 
the two enantiomers can be seen at 3.99 and 4.60 ppm and the % e.e. — reflecting the 
enantioselectivity of the reaction can be calculated as follows. Although the enantioselectivity is low, 
no further optimisation was attempted since the optimisation of the yield had already proved 
challenging. 
 
 
Calculation: 
    
   Ia-Ib        x  100   =  2.94-1.52   =  1.42     =  32%  e.e.       
    Ia+Ib            2.94+1.52       4.46 
    
  Where Ia and Ib are the relative integrals for the pairs of signals a and b 
 
2.4.2.  Exploration of substrate scope of m-CPBA epoxidation 
A range of other alkenes were subjected to the m-CPBA-mediated epoxidation to assess 
substrate effect on the catalytic systems 139-142 (Table 19). Enantiomeric excess was determined in 
each case using integral data from appropriate product signals, following addition of the chiral shift 
reagent, Eu(hfc)3. 
 
 
 
 
% e.e. = 
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           Table 19.  Results of asymmetric epoxidation of different alkenes using m-CPBA in the 
       Presence of catalysts 139-142.    
Substrate Catalyst Time (h) Epoxide Yield (%)a E.e (%)b 
Ph
CH3
172a
139 
140 
141 
142 
3 
16 
11 
9 
Ph
CH3O
173a
30 
39 
40 
70 
32 
13 
15 
11 
Ph
172b  
139 
140 
141 
142 
1 
12 
12 
10 
Ph O
173b  
72 
100 
100 
100 
33 
15 
17 
13 
Ph
Ph
172c  
139 
140 
141 
142 
3 
16 
12 
9 
Ph
PhO
173c  
57 
23 
25 
90 
28 
13 
12 
11 
PhPh
172d  
139 
140 
141 
142 
3 
16 
17 
9 
PhPh
O
173d  
39 
19 
22 
87 
-c 
-c 
-c 
-c 
172e  
139 
140 
141 
142 
1 
12 
13 
10 
O
173e  
72 
100 
100 
100 
23 
13 
11 
10 
a In the case of 100% yield, the 1H NMR spectrum  of the crude mixture did not show any starting    
material or unwanted product; hence, the products were analysed without further purification. Otherwise 
the yields were for isolated products.  b Determined by 1H NMR spectroscopic analysis of the isolated 
products in the presence of Eu(hfc). c The product in this case is not chiral. 
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Generally the % enantiomeric excess of the epoxides obtained ranged from 10-32% e.e., but 
the yields for the various substrates were significantly better than those obtained with trans-
methylstyrene. The decreased nucleophilicity of the alkene moiety in the stilbenes 172c and 172d 
may be due to delocalisation of alkene π-electrons into the  two phenyl rings. It is perhaps significant 
that catalyst 142 gave the best yields (87-100%) in all five cases. 
The Jacobsen catalyst is reported to produce a mixture of cis- and trans-epoxides from cis-
alkenes, and this phenomenon has led to many mechanistic investigations to establish its cause.219  In 
this study, cis-stilbene was included in order to check if the same result would be observed. It was 
found that in the presence of each of the four catalysts, the reactions of cis-stilbene all gave a single 
product. 
In the case of Mn(III)-SALEN complex, the framework is built from two planar 
salicylaldehyde units (Figure 4). The active oxomanganese(V) intermediate is also believed to 
maintain that planarity,217 thus ensuring that the approaching alkene abstracts the oxygen in close 
proximity to the chiral centres, and hence achieving chiral induction. However, catalysts 139-142 are 
composed of two ketopinic acid units. The difference is that the camphor skeleton is not planar like 
SALEN, and we suspect that the distortion of each of the oxo-manganese(V) species is such that all 
the chiral centres may be too far away to influence the approach of the alkene.  
 
2.5.    ASYMMETRIC REDUCTION REACTIONS 
 The term reduction in Organic Chemistry often implies the addition of hydrogen to an sp2 
centre. This encompasses the conversion of unsaturated bonds like C=C, C=O, and C=N to the 
corresponding saturated CH-CH, CH-OH, and CH-NH bonds respectively.3 In this study, we have 
aimed to explore the catalytic asymmetric reduction of ketones (C=O) and imines (C=N) to their 
corresponding alcohols and amines. Many of these reactions have been utilised industrially in the 
production of enantiomerically enriched amino acids, flavour and fragrance materials, 
pharmaceuticals and agrochemicals, all of which are highly valued.4 
 
2.5.1.   Asymmetric reduction of ketones 
Direct catalytic hydrogenation or metal hydride reduction can generally be used to achieve the 
reduction of carbonyl compounds, in particular, ketones. However, reduction of carbonyl compounds 
by catalytic hydrogenation may not be chemoselective let alone stereoselective. This means that 
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other co-existing functional groups such as C=C bonds may also undergo hydrogenation.4 Metal 
hydrides, such as borane (BH3), lithium aluminium hydride (LiAlH4), and sodium borohydride 
(NaBH4), are considered to be appropriate reagents that offer a chemoselective reduction for polar 
bonds. Borane-tetrahydrofuran (BH3THF) and borane-dimethyl sulphide (BH3DMS) have been 
reported as sources of borane for the achiral and chiral reduction of ketones; BH3THF has attracted 
more interest than BH3DMS due to the unpleasant odour of the latter. Both reagents, however, suffer 
from instability.240 LiAlH4 is a powerful reductant, and attempts to fine tune its reactivity by 
replacing the hydrogen atoms with alkoxy groups has been shown to result in a decline in both 
reactivity and selectivity.241  
The use of NaBH4 in the reduction of prochiral ketones offers some advantages over other 
reducing agents, in view of its stability, ease of handling and relatively low cost. Some catalytic 
systems based on chiral transition metal complexes have already been reported for the effective 
reduction of prochiral ketones in the presence of NaBH4,242-245 but its use in the reduction of 
prochiral ketones clearly deserves more attention. The catalytic reaction is normally carried out in 
CHCl3 at 0o C, ‒20 oC or room temperature for 12-24 h. Use of ethanol as an additive (4 equiv. with 
respect to NaBH4) is found to increase both the chemical yield and selectivity.245 In our study, we 
have explored the use of NaBH4 in conjuction with each of the manganese(V) catalysts 139-142.  
 
 
2.5.1.1.  Method development for the use of NaBH4 in the reduction of ketones 
   Reduction of acetophenone at two different temperatures, (-20 oC and 0 oC-room 
temperature) in CHCl3 using NaBH4 (4 equiv.) in the presence of ethanol was studied using each of 
the catalysts with a loading of 10 mole % (Table 20). The progress was monitored regularly during 
24 h. After quenching the reaction with saturated ammonium chloride, and extraction with diethyl 
ether, the crude mixture was purified on silica (hexane:ethyl acetate :: 3:1) to afford 1-phenylethanol 
in the yields of only 2-9% (Table 20). 
 
 
 
 
 
102 
 
                     
Table  20.  Asymmetric NaBH4 reduction of acetophenone      
                 at different temperatures
O OHNaBH4, 139-142 (10 mole %)
EtOH (4 equiv.)
CHCl3 , 20oCor 0oC-rt, 24h
174a 175a  
 
Catalyst Temperature (oC) Yield (%)a 
none 
139 
140 
141 
142 
‒20 
‒20 
‒20 
‒20 
‒20 
2 
5 
4 
3 
5 
none 
139 
140 
141 
142 
0 - rt 
0 - rt 
0 - rt 
0 - rt 
0 - rt 
6 
9 
8 
8 
7 
             a Determined by 1H NMR spectroscopic analysis of the crude reaction mixture. 
 
While the lowest yield (2%) was obtained for the non-catalysed reaction, it can be seen that 
there was very little improvement in the yield in the catalysed reactions. Even when the reactions 
were left to continue for 48 h, no increase in product formation was observed.With regular 
monitoring of the reaction progress during the first 24 h, it was found that the reactions were affected 
by temperature change, in that yields more or less doubled when the reaction were conducted at 0 oC-
room temperature. The use of ethanol as an additive seemed to significantly influence the non-
catalytic pathway, since when the quantity of ethanol was increased, the product was obtained in 
50% yield in the absence of the catalysts! 
The role of the additive is to activate the NaBH4 to facilitate hydride donation. In some papers, 
a combination of two primary alcohols has been reported.245 Thus, both the chemical yield and 
selectivity can be significantly improved.245 Structurally, NaBH4 undergoes modification in the 
presence of the 2-propanol as shown in Scheme 52. It was anticipated that 2-propanol (i-PrOH) could 
provide a dual advantage of basicity and steric bulk. It has been reported that 4 and 14 molar 
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equivalents of the additive have been most often added with respect to the NaBH4,243,244 and are 
explored using the 4, 7, and 14 equivalents of 2-propanol at room temperature (Table 21). 
 
NaBH4 + Na+
Scheme  52.
B H
H
H
-
+ H2
OH
O
 
 
Table  21.  Asymmetric NaBH4 reduction of acetophenone      
                   using i-PrOH as an additive.
O OHNaBH4 , catalyst (10 mole %)
CHCl3 , rt , 24 h
i-PrOH
174a 175a  
Catalyst i-PrOH, equivalents Yield (%)a 
None 4 
7 
14
6 
8 
9
139 4 
7 
14
25 
99 
100 
140 4 
7 
14
21 
88 
90
141 4 
7 
14
22 
85 
86
142 4 
7 
14
12 
51 
53
             a For the catalysed reactions, the % yield corresponds to the isolated products. In the  
                event of 100% yield, no starting material was detected in the crude products and,  
                hence, no further purification was carried out. 
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In the event, i-propanol proved to be an effective additive for the catalytic conversion of 
acetophenone to the corresponding chiral alcohol, 1-phenylethanol. In particular, the use of 7 or 14 
equivalents of the NaBH4 appeared to furnish similar levels of conversion, and the selectivities of 
reactions conducted using 7 equivalents of i-PrOH were therefore evaluated by HPLC analysis using 
a chiral (Phenomenex, lux 5u cellulose-2) column.  Low to good selectivities were achieved for 
catalysts 139 and 140, but no asymmetric induction was observed for catalysts 141 and 142 (Table 
22).  
Table  22.  Enantioselectivity of NaBH4 reduction of                
                 acetophenone using i-PrOH (7 equiv.)
O OHNaBH4 , catalyst (10 mole %)
CHCl3 , rt , 24 h
(7 equiv.)i-PrOH
174a 175a  
Catalyst Yield (%)a E.e. (%)b 
139 99 68 
140 88 33 
141 85 0 
142 51 0 
                                      a Isolated product. 
      b Determined by chiral HPLC (Lux 5u Cellulose-2, Phenomenex).  
     
 
The 1H NMR analysis unambiguously confirmed the conversion of acetophenone to 1-
phenylethanol (Figure 57), and the relevant signals were assigned without difficulty. Thus, the 
methyl signal (CH3) appears as a doublet due to the coupling with the vicinal methine (CH) proton 
which, in turn, resonates as quartet. The hydroxyl (OH) signal appears at 2.34 ppm, and the aromatic 
protons (Ph) resonate as a multiplet at 7.38-7.47 ppm. Racemic 1-phenylethanol was analysed first to 
ascertain the retention times for the two enantiomers. The chromatograms for a sample of the product 
obtained from the reduction of acetophenone in the presence of catalyst 139 are illustrated in Figures 
58 and 59. As described in the case of the aldol reaction, each of the 1-phenylethanol peaks was 
exported to the SigmaPlot (2001) programme and deconvoluted to obtain the total area under each 
peak . The peak integral ratios obtained give the enantiomeric excess in each case.200 
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Figure 57. 400 MHz 1H NMR spectrum of 1-phenylethanol in CDCl3. 
   
 
 
Figure  58. HPLC chromatogram of the racemic mixture of 1-phenylethanol, using a chiral 
        column and eluting with hexane:2-propanol (9:1). 
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Figure 59. HPLC chromatogram of the 1-phenylethanol formed in the presence of catalyst  
                  139, using a chiral column and eluting with hexane:2-propanol (9:1). 
 
2.5.1.2.  Exploration of substrate scope 
 Reaction conditions established using acetophenone, NaBH4 (1 equiv.), catalyst (10 mole %), 
i-PrOH (7 equiv.), and CHCl3 as solvent at room temperature for a duration of 24 h was taken as 
optimal, and reactions of different aryl ketones were examined to evaluate the role of electronic and 
steric factors on chemical yield and stereoselectivity. Comparison of the results summarised in Table 
23 show that the structure of the ketones indeed influence the outcome of the reaction. 
The ketone substrates, with the exception of 4-hydroxyacetophenone, gave excellent yields 
with all of the catalysts. The complete unreactivity of 4-hydroxyacetophenone 174c under these 
conditions may be due to strong competition between the hydroxyl (OH) and carbonyl (C=O) 
oxygens for coordination with the metal centre of the catalysts. It is presumed that actual 
coordination to carbonyl oxygen is necessary to activate the C=O group to nucleophilic attack. 
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          . Table 23.  Asymmetric NaBH4 reduction of selected aryl ketones under optimised conditions. 
Substrate Catalyst Alcohol Yield (%)a E.e. (%)b 
Ph
O
174a  
139 
140 
141 
142 
Ph
OH
175a  
99 
88 
85 
51 
68 
33 
0 
0 
Ph
O
Cl
174b  
139 
140 
141 
142 
Ph
OH
Cl
175b  
100 
100 
96 
93 
13 
11 
0 
0 
HO
O
174c
139 
140 
141 
142 
HO
OH
175c  
0 
0 
0 
0 
- 
- 
- 
- 
O
174d  
139 
140 
141 
142 
OH
175d  
99 
100 
94 
51 
11 
9 
0 
0 
O
OH
174e  
139 
140 
141 
142 
HO
OH
175e  
99 
99 
90 
99 
14 
12 
0 
0 
 a  Isolated product. In the event of 100 % yield, no starting materials were detected in the 1H NMR    
spectrum of the crude product and, hence, no further purification was done. b Determined by chiral 
HPLC (Lux 5u Cellulose-2, Phenomenex). 
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Examination of the results (Table 23), reveals excellent yields but disappointing 
enantioselectivites. It is generally assumed that the C=O group in the substrate coordinates to the Mn 
centre in the catalytic complex thus activating the carbonyl carbon towards nucleophilic attack by the 
hydride ion. The C=O changes to a CH-OBH3 moiety, which experiences further reaction with i-
PrOH to give the secondary alcohol CHOH group. Thus, in the absence of mirror symmetry in the 
transition-state of the complexes (Figure 60), the orientation of the substrate and approach of the 
reducing agent will be determined by the inherent chirality of the ligands.  It seems that our ligands 
are sufficiently bulky to control the approach of the hydride ion. 
 
 
N NO
O
O
O
Mn
Cl
R2R1
O
Figure  60.  Putative transition-state complex involved in the asymmetric reduction of ketone 
                     in the presence of 139.
H BH2

 
 
 
2.5.2.   Asymmetric Imine Reduction 
 Chiral amines are commonly found in a variety of bioactive molecules, including alkaloids, 
peptides, pharmaceuticals and agrochemicals.246 This has sparked off interest in the development of 
catalytic stereoselective processes for the preparation of enantiomerically enriched amines. Of 
particular note are enantioselective hydrogenation, transfer hydrogenation, hydrosilylation, and 
borane reduction of imines.3 
Generally there are two basic synthetic methods employed in the preparation of amines. One is 
reductive amination, which is termed a direct reaction. This method involves the conversion of the 
carbonyl functionality (C=O) into an amino group (NH2) by directly treating a mixture of the 
carbonyl compound and another amine with an appropriate reducing agent in one pot without 
necessarily pre-forming an imine or iminium intermediate (Scheme 53a). The other is referred to as  
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an indirect reaction because it involves the pre-formation of an imine intermediate followed by 
reduction to the derived amine compound (Scheme 53b).247  
 
 
Scheme  53.
R1 R2
O
+ H2NR3
R1 R2
NHR3reducing agent
R1, R3 = alkyl, aryl, or heterocyclic
R2 = H, alkyl, aryl, or heterocyclic
(a)
R1 R2
O
+ H2NR3
R1 R2
NR3
R1 R2
NHR3
reducing agent
R1 R2
NHR3
(b)
R1, R3 = alkyl, aryl, or heterocyclic
R2 = H, alkyl, aryl, or heterocyclic
 
 
Notwithstanding the success of the reported enantioselective methods, there have been recent 
attempts to develop better methods which utilise more selective and environmentally benign reagents 
together with chiral metal complexes.247 One of those reagents is sodium borohydride, NaBH4. The 
use of NaBH4 in the reduction of ketones has been demonstrated with some success using our 
catalysts 139-142. It was therefore intended to further explore its application in the enantioselective 
synthesis of chiral amines. Normally the direct reaction involves use of a Brønsted acid as an 
activator247 but, due to the destructive tendency of acids on these catalysts, it was decided to follow 
the indirect path. Consequently, -tetralone 174d was treated with various amines to afford the 
corresponding imines (Scheme 54). The instability of the imines as Schiff bases was also taken into 
consideration and, after extracting them from the crude mixtures, no chromatographic purification 
was undertaken. The formation of the imine was confirmed by IR analysis which indicated the 
absence of the ketone C=O band at 1750 cm-1 and the presence of the C=N band at 1680 cm-1. 
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It has been reported that the reaction conditions employed in the ketone reduction have also 
proved to be efficient for the reduction of imines.243 Therefore, the reaction conditions used earlier 
[NaBH4 (1 equiv.), catalyst (10 mole %), i-PrOH (7 equiv.), CHCl3, 24 h] were applied to -tetralone 
as a model ketone. The choice of different amines, viz., propylamine, aniline, and benzylamine, was 
guided by the desire to explore steric effects on the reaction. Unfortunately the reaction conditions 
appeared to be unsuitable as no reduction was achieved (Scheme 54), and the imines were recovered 
intact. 
 
NR
NHR
i-PrOH (7 equiv.)
CHCl3, rt, 24 h
   CH3CH2CH2
    Ph
    PhCH2
Scheme  54.
NaBH4, 139-142(10 mol. %)O
R
a
b
c
RNH2
EtOH, 
reflux
174d
176a-c
177a-c 178a-c
 
 
The failure of these reactions did not come as a complete suprise, because Nakagawa and co-
workers have reported similar results when they subjected their imines to reaction conditions that had 
been successfully applied to the corresponding ketones. They suggested that the low electrophilicity 
of the C=N group compared to C=O was partly responsible for the lack of the reactivity.248 A 
literature survey revealed that successful imine reductions catalysed by chiral transition metal 
complexes were normally carried out in THF.246, 247, 249-251 Therefore, as a last resort, it was decided 
to run the trial experiments in THF at room temperature. Beginning with the non-catalysed version in 
control experiments, it was found that the imine was completely reduced (Table 24) to the 
corresponding amines. Given the success of the non-catalysed reactions, we concluded that these 
would compete significantly with the catalysed versions.  
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NR NHR
THF, rt, 24 h
O RNH2
EtOH, 
reflux
NaBH4
Table  24.  Reduction of N-substituted imines using NaBH4.
174d
176a-c
177a-c 178a-c  
Compound R Yield (%) 
178a 
178b 
178c 
CH3CH2CH2 
Ph 
PhCH2 
100 
100 
100 
 
 
2.6.   EXPLORATORY STUDIES ON CATALYST IMMOBILISATION  
 It can be rightly asserted that the field of asymmetric catalysis is dominated by homogeneous 
catalysis despite their cost and the difficulties involved in their separation from the reaction mixture 
and subsequent recycling. The desire to address some of those limitations has resulted in progress in 
the development of stereoselective heterogenous catalysts.252 Heterogeneous catalysis has the 
potential advantages of easy separation, efficient recycling, and the minimisation of metal traces in 
the product. There are also improved handling and process control issues that could, in principle, 
result in an overall reduction of costs and waste.253 
The fundamental requirement in developing a heterogenous catalyst from a homogenous 
catalyst is immobilisation of the homogeneous catalyst onto an appropriate support. Such 
immobilisation may involve covalent or non-covalent attachment of the ligand, the metal, or the pre-
assembled complex onto the support.254 Covalently immobilised chiral catalysts can be prepared by 
linking a part of the catalyst to a polymer anchored moiety by co-polymerising suitable monomers to 
introduce the chiral information into the backbone of the heterogeneous catalyst. Caution must 
always be excercised, however, to ensure that the active site of the catalyst is not blocked by the 
polymeric structure.255 Chiral homogenous catalysts have been covalently linked to inorganic 
materials such as zeolites or other mesoporous materials,254 the rigid structures of which prevents 
aggregation of the active catalysts. Although from one perspective the insolubility of inorganic 
materials in organic solvents may be utilised by employing them as the stationary phase in a 
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continuous process, the fact that they do not swell by absorbing solvent could result in blockage of 
the catalystic sites located within the matrix of the support.256 
Non-covalent immobilisation relies on simple physi-sorption of a chiral ligand or metal ligand 
complex on a support through Van der Waals interactions. Such immobilisation might involve 
adsorption or electrostatic interaction, but a major drawback of this approach is that the catalyst is 
weakly bound to the support and hence readily leached into solution.253 An effective approach was 
recently developed which involves the immobilisation of a homogeneous chiral metal complex by 
coordination.257 The advantage is that no modification of the chiral ligand is necessary, thus allowing 
the structure of the active chiral complex to be preserved.257 The immobilisation of chiral catalysts 
on a polymeric scaffold has become a favourable option since the pioneering work of Merrifield on 
solid-phase peptide synthesis in the 1960’s.258 The Merrified resin (chloromethylated polystyrene) is 
now the most widely used polymer support in chiral heterogeneous catalysis. 
Our aim was to incorporate catalysts 139-142 onto the Merrifield resin by adopting the non-
covalent immobilisation approach. A nitrogenous base (imidazole) would be tethered to the 
Merrifield resin and subsequently coordinated to the manganese atom of the chiral complex. The 
polymer-supported imidazole was expected to offer both the heterogeneous scaffold and provide an 
axial ligand in the corresponding catalytic complexes 179-182 (Scheme 55).  
Cl N
N
MeCN , 48h, reflux MeCN
24h, reflux
N NO
O
O
O
Mn
Cl
N
NNHN
Merrifield's
 resin
N
N
N NO
O
O
O
Mn
Cl
Complexes 
139, 140, 141, 142
N
NN
N
N NO
O
O
O
Mn
Cl
182
O
O
O
O
N N
Mn
Cl
S, S-181
179
R,R-180
Scheme  55.  
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The first step of the synthesis of the polymer-supported complexes 179-182 was the treatment 
of the Merrifield resin with an appropriate quantity of imidazole, in refluxing acetonitrile for 48 h.257 
After cooling, the resin was filtered off and washed with a mixture of aq. K2CO3/MeOH and 
H2O/MeOH followed by MeOH and then EtOAc. The solid was dried under vacuum overnight and 
afforded the product in 99% yield. Elemental analysis of the isolated polymer-supported imidazole 
(PSI) revealed that the nitrogen content was 2.01% which was equivalent to 51% of the chlorine 
substituted. Confirmation of the presence of the imidazoyl-methylene bond was explored using IR 
spectroscopy (Figure 61). Due to the similarity between the Merrifield resin and the PSI in the mid-
IR range, the two spectra were overlayed to carefully ascertain the band differences in this region. 
The lower spectrum is for the Merrifield resin and exhibits a weak band due to the C-Cl bond at 
1265.68cm-1. Upon nucleophilic substitution of chloride by the imidazole nitrogen, the weak band 
has largely disappeared (top spectrum ). 
 
 
 
 
         Figure  61.  Overlayed IR spectra of Merrifield’s resin and the PSI.   
 
The supported chiral complex was then prepared by stirring a suspension of the PSI, in 
solutions of the metal complexes 139-142 in CH3CN as solvent257 (Scheme 55). After stirring at an 
elevated temperature (80oC) for 24 h, the mixture was cooled and, in each case, the resins were 
Cl
 
N
N
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filtered off, washed sequentially with acetonitrile, methanol, and ether. Organic solvent washings 
were checked by IR until no unreacted complex was detected, and thus confirming the stability of the 
coordinative bond, to the PSI. Surface characterisation of the supported catalysts was performed 
using Scanning Electron Microscopy (SEM). The images show some morphological changes on the 
surface of the polymer resin beads. SEM images of the Merrifield resin and immobilised catalyst 179 
are shown in Figures 62 and 63 respectively. 
 
 
 
Figure  62.  SEM image of Merrifield’s resin. 
 
 
Figure  63.  SEM image of the PSI-catalyst 179 with red arrows  
     indicating surface changes in the beads. 
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Finally, thermogravimetric analysis (TGA) was conducted to ascertain the stability of the 
supported catalysts. The Merrifield resin shows single step degradation at approximately 280oC 
(Figure 64). The supported catalysts on the other hand degrade at lower temperatures of 
approximately 200oC as illustrated by the representative TGA curve of catalyst 179 (Figure 65). This 
corresponds to either the dissociation of the coordinatively bound manganese complex or a partial 
scission of the polymeric chain. However, it seems that the supported catalysts are thermally stable 
up to 200 oC. 
 
 
           Figure  64.  TGA curve of Merrifield’s resin. 
 
 
              Figure  65.  TGA curve of PSI-catalyst 179. 
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 The method explored above provided successful attempt in immobilising chiral metal 
complex onto a polymer supported imidazole. It further opens up another research avenue for future 
exploration. 
 
2.7.   SUMMARY AND CONCLUSIONS 
Reaction of ethylenediamine, (R,R)- and (S,S)-diaminocyclohexanes, and 1,2-diaminobenzene 
with (+)-ketopinic acid has afforded four chiral ligands, three of which exhibit C2-symmetry. NMR 
analysis indicated that the ligand prepared using 1,2-diaminobenzene lacked both C-2 (or pseudo C-
2) and mirror symmetry — the presence of twice the number of the expected number of carbon 
signals being attributed to the presence of syn- and anti-configurations about the two imine moieties. 
Mn(III) complexes incorporating the ketopinic acid derivatives were successfully prepared and 
evaluated as catalysts in five different asymmetric transformations. Generally, the syntheses of the 
complexes involved two steps, viz., the condensation of (+)-ketopinic acid with the appropriate 
diamine to generate ligands 135-138, and subsequent treatment of the ligands with Mn(OAc)24H2O 
to afford the corresponding complexes 139-142. The condensation step furnished products in 
moderate yields, the presence of water, produced as a by-product, leading to some decomposition of 
the water-sensitive ligands. Attempts were made to optimise the yield by removing the water using a 
Dean-Stark apparatus, or employing PCl5 and MgSO4 as dehydrating agents; however, none of these 
approaches improved the yield.  
Racemic trans-1,2-diaminocyclohexane was resolved prior to the condensation step by 
employing L(+)-tartaric and D-(‒)-tartaric acids to obtain the R,R-1,2-diaminocyclohexane and S,S-
1,2-diaminocyclohexane, respectively, thus permitting preparation of the enantiomerically pure 
ligands 136 and 137. Ligand 138 is new, and was synthesised by condensation of (+)-ketopinic acid 
with 1,2-diamino benzene, with the expectation that the planarity of the benzene ring would permit 
ready access of substrates to the manganese active site of the catalyst. The solution structure of 
ligand 138 is proposed, on the basis of 1-D and 2-D NMR spectroscopic data to contain both syn- 
and anti- imino group. 
Complexes 139-142 were obtained by refluxing the respective ligands 135-138 with 
Mn(OAc)2H2O in the presence of KOH as a deprotonating agent; addition of saturated NaCl 
furnished the axial ligand. All four complexes were obtained as brown powders and successfully 
characterised by elemental analysis and IR spectroscopy. Attempts to grow crystals of these 
complexes to confirm their solid-state geometry proved unsuccessful. Hence, DFT optimisation at 
the B3LYP/LANL2DZ level was performed using Gaussian 03 to obtain their putative geometries.  
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The asymmetric transformations carried out focused on homogenous systems. Firstly, each of 
the four catalysts was used in aldol reactions of benzaldehyde with different aryl ketones, viz., 
acetophenone, propiophenone, -tetralone, 4-nitroacetophenone, and 4-methoxyacetophenone. 
Under optimised reaction conditions, it was found that catalysts 139 and 142 were active and gave 
enantioselectivities as high as 99% and 85% e.e., respectively. The aliphatic ketones, cyclohexanone, 
2-methylcyclohexanone, 4-methylcyclohexanone, 2-hexanone, and pinacolone were also subjected to 
the same reaction conditions. It was found however, that the aldol products were only formed in trace 
amounts. When the reaction was run at ambient temperature, the dehydrated products i.e. ,-
unsaturated derivatives, were formed exclusively. The same situation was observed when 
isobutyraldehyde was used as the aldehyde.  
Baylis-Hillman reactions of methyl- and tert-butyl acrylates with pyridine-2-carbaldehyde, 6-
methylpyridine-2-carbaldehyde, 5-chlorosalicylaldehyde, benzaldehyde, 4-chlorobenzaldehyde, and 
2-nitrobenzaldehyde were explored in the presence of catalyst 139, and enantioselectivities of 44% 
e.e. were achieved in the case of pyridine-2-carbaldehyde. Racemic Baylis-Hillman adducts were 
subjected to conjugate addition using piperidine and catalyst 139, and excellent diastereoselectivity 
(91 % d.e.) was observed in the case of the BH adduct formed from pyridine-2-carbaldehyde and 
tert-butyl acrylate. The lowest diastereoselectivity of 14% d.e. was recorded when the 2-
nitrobenzaldehyde/methyl acrylate BH adduct was reacted with piperidine.  
Asymmetric epoxidation studies involved use of NaOCl, H2O2, UHP, t-BuOOH, PhIO, and m-
CPBA as sources of oxygen, and trans-methylstyrene, styrene, trans-stilbene, cis-stilbene, and 
indene as substrates. Optimal epoxidation conditions were achieved using m-CPBA as the oxygen 
source, and the highest selectivity of 32% e.e. was achieved with catalyst 142 in the epoxidation of 
indene. 
Attention was then turned to the asymmetric reduction of the aryl ketones, acetophenone, 3-
chloropropiophenone, 4-hydroxyacetophenone, -tetralone, and 2-hydroxy-1-acetonapthone, using 
NaBH4 as reducing agent. The best selectivity was found in the reduction of acetophenone with 68% 
and 33% e.e. with catalysts 139 and 140, respectively. Attempts were made to extend this 
methodology to the asymmetric reduction of imines by adopting the optimised conditions of the 
ketone reduction. The approach involved the pre-formation of the imine followed by treatment with 
NaBH4. Testing the reaction on the N-phenylimine of -tetralone proved to be unsuccessful.  
The growing interest in developing heterogeneous catalysts from homogeneous systems 
prompted the immobilisation of the synthesised complexes onto a polymer support. This was 
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achieved by refluxing a polymer-supported imidazole (PSI) with each of the complexes in 
acetonitrile. The Lewis basicity of the imidazole nitrogen resulted in coordination of the PSI to the 
Mn atom of the complexes and led to the polymer supported catalytic systems 179, 180, 181, and 
182. Surface characterisation of the immobilised catalysts was conducted using SEM and TGA. This 
was an exploratory study and has laid the foundation for further studies in the extension of the 
application of these catalysts, since ease of recovery is an important consideration. This is 
particularly true where catalysts may be used in flow chemistry applications or on a large scale.  
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3. EXPERIMENTAL 
3.1.   INSTRUMENTATION 
1D and 2D NMR spectra were recorded on Bruker Avance III HD spectrometers (400 and 600 
MHz). All signals were expressed as ppm down field from TMS, referenced to the residual 
protonated solvent signals in 1H NMR (7.26 ppm for CDCl3, and 2.50 ppm for DMSO) and to the 
deuterated carbon signals in 13C NMR (77.36 ppm for CDCl3, and 39.5 ppm for DMSO). 
Measurements of optical rotations were performed using a Perkin Elmer 141 polarimeter. IR spectral 
measurements were carried out on a Perkin Elmer spectrum 400 FT-IR spectrometer (ATR). 
Thermogravimetric analyses of the catalysts were performed using a Perkin Elmer 2000 TGA 7. 
Scanning electron micrographs of the catalysts were taken on a TESCAN VEGAN III XMU Q150 
TE. The HPLC analyses were performed on a Spectra-Physics instrument equipped with a P100 
isocratic pump and a Waters 410 Differential Refractometer. Enantiomer excess (% e.e.) measured 
by HPLC was determined using a commercially available Phenomenex Lux 5u Cellulose chiral 
column. Elemental analyses were conducted using an Elementar Vario micro cube. Melting points 
were determined by means of a Reichert apparatus and are uncorrected. The titles of compounds 
written in normal font are known compounds, while those of novel compounds are written in 
italics. 
 
3.2.    MATERIALS 
 Reagent-grade acetonitrile, methanol, and ethanol were used as received from commercial 
sources. Benzene, toluene, tetrahydrofuran, and diethyl ether were distilled from benzophenone/ketyl 
solutions. Dichloromethane was distilled from CaH2 and chloroform was passed through a column of 
basic alumina. Analytical thin-layer chromatography was performed on ALUGRAM XTRA silica 
gel 0.2 mm (containing a fluorescent indicator at 254 nm). Flash chromatography was carried out on 
MN Kieselgel 60 0.063-0.2 mm/ 70-230 mesh. All other reagents were purchased from Aldrich and 
used as received.   
3.3.  CATALYST SYNTHESIS 
 3.3.1.  General Procedure for the Synthesis of Ligands 135-138 
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 To a solution of (+)-ketopinic acid (2.096 mmol), in CHCl3 (5 mL) were added appropriate 
diamine (1.048 mmol) and acetic acid (0.1 mL) at room temperature. The resulting mixture was 
refluxed for 36 h and the reaction was quenched with H2O (5 mL). The resulting solution was 
extracted with CH2Cl2 (10 mL), and the layers were separated. The organic layer was washed with 
brine (5 mL), dried over anhydrous MgSO4, and concentrated. The crude product was purified by 
column chromatography on silica gel using 4/1 EtOAc/CH2Cl2 as eluent to obtain the products. 
 
2,2'-[ethane-1,2-diylbis(azan-1-yl-1-ylidene)]bis(7,7-dimethylbicyclo[2.2.1]heptane-1-carboxylic 
acid) 135127 
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Following the general procedure outlined in 3.3.1., (+)-ketopinic acid (382 mg, 2.096 mmol) and 
ethane-1,2-diamine (70 µL, 1.1 mmol ) were used to afford the product as a white solid (0.55 g, 
52%); m.p. 149-153 oC; H (400 MHz; CDCl3) 0.87 (s, 6H), 1.25 (s, 6H), 1.30-1.43 (m, 2H), 1.68 
(td, J = 12.8, 4.0 Hz, 2H), 1.97-2.15 (m, 6H), 2.40 (td, J = 12.2, 3.6 Hz, 2H), 2.56 (dd, J = 18.2, 3.6 
Hz, 2H), 3.65 (dd, J = 15.0, 3.8 Hz, 4H); C (100 MHz; CDCl3) 20.0 (2CH3), 20.1 (2CH3), 27.7 
(C7,C7’), 31.7 (C5,C5’), 35.5 (C4,C4’), 43.9 (C3,C3’), 50.4 (C6,C6’), 50.7 (C11, C11’), 60.7 
(C1,C1’), 173.2 (C2,C2’), 185.3 (C10,C10’). IR (neat, cm-1) 2995, 2962, 1700, 1504.  
 
2,2'-(1R,2R)-cyclohexane-1,2-diylbis(azan-1-yl-1-ylidene)bis(7,7-dimethylbicyclo[2.2.1]heptane-
1-carboxylic acid) 136127 
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Following the general procedure outlined in 3.3.1., (+)-ketopinic acid (382.4 mg, 2.096 mmol) and 
R,R-1,2-diaminocyclohexane (126 µL, 1.05 mmol ) were used to afford the product as a white solid 
(0.487g, 40%); m.p. 159-163 oC; H (400 MHz; CDCl3) 0.83 (s, 6H), 1.23 (s, 6H), 1.24-1.25 (m, 2H), 
1.27-1.65 (m, 10H), 1.83 (d, J = 6.6 Hz, 2H), 1.92-2.11 (m, 6H), 2.35 (td, J = 12.1, 4.6 Hz, 2H), 2.54 
(t, J = 3.8 Hz, 1H), 2.61 (t, J = 3.0 Hz, 1H), 3.43 (dd, J = 5.2, 3.2 Hz, 2H); C (100 MHz; CDCl3) 
19.9 (2CH3), 20.3 (2CH3), 24.1 (C13,13’), 28.0 (C12,12’), 30.9 (C7,7’), 32.1 (C5,5’), 35.2 
(C4,4’), 43.6 (C6,6’), 49.6 (C3,3’), 60.5 (C11,11’), 64.5 (C1,1’), 173.2 (C2,2’), 183.4 (C10,10’). IR 
(neat, cm-1) 2892, 2503, 1760, 1554 
 
2,2'-(1S,2S)-cyclohexane-1,2-diylbis(azan-1-yl-1-ylidene)bis(7,7-dimethylbicyclo[2.2.1]heptane-
1-carboxylic acid) 137127 
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Following the general procedure outlined in 3.3.1., (+)-ketopinic acid (382.4 mg, 2.096 mmol) and 
S,S-1,2-diaminocyclohexane (126 µL, 1.05 mmol ) were used to afford the product as a white solid 
(0.35 g, 29%); m.p. 161-164 oC; H (400 MHz; CDCl3) 0.86 (s, 6H), 1.22 (s, 6H), 1.24-1.60 (m, 6H), 
1.67-1.81 (m, 4H), 1.98-2.11 (m, 6H), 2.36 (m, 2H), 2.52 (m, 2H), 3.45 (m, 2H); C (100 MHz; 
CDCl3) 20.2 (2CH3), 20.5 (2CH3), 27.2 (C13,13’), 28.2 (C12,12’), 31.7 (C7,7’), 32.7 (C5,5’), 35.3 
(C4,4’), 43.8 (C6,6’), 50.0 (C3,3’), 60.8 (C11,11’), 64.7 (C1,1’), 173.3 (C2,2’), 183.6 (C10,10’) IR 
(neat, cm1) 2988, 2543, 1726, 1580 
 
2,2'-[1,2-phenylenebis(azan-1-yl-1-ylidene)]bis(7,7-dimethylbicyclo[2.2.1]heptane-1-carboxylic 
acid) 138 
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Following the general procedure outlined in 3.3.1., (+)-ketopinic acid (382.4 mg, 2.096 mmol) and 
1,2-diaminobenzene (114 mg, 1.05 mmol) were combined in acetic acid. This ligand was purified by 
trituration in chloroform to afford the product as a pale pink solid (0.97g, 90%), m.p. 162-168 oC; H 
(400 MHz; CD3OD) 0.78 (s, 3H), 0.99 (s, 3H), 1.02 (s, 3H), 1.13 (s, 3H), 1.45 (m, 2H), 1.71-1.82 
(m, 6H), 2.08 (m, 2H), 2.26 (m, 2H), 2.49-2.66 (m, 4H), 2.97 (m, 2H), 7.20 (s, 2H), 7.47 (s, 2H); C 
(100 MHz; CD3OD) 16.9 (CH3), 24.6 (CH3) , 24.8 (CH3), 26.6, 27.0 (C7,7’), 29.1, 30.0 (C5,5’), 
30.2, 30.7 (C4,4’), 45.1, 45.2 (C3,3’), 51.5 (C6,6’), 56.4, 56.6 (C1,1’), 115.2 (C13,13’), 123.9, 124.0 
(C12,12’), 138.1, 138.2 (C11,11’), 156.2, 156.4 (C2,2’), 177.5, 179.2 (C10,10’). IR (neat, cm-1) 
2962, 2443, 2013, 1760, 1554. Anal. Calcd for C26H32N2O4 % : C, 71.53; H, 7.39; N, 6.42. Found: C, 
71.54; H, 7.42; N, 6.43.  
 
3.3.2.  Resolution of (±)-trans-Diaminocyclohexane 
A 100 ml round bottom flask was charged with either L(+)- or D(‒)-tartaric acid (1.48 g, 9.86 
mmol), and distilled water (5 mL). The mixture was stirred at room temperature until complete 
dissolution occurred, at which point a mixture of (±)-trans-diaminocyclohexane (2.36 g, 19.7 mmol) 
was added at such a rate that the reaction temperature just reached 70oC. To the resulting solution 
was added glacial acetic acid (0.96 mL, 17 mmol) at a rate such that the reaction temperature did not 
exceed 90oC. A white precipitate formed immediately upon addition of the acid, and the slurry was 
vigorously stirred as it cooled to room temperature. The mixture was then cooled to 5oC in an ice 
bath and the precipitate was collected by vacuum filtration. The wet cake was washed with 5oC water 
(3 mL) and rinsed with methanol (53 mL). The R,R-1,2-diammoniumcyclohexane mono-(+)-
tartarate (2.28g, 90%) and S,S-1,2-diammoniumcyclohexane mono-(‒)-tartarate salts (2.34g, 90%) 
were both obtained as white solids.  The analytical data is given below. 
 
R,R-1,2-diammoniumcyclohexane mono-(+)-tartarate 
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[]D20 = +12.3 (c, 2 in H2O) [Lit.,259 +12.4 (c, 2 in H2O)].; Anal. Calcd for C10H20N2O6 % : C, 45.45; 
H, 7.63; N, 10.60. Found: C, 45.41; H, 7.50; N, 10.59. 
S,S-1,2-diammoniumcyclohexane mono-(‒)-tartarate 
[]D20 = ‒12.3 (c, 2 in H2O);  Anal. Calcd for C10H20N2O6 % : C, 45.45; H, 7.63; N, 10.60. Found: C, 
45.44; H, 7.61; N, 10.62. 
 
 
  
NH3H3N
CO2
HO
O2C
OH
.
NH3H3N
CO2
HO
O2C
OH
.
NH2H2N
R,R- 1,2-diaminocyclohexane
NH2H2N
S,S- 1,2-diaminocyclohexane
R,R-1,2-diammoniumcyclohexane
 mono-(+)-tartarate
S,S-1,2-diammoniumcyclohexane
 mono-()-tartarate  
 
Each of the salts was dissolved in CH2Cl2 (5 mL) and treated with 3 ml of 4M NaOH to afford 
the respective enantiomers as colourless liquids. 
 
3.3.3.   Preparation of Mn-complexes 139-142 
General Procedure: Ethanolic solutions of the ligands (0.268 mmol) containing KOH (0.5M, 
8 mL) were allowed to reflux under nitrogen atmosphere with Mn(OAc)2  4H2O (0.563 mmol) for 12 
h. The reaction mixture was cooled to room temperature and brine (8 mL) was added. The resulting 
solution was filtered and concentrated in vacuo. The residue was redissolved in dichloromethane 
filtered and concentrated again and water was removed using a separating funnel and the solution 
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was again concentrated till dryness. The complexes were recrystallized from acetonitrile and were 
obtained as brown amorphous powders. The analytical data for the complexes is given below. 
 
 
 
 
 
2,2'-[ethane-1,2-diylbis(azan-1-yl-1-ylidene)]bis(7,7-dimethylbicyclo[2.2.1]heptane-1-carboxylato) 
manganese (III) chloride 139 
 
 
N NO
O
O
O
Mn
Cl
139  
    
 
2,2'-(1R,2R)-cyclohexane-1,2-diylbis(azan-1-yl-1-ylidene)bis(7,7-dimethylbicyclo[2.2.1]heptane-1-
carboxylato) manganese (III) chloride 140 
  
 
N NO
O
O
O
Mn
Cl
140    
 
 
2,2'-(1S,2S)-cyclohexane-1,2-diylbis(azan-1-yl-1-ylidene)bis(7,7-dimethylbicyclo[2.2.1]heptane-1-
carboxylato) manganese (III) chloride 141 
 
 
Following the general procedure outlined in 3.3.3., ligand 
135 (104 mg, 0.268 mmol) and Mn(OAc)2.4H2O (138 mg, 
0.563 mmol) were used to afford complex 139 (77 mg, 60% 
yield). Anal. Calcd for C22H30ClMnN2O2 %: C, 55.41; H, 
6.34; N, 5.87. Found: C, 55.41; H, 6.35; N, 5.88. IR (neat, 
cm-1): 1739 (C=O), 1687 (C=N). 
 
Following the general procedure outlined in 3.3.3., ligand 
136 (119 mg, 0.268 mmol) and Mn(OAc)2.4H2O (138 mg, 
0.563 mmol) were used to afford complex 140 (71 mg, 50% 
yield). Anal. Calcd for C26H36ClMnN2O4 % : C, 60.75; H, 
8.50; N, 4.72. Found: C, 60.75; H, 8.51; N, 4.74. IR (neat, 
cm-1): 1738 (C=O), 1687 (C=N). 
 
Following the general procedure outlined in 3.3.3., ligand 
137 (119 mg, 0.268 mmol) and Mn(OAc)2.4H2O (138 mg, 
0.563 mmol) were used to afford complex 141 (66.8 mg, 
47% yield). Anal. Calcd for C26H36ClMnN2O4 %: C, 60.75; 
H, 8.50; N, 4.72. Found: C, 60.75; H, 8.52; N, 4.73. IR 
(neat, cm-1): 1738 (C=O), 1687 (C=N). 
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N N
Mn
Cl
141    
 
 
 
2,2'-(1,2-phenylenebis(azan-1-yl-1-ylidene))bis(7,7-dimethylbicyclo[2.2.1]heptane-1-carboxylato 
manganese (III) chloride 142 
 
 
 
N NO
O
O
O
Mn
Cl
142  
    
 
 
3.3.4.  Determination of manganese content260 
Preparation of solutions 
EDTA, (0.01M) 
3.8 g of the sodium salt of the dihydrate of EDTA (Na2-EDTA) and 0.1 g MgCl2 were 
dissolved in 1 L of deionised water and the mixture stirred thoroughly. The resulting solution was 
filtered using suction and stored in a clean 1 L plastic bottle. 
Calcium standard solution 
A CaCO3 solution was prepared as a primary standard for Ca and used to standardise the 0.01 
M EDTA prepared. 
Following the general procedure outlined in 3.3.3., 
ligand 138 (117 mg, 0.268 mmol) and 
Mn(OAc)2.4H2O (138 mg, 0.563 mmol) were used to 
afford complex 142 (77 mg, 55% yield).Calculated for 
C26H30ClMnN2O4: C, 61.38: H, 7.55: N, 4.77. Found: 
C, 60.75: H, 8.51: N, 4.79 IR (neat, cm-1): 1740 (C=O), 
1689 (C=N).
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0.25 g of  reagent grade CaCO3 was transferred into a 250 mL beaker. 25 mL of deionised 
water, and a few drops of concentrated hydrochloric acid were added with periodic stirring until the 
sample dissolved. The solution was then transferred into a 250 mL volumetric flask and carefully 
diluted to the mark. The molarity (M) of the calcium ions was found as follows: 
 
 
Molarity (M) = solute concentration in moles per litre (mol/L) 
       = amount of solute (mol)/total solution volume (L) 
 Molarity of calcium ions = 0.25g  1/100.086 1/0.250 = 0.0099M 
Standardisation of the EDTA solution  
10 ml aliquots of the Ca2+ solution were pipetted into three 250 mL conical flasks. 7-8 mL of 
pH buffer, 15 mL of deionised water, and 3 drops of Eriochrome Black T indicator were added 
sequentially. Each of the three aliquots was then titrated with the EDTA solution using a 50 mL 
burette. The molarity was calculated to be 0.01M using the following relation: The mean corrected 
titration volume of the EDTA solution was 8.9 mL. Thus the molarity of the EDTA was calculated as 
follows: 
Molarity EDTA (mol/L) = Volume Ca (L)  Molarity Ca (mol/L)  1 mol EDTA/1 mol Ca  
 
       
     Calculate mol of Ca        converts to mol of EDTA 
             
1/volume of EDTA (L) 
 
           
    Converts to mol/L EDTA 
 
Molarity EDTA (mol/L) = 0.01L0.0099 mol/L  1 mol EDTA/1 mol Ca  1/8.9 
       = 0.010.0099112.36 
       = 0.011M 
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        Titration of complexes 139-142 
 Complex 139 
 15 mL of conc. HNO3/conc. H2SO4 mixture (1:1) was added to 500 mg of complex 139 and 
heated at 100oC till dryness. 100 mL of the acid mixture was added and heated again till dryness. 10 
mL of 0.1 M HNO3 acid was added and the mixture filtered. The volume was finally made up to 100 
mL with 0.1 M HNO3 acid. Three 2.00 mL samples of the total solution were titrated with 0.011 M 
EDTA solution and the mean corrected volume was 2.1 mL (0.0021 L). 
To find the manganese content of the complex in mg, the following relationship was used 
Mass of Mn (mg) = Volume EDTA (L)  Molarity EDTA (mol/L)   1 mol Mn/1 mol EDTA 
     Calculates mol of EDTA  Converts to mol of Mn 
  Mn atomic mass/1 mol  1000mg/1g  100 ml total volume/2 ml sampled volume 
   
  Convert to g of Mn       Converts   Converts to total mg on Mn 
           To mg of 
           Mn in sampled volume  
      
Substituting the values in the relation we obtained 
   0.00210.01154.94100050 = 58 mg  
Complex 140 
Following the same procedure as in complex 139, the mean corrected volume of EDTA was 
found to be 1.88 mL (0.00188 L). 
   0.001880.01154.94100050 = 52mg 
Complex 141 
Following the same procedure as in complex 139, the mean corrected volume of EDTA was 
found to be 1.88 mL (0.00188 L). 
   0.001880.01154.94100050 = 52mg 
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Complex 142 
Following the same procedure as in complex 139, the mean corrected volume of EDTA was 
found to be 1.9 mL (0.0019 L). 
   0.00190.01154.94100050 = 52mg 
 
   
3.3.5.  Attempts to grow crystals for x-ray crystallography 
   General methods: 
 Vapour Diffusion: In a small vial, 100 mg of the complex was dissolved in 1 mL 
MeOH: H2O (3:1). Then the vial was placed inside a larger vessel containing hexane, 
toluene, or benzene in which the sample is insoluble. The outer vessel was then sealed. 
After one month, no crystals were observed. 
 Solvent Diffusion: In a small vial, 100 mg of the complex was dissolved in 1 mL of 
MeOH: H2O (3:1). Toluene or benzene was then carefully layered on top of the 
solution. After the solvent mixture evaporated, no crystal was obtained. 
 Slow evaporation: In a small vial, 100 mg of the complex was dissolved in 1 mL of 
MeOH. The vial was covered with a septum and a needle inserted on top to slow the 
evaporation process. After the solvent evaporated, no crystal was obtained.  
 Slow cooling: In a small vial, 100 mg of the complex was dissolved in 1 mL hot i-
PrOH. The vial was put into a larger vessel layered with cotton and then put inside a 
fridge. After the solvent evaporated, no crystal was obtained.   
    
3.4.   ASYMMETRIC SYNTHESIS 
3.4.1.  Aldol reactions 
3.4.1.1 General procedure for the uncatalysed aldol reactions 
 To a stirred solution of potassium hexamethyldisilazide (KHMDS, 43.2 µl, 0.0216 mmol, 0.5 
M in toluene) at 0 oC, was added a solution of water (48 µl, 0.048 mmol, 1 M in THF). The solution 
was stirred for 20 min at 0 oC and then ketone (1.5 mmol) was added and the mixture stirred for 10 
min. The resulting solution was then cooled to ‒20 oC, and aldehyde (0.3 mmol) in THF was added. 
Stirring was continued for 24 h with monitoring by TLC. The mixture was then quenched by addition 
of 1M HCl (1 mL) and the aqueous layer extracted with ether (210 mL). The combined organic 
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layers were washed with brine and dried over Na2SO4. Purification was performed on silica 
(hexane/EtOAc 3:1) to obtain the respective aldol products below. 
 
 
 
3.4.1.2. General Procedure for the catalysed aldol reactions  
To a stirred solution of potassium hexamethyldisilazide (KHMDS, 43.2 µl, 0.0216 mmol, 0.5M 
in toluene) at 0 oC, was added a solution of water (48 µl, 0.048 mmol, 1M in THF). The solution was 
stirred for 20 min at 0 oC and then ketone (1.5 mmol) was added and the mixture stirred for 10 min. 
The resulting solution was then cooled to ‒20 oC, and a solution of the catalyst (10 mole %; 139 = 66 
mg, 140 = 80 mg, 141 = 80 mg, and 142 = 79 mg) and aldehyde (1.5 mmol) in THF (0.5 mL) was 
added. Stirring was continued for 24 h with monitoring by TLC. The mixture was then quenched by 
addition of 1M HCl (1 mL) and the aqueous layer extracted with ether (210 mL). The combined 
organic layers were washed with brine and dried over Na2SO4. Purification was performed on silica 
(hexane/EtOAc 3:1) to obtain the respective aldol products below. 
3.4.1.3.  Determination of enantioselectivity 
200µL (0.1 mg/µL) of the appropriate pure aldol product in iso-propanol was injected onto the 
HPLC column. Hexane/2-propanol (9:1) mixture was run into the column at 0.2 ml/minute. The 
signal for each enantiomer was observed. 
3.4.1.4. Aldol products 
3-hydroxy-1,3-diphenylpropan-1-one 145a261 
 
  
OH O
145a  
Following the general procedure outlined in 3.4.1.2, acetophenone (174 µL), benzaldehyde (152 µL, 
1.5 mmol) and catalyst (10 mole %) were used to afford the product as a pale yellow oil; 25-39% 
yield (60-99% e.e., Retention time 8-13 min, see Table 8, page 62); H (600 MHz; CDCl3) 3.37-3.39 
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(m, 2H, CH2), 3.48 (s, 1H, OH), 5.36 (m, 1H, CH-OH), 7.29-7.31 (m, 1H, Ar), 7.40 (m, 2H, Ar), 
7.46 (m, 4H, Ar), 7.60 (t, J = 7.59 Hz, 1H, Ar), 7.95 (d, J = 7.96 Hz, 2H, Ar); C (100 MHz; CDCl3) 
47.5 (CH2), 70.1 (CH-OH), 126.0 (2ArC), 128.0 (2CH, Ar), 128.3 (2CH, Ar), 128.7 (2CH, Ar), 
128.8 (2CH, Ar), 133.7 (ArC), 137.0 (ArC), 143.1 (C=O). IR (neat, cm-1); 3460, 3028, 1738, 1674, 
1364, 1215, 746, 699. 
  
  
 
3-hydroxy-2-methyl-1,3-diphenylpropan-1-one 145b262,263 
 
    
  
OH O
145b  
 
Following the general procedure outlined in 3.4.1.2, propiophenone (200 µL, 1.5 mmol), 
benzaldehyde (152 µL, 1.5 mmol) and catalyst (10 mole %) were used to afford the product as a pale 
yellow oil; 30-32% yield (82-83% e.e. Retention time 8-13 min, see Table 8, p62); H (600 MHz; 
CDCl3) 0.95 (d, J = 0.5 Hz, CH3), 2.88 (q, J = 2.8 Hz, CH-CH3), 4.40 (s, 1H, OH), 4.78 (d, J = 4.5 
Hz, CH-OH), 7.31 (m, 1H, Ar), 7.39-7.40 (m, 2H, Ar), 7.44-7.46 (m, 4H, Ar), 7.60 (t, J = 7.6 Hz, 
1H, Ar), 7.95 (d, J = 8.0 Hz, 2H, Ar); C (100 MHz; CDCl3) 10.2 (CH3), 47.5 (CH-CH3), 70.1 (CH-
OH), 126.0 (2ArC), 128.0 (2CH, Ar), 128.3 (2CH, Ar), 128.7 (2CH, Ar), 128.8 (2CH, Ar), 
133.7 (ArC), 137.0 (ArC), 143.1 (C=O). IR (neat, cm-1); 3455, 3028, 1738, 1448, 1365, 1228, 968, 
699. 
 
2-[hydroxy(phenyl)methyl]-3,4-dihydronaphthalen-1(2H)-one 145c264 
 
 
  
OH O
145c  
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Following the general procedure outlined in 3.4.1.2, -tetralone (200 µL, 1.5 mmol), benzaldehyde 
(152 µL, 1.5 mmol), catalyst (10 mole %) were used to afford the product as a pale yellow oil; 23-
27% yield (85% e.e. Retention time 8-13 min, See Table 8, p 62); H (600 MHz; CDCl3) 1.27 (t, J = 
1.3 Hz, 2H), 2.80 (s, 1H, OH), 2.83-2.94 (m, 2H), 4.13 (q, J = 4.1 Hz, 1H), 5.0 (d, J = 5.0 Hz, 1H), 
7.20-7.51 (m, 8H), 8.06-8.10 (m, 1H); C (100 MHz; CDCl3) 19.1 (CH2), 20.1 (CH2), 50.2 (CH), 
70.1 (CH-OH), 126.0 (CH, Ar), 126.3 (CH, Ar), 128.0 (2CH, Ar), 129.0 (2CH, Ar), 131.0 (CH, 
Ar), 132.1 (CH, Ar), 132.5 (CH, Ar), 134.3 (ArC), 137.1 (ArC), 139.1 (ArC), 143.2 (C=O). IR (neat, 
cm-1); 3447, 3027, 1738, 1665, 1596, 1365, 1205, 702.  
 
 3-hydroxy-1-(4-methoxyphenyl)-3-phenylpropan-1-one 145e265 
 
 
  
OCH3
OH O
145e  
Following the general procedure outlined in 3.4.1.2, 4-methoxy acetophenone (255 mg, 1.5 mmol), 
benzaldehyde (152 µL, 1.5 mmol) and catalyst (10 mole %) were used to afford the product as a 
colourless oil;327 22-50% yield (53-78% e.e. Retention time 8-13min); H (600 MHz; CDCl3) 3.30-
3.31 (m, 2H), 3.73 (s, 1H), 3.80 (s, 3H), 5.32 (t, J = 5.3 Hz, 1H), 6.92 (d, J = 7.0 Hz, 2H), 7.30 (t, J = 
7.3 Hz, 1H), 7.32 (t, J = 7.4 Hz, 2H), 7.40 (d, J = 7.4 Hz, 2H), 7.92 (d, J = 7.9 Hz, 2H); C (100 
MHz; CDCl3) 47.5 (CH2), 50.1 (OCH3), 70.1 (CH-OH), 124.0 (2CH, Ar), 125.0 (2CH, Ar), 126.0 
(ArC), 127.2 (2ArC) 128.0 (2CH, Ar), 128.3 (2CH, Ar), 135.2 (ArC-OCH3), 143.1 (C=O). IR 
(neat, cm-1); 3457, 3016, 2970, 1738, 1596, 1365, 1228, 1021, 699. 
 
 
3.4.1.5.  ,-unsaturated products  
For the aliphatic substrates; isobutyraldehyde (137 µL, 1.50 mmol), cyclohexanone (155 µL, 
1.50 mmol), 4-methylcyclohexanone (184 µL, 1.50 mmol), 2-methylcyclohexanone (182 µL, 1.50 
mmol), 2-hexanone (185.5 µL, 1.498 mmol), and pinacolone (186.6 µL, 1.492 mmol) were used.  
trans-1,3-diphenylprop-2-en-1-one 146266 
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O
146   
 
 
Yellow solid; 100% yield; m.p. 57-59 oC (lit.266 56-58 oC); H (600 MHz; CDCl3) 7.41-7.47 (m, 2H), 
7.51-7.55 (m, 2H), 7.63-7.66 (m, 2H), 7.72-7.83 (m, 2H), 7.84-7.85 (m, 2H), 7.86-7.87 (m, 2H), 8.01 
(d, J = 12.0 Hz, 1H), 8.31 (d, J = 12.0 Hz, 1H); C (100 MHz; CDCl3) 123.0 (CH), 131.2 (2ArC), 
133.1 (2ArC), 134.3 (2ArC), 136.1 (2ArC), 138.2 (ArC), 140.1 (ArC), 141.4 (ArC), 143.0 (ArC), 
145.2 (CH), 192.3 (C=O). IR (neat, cm-1) 3072, 1681, 1661, 1521. 
 
 (Z)-2-benzylidenecyclohexanone 148a196 
   
O
148a  
Yellow oil; 100% yield, H (600 MHz; CDCl3) 1.50 (q, J = 2.0 Hz, CH2), 1.55 (q, J = 2.3 Hz, CH2), 
1.57 (t, J = 3.1 Hz, CH2), 1.63 (t, J = 3.1 Hz, CH2), 6.88 (s, 2H), 7.32-7.33 (m, 2H), 7.40 (s, 1H), 
7.61 (s, 1H), C (100 MHz; CDCl3) 22.2 (2CH2), 24.3 (CH2), 35.0 (CH2), 128.2 (2ArC), 128.3 
(2ArC), 128.4 (ArC), 133.1 (ArC), 134.0 (CH), 139.5 (C), 198.3 (C=O). IR (neat, cm-1) 3038, 1671, 
1638,1450. 
    
 
 (Z)-2-benzylidene-6-methylcyclohexanone 148b267 
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O
148b  
 Yellow oil; 100% yield; H (600 MHz; CDCl3) 1.22 (d, J = 1.2 Hz, CH3), 1.23-1.24 (m, 2H), 1.32-
1.36 (m, 2H), 2.10-2.12 (m, 2H), 2.22-2.32 (m, 2H), 6.89 (s, 2H), 7.41-7.43 (m, 2H), 7.54 (s, 1H), 
7.81 (s, 1H). C (100 MHz; CDCl3) 16.2 (CH3), 26.3 (CH2), 29.2 (CH2), 30.6 (CH2), 40.6 (C-CH3), 
133.2 (2ArC), 136.3 (2ArC), 136.7 (ArC), 134.2 (CH), 134.8 (ArC), 140.1 (C), 199.3 (C=O). IR 
(neat, cm-1) 3045, 1674, 1632, 1447.  
(E)-2-benzylidene-4-methylcyclohexanone 148c196 
148c
O
 
Yellow oil; 100% yield, H (600 MHz; CDCl3) 0.99 (d, J = 0.5 Hz, CH3), 1.62-1.68 (m, 2H), 1.85-
1.93 (m, 2H), 2.33-2.80 (m, 2H), 2.86-2.93 (m, 1H), 3.20-3.52 (m, 1H), 3.62-3.72 (m, 1H), 7.02 (s, 
CH), 7.61-7.68 (m, 2H), 7.72 (s, 1H), 7.84 (s, 1H). C (100 MHz; CDCl3) 16.2 (CH3), 26.3 (CH2), 
29.2 (CH2), 30.6 (CH2), 40.3 (C-CH3), 133.2 (2ArC), 136.3 (2ArC), 136.7 (ArC), 134.2 (CH), 
134.8 (ArC), 140.1 (C), 199.5 (C=O). IR (neat, cm-1) 3044, 1675, 1632, 1447. 
 
trans-1-phenylhept-1-en-3-one 148d268 
O
148d  
Yellow oil; 100% yield, H (600 MHz; CDCl3) 0.96 (t, J = 0.9 Hz, 3H), 1.52-1.59 (m, 4H), 3.20 (t, J 
= 3.1 Hz, 2H), 6.83 (d, J = 6.5, 2H), 7.66-7.68 (m, 3H), 7.53 (d, J = 12.0 Hz, 1H), 7.66 (d, J = 12.0 
Hz, 1H). C (100 MHz; CDCl3) 12.3 (CH3), 23.4 (CH2), 28.6 (CH2), 40.2 (CH2), 128.3 (CH), 129.0 
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(2ArC), 131.1 (2ArC), 135.1 (ArC), 140.1 (ArC), 147.2 (CH), 199.5 (C=O). IR (neat, cm-1) 3051, 
1668, 1646, 1510. 
     
  cis-4,4-dimethyl-1-phenylpent-1-en-3-one 148e269 
  
O
148e  
  
Yellow oil; 100% yield, H (600 MHz; CDCl3) 1.51 (s, 9H), 6.93 (d, J = 6.0 Hz, 1H), 7.43 (d, J = 6.0 
Hz, 1H), 7.66-7.68 (m, 2H), 7.72-7.75 (m, 3H). C (100 MHz; CDCl3) 33.2 (CH3)3 43.1 [C(CH3)3], 
127.3 (CH), 129.1 (2ArC), 129.8 (2ArC), 133.1 (ArC), 138.0 (ArC), 140.2 (CH), 198.5 (C=O). IR 
(neat, cm-1) 3055, 1671, 1644, 1525. 
 
 trans-4-methyl-1-phenylpent-2-en-1-one 151a270 
 
  
O
151a  
    
Yellow oil; 100% yield, H (600 MHz; CDCl3) 1.45 (d, J = 1.2 Hz, 6H), 2.64-2.65 (m, 1H), 7.21 (d, J 
= 12.0 Hz, 1H), 7.39-7.40 (m, 2H), 7.61-7.65 (m, 1H), 7.73-7.76 (m, 3H). C (100 MHz; CDCl3) 
21.2 (CH3)2, 33.2 (C(CH3)2), 121.1 (CH), 129.2 (4ArC), 132.1 (ArC), 167.1 (ArC), 158.2 (CH), 
190.1 (C=O). IR (neat, cm-1) 3085, 1682, 1673, 1449. 
 
 (Z)-2,4-dimethyl-1-phenylpent-2-en-1-one 151b271 
   
O
151b  
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Yellow oil; 100% yield; H (600 MHz; CDCl3) 1.45 (d, J = 1.2 Hz, 6H), 2.32 (s, 3H), 2.66 (d, J = 6.0 
Hz, 1H), 6.30-6.35 (m, 1H), 7.20-7.35 (m, 2H), 7.39-7.40 (m, 1H), 7.61-7.65 (m, 2H), 7.73-7.76 (m, 
2H). C (100 MHz; CDCl3) 18.1 (CH3), 21.20 (CH3)2, 33.2 [C(CH3)2], 121.1 (CH), 129.2 (2ArC), 
129.8 (2ArC), 132.1 (ArC), 167.1 (ArC), 158.2 (CH), 190.1 (C=O). IR (neat, cm-1) 3085, 1684, 
1671, 1447. 
          
 
 
 
 
 
 
 
 
(E)-2-(2-methylpropylidene)-3,4-dihydronaphthalen-1(2H)-one 151c272 
 
  
O
151c  
 
Yellow oil; 100% yield; H (600 MHz; CDCl3) 1.45 (d, J = 1.2 Hz, 6H), 2.31 (t, J = 2.2 Hz, 2H), 
2.52-2.58 (m, 1H), 2.72 (t, J = 2.2 Hz, 2H) 6.45 (t, J = 6.3 Hz, 1H), 7.35 (t, J = 7.0 Hz, 1H), 7.42 (d, 
J = 7.2 Hz, 1H), 7.63 (t, J = 7.3 Hz, 1H), 8.10 (d, J = 8.0 Hz, 1H). C (100 MHz; CDCl3) 22.1 
(2CH3), 29.1 [C(CH3)2] 30.1 (2CH2), 128.5 (ArC), 128.6 (ArC), 130.1 (ArC), 130.2 (ArC), 133.2 
(C), 136.3 (ArC) 139.1 (ArC), 150.1 (CH), 190.2 (C=O). IR (neat, cm-1) 3072, 1674, 1662, 1403. 
 
  trans-4-methyl-1-(4-nitrophenyl)pent-2-en-1-one 151d 
 
  
O
NO2
151d  
 
Yellow oil; 100% yield; H (600 MHz; CDCl3) 1.45 (d, J = 1.2 Hz, 6H), 2.52-2.58 (m, 1H), 6.93 (d, J 
= 12.0 Hz, 1H), 7.11 (d, J = 12.0 Hz, 1H), 7.80-7.82 (m, 2H), 7.92-7.98 (m, 2H), C (100 MHz; 
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CDCl3) 22.1 (2CH3), 31.2 [C(CH3)2], 122.1 (CH), 124.2 (ArC), 129.2 (ArC), 138.0 (ArC), 148.2 
(ArC), 158.3 (ArC), 195.80 (C=O). Anal. Calcd for C12H13NO3 % : C, 65.74; H, 5.98; N, 6.33. 
Found: C, 65.75; H, 5.99; N, 6.41. IR (neat, cm-1) 3098, 1675, 1671, 1492. 
 
 trans-1-(4-methoxyphenyl)-4-methylpent-2-en-1-one 151e273 
  
 
O
OCH3151e   
 
Yellow oil; 100% yield; H (600 MHz; CDCl3) 1.45 (d, J = 1.2 Hz, 6H), 2.52-2.58 (m, 1H), 3.80 (s, 
3H), 6.93 (d, J = 12.0 Hz, 1H), 7.11 (d, J = 12.0 Hz, 1H), 7.80-7.82 (m, 2H), 7.92-7.98 (m, 2H), C 
(150 MHz; CDCl3) 22.1 (2CH3), 31.2 [C(CH3)2], 56.2 (OCH3), 122.1 (CH), 124.2 (ArC), 129.2 
(ArC), 138.0 (ArC), 148.2 (ArC), 158.3 (ArC), 195.8 (C=O). IR (neat, cm-1) 3088, 1678, 1674, 1489. 
3.4.2. Baylis-Hillman reactions 
.3.4.2.1.  General procedure for the uncatalysed Baylis-Hillman reactions 
To a solution of the appropriate aldehyde derivative (1 mmol) and methyl or tert-butyl acrylate 
(1 mmol) in CHCl3 (1 mL), was added DABCO (30 mol. %) and the reaction mixture was stirred in a 
stoppered flask at room temperature. After 21 days the solvent was removed in vacuo and the crude 
material purified by preparative TLC (10 % EtOAc in hexane) to obtain the pure Baylis-Hillman 
adducts. 
3.4.2.2.  General procedure for the catalysed Baylis-Hillman reactions 
To a solution of the catalyst (10 mole %) in CHCl3 (1mL), was added an aldehyde derivative (1 
mmol). This was stirred for 10 min and the appropriate acrylate (1 mmol), DABCO (33 mg, 30 mole 
%) were added sequentially. The reaction mixture was stirred in a stoppered flask at room 
temperature for 21 days. The solvent was removed in vacuo and the crude material purified by 
preparative TLC (10% EtOAc in hexane) to obtain the pure Baylis-Hillman adducts. 
3.4.2.3.  Determination of enantioselectivity 
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Pure Baylis-Hillman adduct (10 mg) was weighed into an NMR tube and CDCl3 (0.5 mL) was 
added. The solution was treated with 10 mg Eu(hfc)3 and thoroughly shaken to ensure homogeneity. 
The 1H NMR was then recorded. 
3.4.2.4.  Baylis-Hillman adducts 
tert-Butyl 3-hydroxy-2-methyl-3-(2-pyridinyl)propanoate 152205 
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Following the general procedure outlined in 3.4.2.2., pyridine-2-carbaldehyde (107 mg, 1.00 
mmol), and tert-butyl acrylate (146 µL, 1.00 mmol), were used to afford the product as white 
crystals; (212 mg, 90%) yield, (26 % e.e.), m.p. 96-98 °C; δH (600 MHz; CDCl3) 1.40 [9H, s, 
C(CH3)3], 4.81 (1H, br s, OH), 5.62 (1H, s, CHOH), 5.95 and 6.35 (2H, 2 × s, CH2), 7.21 (1H, t, 
J = 6.0 Hz, ArH), 7.41 (1H, d, J = 7.6 Hz, ArH), 7.67 (1H, t, J = 7.6 Hz, ArH) and 8.54 (1H, d, J 
= 4.4 Hz, ArH); δC  (200 MHz; CDCl3) 24.3 [C(CH3)3], 70.7 (C-3), 126.2 (2-CH2),137.4 (C-2), 
123.4 (C-5’), 134.5 (C-3’), 141.6 (C-4’), 148.3 (C-6’) and 148.6 (C-2’) and 166.3 (C=O). 
 
Methyl 3-hydroxy-2-methylene-3-(2-pyridinyl)propanoate 153205 
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Following the general procedure outlined in 3.4.2.2., pyridine-2-carbaldehyde (107. mg, 1.00 
mmol), and methyl acrylate (90 µL, 1.0 mmol), were used to afford the product as a white crystals; 
(177 mg, 93% yield), (44% e.e.), m.p. 51-53 °C (lit.205 50-51oC) ; δH (600 MHz; CDCl3) 3.73 
(3H, s, CH3O), 4.81 (1H, br s, OH), 5.62 (1H, s, CHOH), 5.95 and 6.35 (2H, 2 × s, CH2), 7.21 
(1H, t, J = 6.0 Hz, ArH), 7.41 (1H, d, J = 7.6 Hz, ArH), 7.67 (1H, t, J = 7.6 Hz, ArH) and 8.54 
(1H, d, J =4.4 Hz, ArH); δC  (100 MHz; CDCl3) 52.0 (CH3O), 70.7 (C-3), 126.2 (2-CH2),137.4 
(C-2), 123.4 (C-5’), 134.5 (C-3’), 141.6 (C-4’), 148.3 (C-6’) and 148.6 (C-2’) and 166.3 (C=O). 
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tert-Butyl 3-hydroxy-2-methylene-3-(6-methyl-2-pyridinyl)propanoate 154205 
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Following the general procedure outlined in 3.4.2.2., 6-methyl pyridine-2-carbaldehyde (121 mg, 
1.00 mmol), and tert-butyl acrylate (146 µL, 1.00 mmol), were used to afford the product as 
colourless crystals; (227 mg, 91% yield), (25% e.e.), m.p. 93-95°C (lit.279 96-98oC) ; δH (600 MHz; 
CDCl3) 2.53 (3H, s, CH3), 1.40 [9H, s, C(CH3)3], 5.21 (1H, br s, OH), 5.59 (1H, s, CHOH), 5.92 
and 6.32 (2H, 2s, CH2), 7.04 (1H, d, J = 7.2 Hz, ArH), 7.08 (1H, d, J = 7.6 Hz, ArH) and 7.53 
(1H, t, J =8.0 Hz, ArH); δC   (150 MHz; CDCl3) 24.2 (CH3), 24.3 [C(CH3)3], 71.2 (C-3), 
126.6 (CH2),142.1 (C-2), 118.0 (C-3’), 122.1 (C-5’), 137.0 (C-4’), 157.0 (C-2’), 158.3 (C-6’) and 
166.5 (C=O). 
Methyl 3-hydroxy-2-methylene-3-(6-methyl-2-pyridinyl)propanoate 155205 
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Following the general procedure outlined in 3.4.2.2., 6-methyl pyridine-2-carbaldehyde (121 mg, 
1.00 mmol), and methyl acrylate (90 µL, 1.0 mmol), were used to afford the product as colourless 
crystals; (187 mg, 90% yield), (45% e.e.), m.p. 78-80 °C (lit.205 84-85 oC); δH (600 MHz; CDCl3) 
2.53 (3H, s, CH3), 3.73 (3H, s, CH3O), 5.21 (1H, br s, OH), 5.59 (1H, s, CHOH), 5.92 and 6.32 
(2H, 2s, CH2), 7.04 (1H, d, J = 7.2 Hz, ArH), 7.08 (H, d, J = 7.6 Hz, ArH) and 7.53 (1H, t, J = 
8.0 Hz, ArH); δC   (150 MHz; CDCl3) 24.2 (CH3), 51.8 (CH3O), 71.2 (C-3), 126.6 (CH2), 
142.1 (C-2), 118.0 (C-3’), 122.1 (C-5’), 137.0 (C-4’), 157.0 (C-2’), 158.3 (C-6’) and 166.5 (C=O). 
tert-Butyl 3-(5-chloro-2-hydroxyphenyl)-3-hydroxy-2-methylenepropanoate 156274 
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Following the general procedure outlined in 3.4.2.2., 5-chlorosalicylaldehyde (157 mg, 1.00 
mmol) and tert-butyl acrylate (146 µL, 1.00 mmol), were used to afford the product as a white 
solid; (242 mg, 85% yield), (10% e.e.), m.p. 166-168 °C (lit.266 185-187 oC); δH (600 MHz; 
DMSO-d6) 1.40 [9H, s, C(CH3)3], 5.67 (1H, s, CHOH), 5.64 and 6.05 (2H, s, C=CH2), 6.79 (1H, 
d, J = 8.5 Hz, ArH), 7.05-7.11 (2H, m, ArH); δC   (150 MHz; DMSO-d6) 27.6 [C(CH3)3], 64.6 
(CHOH), 80.1 [C(CH3)3], 116.6 (C-5’), 117.8 (C-6’), 122.1 (C-4’), 123.1 (C=CH2), 126.9 (C-1’), 
131.4 (C-2’), 144.9 (C=CH2), 153.4 [ArC(OH)] and 165.0 (C=O). 
Methyl 3-hydroxy-2-methylene-3-phenylpropanoate 157209 
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Following the general procedure outlined in 3.4.2.2., benzaldehyde (102 µL, 1.00 mmol), and 
methyl acrylate (90 µL, 1.0 mmol) were used to afford the product as colourless crystals; (163 mg, 
85%) yield, m.p. 41-43 °C; δH (600 MHz; CDCl3) 3.73 (3H, s, CH3O), 5.21 (1H, br s, OH), 5.59 
(1H, s, CHOH), 5.92 and 6.32 (2H, 2s, CH2), 7.25-7.36 (4H, m, ArH) 7.51 (1H, d, J = 7.2 Hz, 
ArH), δC  (150 MHz; C D C l 3 ) , 51.8 (CH3O), 64.6 (CHOH), 116.6 (C-6’), 122.1 (C-2’), 123.1 
(C=CH2), 126.9 (C-4’), 129.2 (C-5’), 130.7 (C-3’), 131.4 (C-1’), 144.9 (C=CH2), 153.4 
[ArC(OH)] and 165.0 (C=O). 
tert-Butyl 3-(4-chlorophenyl)-3-hydroxy-2-methylenepropanoate 158274 
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Following the general procedure outlined in 3.4.2.2., 4-chlorobenzaldehyde (141 mg, 1.00 mmol), 
and tert-butyl acrylate (146 µL, 1 mmol) were used to afford the product as a white solid; (242 
mg, 90% yield), (7% e.e.), m.p. 43-48 °C; δH (600 MHz; CDCl3), 1.40 [9H, s, C(CH3)3], 5.21 (1H, 
br s, OH), 5.59 (1H, s, CHOH), 5.92 and 6.32 (2H, 2s, CH2), 7.25-7.36 (4H, m, ArH). δC   (150 
MHz; C D C l 3 ) , 27.6 [C(CH3)3] , 64.6 (CHOH), 116.6 (C-2’ and C-6’), 122.1 (C-3’ and C-5’), 
80.1 [C(CH3)3], 123.1 (C=CH2), 126.9 (C-4’), 131.4 (C-1’), 144.9 (C=CH2), 153.4 [ArC(OH)] and 
165.0 (C=O). 
 
 
Methyl 3-(4-chlorophenyl)-3-hydroxy-2-methylenepropanoate 159275 
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Following the general procedure outlined in 3.4.2.2., 5-chlorobenzaldehyde (157 mg, 1.00 mmol), 
and methyl acrylate (90 µL, 1.0 mmol), were used to afford the product as a white solid; (206 mg, 
91% yield), (13% e.e), m.p. 49-51 °C; δH (600 MHz; CDCl3) , 3.73 (3H, s, CH3O), 5.21 (1H, br s, 
OH), 5.59 (1H, s, CHOH), 5.92 and 6.32 (2H, 2s, CH2), 7.25-7.36 (4H, m, ArH). δC   (150 
MHz; C D C l 3 ), 51.8 (CH3O), 64.6 (CHOH), 116.6 (C-2’ and C-6’), 122.1 (C-3’ and C-5’), 123.1 
(C=CH2), 126.9 (C-4’), 131.4 (C-1’), 144.9 (C=CH2), 153.4 [ArC(OH)] and 165.0 (C=O). 
tert-Butyl 3-hydroxy-2-methylene-3-(2-nitrophenyl)propanoate 160276 
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Following the general procedure outlined in 3.4.2.2., 2-nitrobenzaldehyde (151 mg, 1.00 mmol), 
and tert-butyl acrylate (146 µL, 1 mmol), were used to afford the product as a brown gel, (215 
mg, 77% yield), (13% e.e.), δH (600 MHz; CDCl3) 1.40 [9H, s, C(CH3)3], 3.39 (1H, s, OH), 
5.73 and 6.20 (2H, 2s, C=CH2), 6.36 (1H, s, 3-H), 7.46 (1H, t, J = 7.7 Hz, 4’-H), 7.65 (1H, t, J = 
7.6 Hz, 5’-H), 7.75 (1H, d, J = 7.8 Hz, 6’-H), 7.94 (1H, d, J = 8.1 Hz, 3’-H); δC   (150 MHz; 
C D C l 3 ) 27.6 [C(CH3)3], 67.5 (C-3), 124.4 (C-6’), 126.3 (C=CH2), 128.7 (C-4’), 128.9 (C-5’), 
129.0 (C-3’), 133.3 (C-1’), 135.8 (C-2), 148.1 (C-2’), 166.2 (C=O). 
 
 
 
Methyl 3-hydroxy-2-methylene-3-(2-nitrophenyl)propanoate 161277 
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Following the general procedure outlined in 3.4.2.2., 2-nitrobenzaldehyde (151 mg, 1.00 mmol), 
and methyl acrylate (90 µL, 1.0 mmol) were used to afford the product as a brown gel, (183 mg, 
77% yield), (15% e.e.), δH (600 MHz; CDCl3), 3.39 (1H, s, OH), 3.73 (3H, s, OCH3) 5.73 and 
6.20 (2H, 2s, C=CH2), 6.36 (1H, s, 3-H), 7.46 (1H, t, J = 7.7 Hz, 4’-H), 7.65 (1H, t, J = 7.6 Hz, 
5’-H), 7.75 (1H, d, J = 7.8, 6’-H), 7.94 (1H, d, J = 8.1, 3’-H); δC   (150 MHz; C D C l 3 ) 52.0 
(OCH3), 67.5 (C-3), 124.4 (C-6’), 126.3 (C=CH2), 128.7 (C-4’), 128.9 (C-5’), 129.0 (C-3’), 133.3 
(C-1’), 135.8 (C-2), 148.1 (C-2’), 166.2 (C=O). 
 3.4.3.  Aza-Michael additions to Baylis-Hillman adducts 
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3.4.3.1 General procedure for the uncatalysed aza-Michael additions 
To a solution of the appropriate Baylis-Hillman adduct (0.4 mmol) in dry THF (0.5 mL) was 
added piperidine (0.72 µL) and the mixture stirred at room temperature. After completion of the 
reaction as monitored by TLC. The 1H and 13C NMR spectra of the diastereomeric mixtures were 
then recorded. 
3.4.3.2.  General procedure for the catalysed aza-Michael additions 
To a solution of the appropriate Baylis-Hillman adduct (0.4 mmol) in dry THF (0.5 mL) was 
added catalyst 128 (5 mole %). After stirring for 10 min, piperidine (0.72 µL, 0.4 mmol) was then 
added and the mixture stirred at room temperature. After completion of the reaction as monitored 
by TLC, the mixture was passed through a pad of celite to remove the manganese metal. The 1H 
and 13C NMR spectra of the diastereomeric mixtures were then recorded. 
 
 
 
 
 
3.4.3.3.  Aza-Michael adducts 
 
 tert-Butyl 3-hydroxy-2-[(piperidin-1-yl)methyl]-3-(pyridin-2-yl)propanoate 162 
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Following the general procedure outlined in 3.4.3.2., tert-butyl 3-hydroxy-2-methyl-3-(2-
pyridinyl)propanoate 152 (100 mg, 0.4 mmol), catalyst 139 (17.6 mg, 10 mole %), and piperidine 
(71 µL, 0.72 mmol) were used to afford the product as a brown gel ; 100% yield, (91% d.e); δH 
(600 MHz; CDCl3) 1.40 [9H, s, C(CH3)3], 1.50 (6H, s, 2CH2), 2.24 (4H, s, 2CH2), 2.71-2.73 
(2H, m, CH2), 4.81 (1H, br s, OH), 5.62 (1H, s, CHOH), 7.21 (1H, t, J = 6.0 Hz, ArH), 7.41 (1H, 
d, J = 7.6 Hz, ArH), 7.67 (1H, t, J = 7.6 Hz, ArH) and 8.54 (1H, d, J = 4.4 Hz, ArH); δC  (150 
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MHz; CDCl3) 25.8 (C-6 & C-8), 27.3 (C-7), 27.9 [C(CH3)3], 48.0 (C-4), 52.7 (C-5 & C-9) 70.7 
(C-3), 80.1 [C(CH3)3],  137.4 (C-2), 123.4 (C-5’), 134.5 (C-3’), 141.6 (C-4’), 148.3 (C-6’), 148.6 
(C-2’) and 166.3 (C=O). IR (neat, cm-1) 1722, 1526, 1252, 1135. Anal. Calcd for C18H28N2O3 % : 
C, 67.47; H, 8.81; N, 8.74. Found C, 67.58; H, 8.92; N, 8.79. 
Methyl 3-hydroxy-2-[(piperidin-1-yl)methyl]-3-(pyridin-2-yl)propanoate 163 
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Following the general procedure outlined in 3.4.3.2., methyl 3-hydroxy-2-methylene-3-(2-
pyridinyl)propanoate 153 (77 mg, 0.39 mmol), catalyst 139 (17.6 mg, 10 mole %), and piperidine 
(71 µL, 0.72 mmol) were used to afford the product as a brown gel; 100% yield, (85% d.e.) ; δH 
(600 MHz; CDCl3) 1.48 (6H, s, 2CH2), 2.19 (4H, s, 2CH2), 2.72-2.75 (2H, m, CH2), 3.70 
(3H, s, OCH3), 4.83 (1H, br s, OH), 5.59 (1H, s, CHOH), 7.20 (1H, t, J = 6.0 Hz, ArH), 7.40 (1H, 
d, J = 7.6 Hz, ArH), 7.66 (1H, t, J = 7.6 Hz, ArH) and 8.53 (1H, d, J = 4.4 Hz, ArH); δC  (150 
MHz; CDCl3) 25.69 (C-6 & C-8), 27.3 (C-7), 47.9 (C-4), 52.0 (OCH3), 53.1 (C-5 & C-9), 70.3 
(C-3), 137.0 (C-2), 123.2 (C-5’), 134.5 (C-3’), 140.9 (C-4’), 148.3 (C-6’), 147.9 (C-2’) and 166.3 
(C=O). IR (neat, cm-1) 1721, 1524, 1252, 1135. Anal. Calcd for C15H22N2O3 % : C, 64.73; H, 7.97; 
N, 10.06. Found C, 64.91; H, 8.13; N, 10.11. 
 
tert-Butyl 3-hydroxy-3-(6-methylpyridin-2-yl)-2-[(piperidin-1-yl)methyl]propanoate 164 
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Following the general procedure outlined in 3.4.3.2., tert-butyl 3-hydroxy-2-methylene-3-(6-
methyl-2-pyridinyl)propanoate 154 (99.7 mg, 0.399 mmol), catalyst 139 (17.6 mg, 10 mole %), 
and piperidine (71 µL, 0.72 mmol) were used to afford the product as a brown gel; 100% yield, 
(77% d.e.) ; δH (600 MHz; CDCl3) 1.40 [9H, s, C(CH3)3], 1.50 (6H, s, 2CH2), 2.24 (4H, s, 
2CH2), 2.53 (3H, s, CH3),  2.73 (2H, m, CH2), 4.81 (1H, br s, OH), 5.62 (1H, s, CHOH), 7.21 
(1H, t, J = 6.0 Hz, ArH), 7.41 (1H, d, J = 7.6 Hz, ArH), 7.67 (1H, t, J = 7.6 Hz, ArH) and 8.54 
(1H, d, J = 4.4 Hz, ArH); δC  (150 MHz; CDCl3) 24.2 (CH3), 25.8 (C-6 & C-8) 27.3 (C-7), 27.9 
[C(CH3)3],  48.0 (C-4), 52.7 (C-5 & C-9), 70.7 (C-3), 80.1 [C(CH3)3],  137.4 (C-2), 123.4 (C-3’), 
134.5 (C-5’), 141.6 (C-4’), 148.3 (C-6’), 148.6 (C-2’) and 166.3 (C=O). IR (neat, cm-1) 1722, 
1524, 1251, 1135. Anal. Calcd for C19H30N2O3 % : C, 68.23; H, 9.04; N, 8.38. Found C, 68.47; H, 
9.13; N, 8.53. 
 
 
 
 
Methyl 3-hydroxy-3-(6-methylpyridin-2-yl)-2-[(piperidin-1-yl)methyl]propanoate 165 
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Following the general procedure outlined in 3.4.3.2., methyl 3-hydroxy-2-methylene-3-(6-methyl-2-
pyridinyl)propanoate 155 (82.8 mg, 0.395 mmol), catalyst 139 (17.6 mg, 10 mole %), and 
piperidine (71 µL, 0.72 mmol) were used to afford the product as a brown gel; 100% yield, (75% 
d.e.) ; δH (600 MHz; CDCl3) 1.48 (6H, s, 2CH2), 2.22 (4H, s, 2CH2), 2.49 (3H, s, CH3), 2.72-
2.73 (2H, m, CH2), 3.70 (3H, s, OCH3), 4.77 (1H, br s, OH), 5.58 (1H, s, CHOH), 7.21 (1H, t, J 
= 6.0 Hz, ArH), 7.40 (1H, d, J = 7.6 Hz, ArH), 7.56 (1H, t, J = 7.6 Hz, ArH) and 8.50 (1H, d, J = 
4.4 Hz, ArH); δC  (150 MHz; CDCl3) 24.0 (CH3), 26.1 (C-6 & C-8), 27.0 (C-7), 47.9 (C-4), 52.2 
(OCH3), 52.6 (C-5 & C-9), 71.7 (C-3), 123.5 (C-3’), 134.7 (C-5’), 137.0 (C-2), 142.6 (C-4’), 
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148.0 (C-6’), 148.4 (C-2’) and 166.5 (C=O). IR (neat, cm-1) 1721, 1524, 1252, 1133. Anal. Calcd 
for C16H24N2O3 % : C, 65.73; H, 8.27; N, 9.58. Found C, 65.81; H, 8.36; N, 9.67. 
 
tert-Butyl 3-(5-chloro-2-hydroxyphenyl)-3-hydroxy-2-[(piperidin-1-yl)methyl]propanoate 166 
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Following the general procedure outlined in 3.4.3.2., tert-butyl 3-(5-chloro-2-hydroxyphenyl)-3-
hydroxy-2-methylenepropanoate 156 (114 mg, 0.397 mmol), catalyst 139 (17.6 mg, 10 mole %), 
and piperidine (71 µL, 0.72 mmol) were used to afford the product as a light brown gel; (123 mg, 
83% yield), (52% d.e.); δH (600 MHz; DMSO-d6) 1.40 [9H, s, C(CH3)3], 1.50 (6H, s, 2CH2), 
2.24 (4H, s, 2CH2), 2.72-2.73 (2H, m, CH2), 5.67 (1H, s, CHOH), 6.79 (1H, d, J = 8.5 Hz, 
ArH), 7.05-7.11 (2H, m, ArH); δC   (150 MHz; DMSO-d6) 25.8 (C-6 & C-8), 27.3 (C-7), 48.0 (C-
4), 27.6 [C(CH3)3], 52.7 (C-5 & C-9), 64.6 (CHOH), 80.1 [C(CH3)3], 116.6 (C-5’), 117.8 (C-6’), 
122.1 (C-4’), 126.9 (C-1’), 131.4 (C-2’), 153.4 [ArC(OH)] and 165.0 (C=O). IR (neat, cm-1) 1731, 
1534, 1232, 1137. Anal. Calcd for C19H28ClNO4 % : C, 61.70; H, 7.63; N, 3.79. Found C, 61.73; 
H, 7.67; N, 3.81. 
 
Methyl 3-hydroxy-3-phenyl-2-[(piperidin-1-yl)methyl]propanoate 167 
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Following the general procedure outlined in 3.4.3.2., methyl 3-hydroxy-2-methylene-3-
phenylpropanoate 157 (77.0 mg, 0.396 mmol), catalyst 139 (17.6 mg, 10 mole %), and piperidine 
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(71 µL, 0.72 mmol) were used to afford the product as a light brown gel; (94 mg, 85% yield), 
(56% d.e.) ; δH (600 MHz; CDCl3) 1.50 (6H, s, 2CH2), 2.32 (4H, s, 2CH2), 2.69 (2H, m, 
CH2), 3.71 (3H, s, CH3O), 5.19 (1H, br s, OH), 5.57 (1H, s, CHOH), 7.23-7.37 (4H, m, ArH) 
7.48 (1H, d, J = 7.2 Hz, ArH), δC   (150 MHz; C D C l 3 ), 25.5 (C-6 & C-8), 27.4 (C-7), 48.2 (C-
4), 52.3 (C-5 & C-9),  52.0 (CH3O), 64.1 (CHOH), 116.7 (C-6’), 121.8 (C-2’), 127.0 (C-4’), 129.5 
(C-5’), 131.7 (C-3’), 131.0 (C-1’), 153.0 [ArC(OH)] and 165.2 (C=O). IR (neat, cm-1) 1739, 1564, 
1237, 1131. Anal. Calcd for C16H23NO3 % : C, 69.29; H, 8.36; N, 5.05. Found C, 69.33; H, 8.41; 
N, 5.13. 
tert-Butyl 3-(4-chlorophenyl)-3-hydroxy-2-[(piperidin-1-yl)methyl]propanoate 168 
 
O
N
OH O
1'
2'
3'
4'
5'
6' 123
4 5
6
7
8
9
168
Cl
 
Following the general procedure outlined in 3.4.3.2., tert-butyl 3-(4-chlorophenyl)-3-hydroxy-2-
methylenepropanoate 158 (107.5 mg, 0.395 mmol), catalyst 139 (17.6 mg, 10 mole %), and 
piperidine (71 µL, 0.72 mmol) were used to afford the product as a light brown gel; (114.6 mg, 
81% yield), (52% d.e.); δH (600 MHz; CDCl3) , 1.40 [9H, s, C(CH3)3], 1.49 (6H, s, 2CH2), 2.27 
(4H, s, 2CH2), 2.68-2.73 (2H, m, CH2),  5.27 (1H, br s, OH), 5.62 (1H, s, CHOH), 7.15-7.32 
(4H, m, ArH). δC  (150 MHz; C D C l 3 ),  25.1 (C-6 & C-8), 26.3 (C-7), 27.0 [C(CH3)3] , 47.3 (C-
4), 52.2 (C-5 & C-9), 64.1 (CHOH), 79.1 [C(CH3)3], 116.1 (C-2’ and C-6’), 121.8 (C-3’ and C-
5’), 127.1 (C-4’), 131.4 (C-1’), 153.4 [ArC(OH)] and 165.6 (C=O). IR (neat, cm-1) 1741, 1544, 
1231, 1136. Anal. Calcd for C19H28ClNO3 % : C, 64.49; H, 7.98; N, 3.96. Found C, 64.53; H, 8.17; 
N, 4.23. 
Methyl 3-(4-chlorophenyl)-3-hydroxy-2-[(piperidin-1-yl)methyl]propanoate 169 
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Following the general procedure outlined in 3.4.3.2., methyl 3-(4-chlorophenyl)-3-hydroxy-2-
methylenepropanoate 159 (90.6 mg, 0.396 mmol), catalyst 139 (17.6 mg, 10 mole %), and 
piperidine (71 µL, 0.72 mmol) were used to afford the product as a light brown gel; (97.2 mg, 78% 
yield), (49% d.e.) ; δH (600 MHz; CDCl3), 1.50 (6H, s, 2CH2), 2.24 (4H, s, 2CH2), 2.72-2.73 
(2H, m, CH2), 3.73 (3H, s, CH3O),  5.21 (1H, br s, OH), 5.59 (1H, s, CHOH), 7.25-7.36 (4H, m, 
ArH). δC  (150 MHz; C D C l 3 ),  25.8 (C-6 & C-8), 27.3 (C-7), 48.0 (C-4), 51.8 (CH3O), 52.7 (C-
5 & C-9), 64.6 (CHOH), 116.6 (C-2’ and C-6’), 122.1 (C-3’ and C-5’), 126.9 (C-4’), 131.4 (C-1’), 
153.4 [ArC(OH)] and 165.0 (C=O). IR (neat, cm-1) 1703, 1534, 1232, 1137. Anal. Calcd for 
C16H22ClNO3 % : C, 61.63; H, 7.11; N, 4.49. Found C, 61.74; H, 7.27; N, 4.62. 
 
tert-Butyl 3-hydroxy-3-(2-nitrophenyl)-2-[(piperidin-1-yl)methyl]propanoate 170 
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Following the general procedure outlined in 3.4.3.2., tert-butyl 3-hydroxy-2-methylene-3-(2-
nitrophenyl)propanoate 160 (112 mg, 0.401 mmol), catalyst 139 (17.6 mg, 10 mole %), and 
piperidine (71 µL, 0.72 mmol) were used to afford the product as a brown gel, (120 mg, 82% 
yield), (21% d.e.); δH (600 MHz; CDCl3) 1.40 [9H, s, C(CH3)3], 1.50 (6H, s, 2CH2), 2.24 (4H, 
s, 2CH2), 2.72-2.73 (2H, m, CH2), 3.42 (1H, s, OH), 6.36 (1H, s, 3-H), 7.46 (1H, t, J = 7.7 Hz, 
4’-H), 7.65 (1H, t, J = 7.6 Hz, 5’-H), 7.75 (1H, d, J = 7.8 Hz, 6’-H), 7.94 (1H, d, J = 8.1 Hz, 3’-H); 
δC   (150 MHz; C D C l 3 ) 26.1 (C-6 & C-8), 26.9 (C-7), 27.6 [C(CH3)3], 53.2 (C-5 & C-9),  67.5 
(C-3), 80.1 [C(CH3)3], 124.4 (C-6’), 128.7 (C-4’), 128.9 (C-5’), 129.0 (C-3’), 133.3 (C-1’), 135.8 
(C-2), 148.1 (C-2’), 166.2 (C=O). IR (neat, cm-1) 1763, 1563, 1265, 1177. Anal. Calcd for 
C19H28N2O5 % : C, 62.62; H, 7.74; N, 7.69. Found C, 62.71; H, 7.78; N, 7.71. 
   Methyl 3-hydroxy-3-(2-nitrophenyl)-2-[(piperidin-1-yl)methyl]propanoate 171 
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Following the general procedure outlined in 3.4.3.2., methyl 3-hydroxy-2-methylene-3-(2-
nitrophenyl)propanoate 161 (109.3 mg, 0.339 mmol), catalyst 139 (17.6 mg, 10 mole %), and 
piperidine (71 µL, 0.72 mmol) were used to afford the product as a brown gel, (114 mg, 77% 
yield), (14% d.e.);δH (600 MHz; CDCl3) 1.53 (6H, s, 2CH2), 2.24 (4H, s, 2CH2), 2.70-2.73 
(2H, m, CH2), 3.39 (1H, s, OH), 3.73 (3H, s, CH3O),   6.38 (1H, s, 3-H), 7.41 (1H, t, J = 7.7 Hz, 
4’-H), 7.61 (1H, t, J = 7.6 Hz, 5’-H), 7.79 (1H, d, J = 7.8 Hz, 6’-H), 7.88 (1H, d, J = 8.1 Hz, 3’-H); 
δC   (150 MHz; C D C l 3 ) 25.8 (C-6 & C-8), 27.3 (C-7), 51.8 (CH3O),  52.7 (C-5 & C-9),  67.3 
(C-3), 124.0 (C-6’), 128.3 (C-4’), 129.3 (C-5’), 129.7 (C-3’), 133.0 (C-1’), 136.1 (C-2), 148.1 (C-
2’), 166.2 (C=O). IR (neat, cm-1) 1764, 1563, 1265, 1177. Anal. Calcd for C16H22N2O5 % : C, 
59.61; H, 6.88; N, 8.69. Found C, 59.73; H, 6.92; N, 8.74. 
3.4.4. Epoxidation reactions 
3.4.4.1.  General procedure for the uncatalysed epoxidation reactions 
NaOCl as oxidant 
A solution of 0.05 M Na2B4O710H2O (20 mL) was added to 50 mL of undiluted commercial 
household bleach. The pH of the resulting buffered solution (0.55 M in NaOCl) was adjusted to pH 
11.3 by addition of a few drops of 1 M HCl solution. This solution was cooled to 0 oC and then 0.35 
mL was added at once to a 0 oC solution of the alkene (0.1 mmol) in 0.5 mL of CH2Cl2. The two-
phase mixture was stirred at room temperature, and the reaction progress was monitored by NMR, 
and only traces of the products were observed. 
 
H2O2 as oxidant 
A 100 ml flask containing alkene (0.1 mmol) in 0.5 mL of CH2Cl2 was stirred at 0 oC for 10 
minutes, 35% aqueous H2O2 (30 µl, 0.34 mmol) was added in four portions over the course of 40 
minutes. The progress was monitored by NMR, and only 1% conversion was observed. 
 
Urea Hydrogen Peroxide, UHP as oxidant 
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Preparation of UHP 
A solution of urea in 30% H2O2, in the molecular ratio 2:3, was heated in a beaker for a few 
minutes at a temperature of about 60 oC. When cool it was transferred to a crystallising dish for slow 
evaporation and crystallisation to afford white crystals in 96% yield. IR (neat, cm-1) 3401, 3380, 
2953, 2802, 2750, 1602, 1490, 1402. 
 
Epoxidation reaction 
To a solution of alkene (0.15 mmol) in 1:1 mixture of CH3OH: CH2Cl2 (1 mL) was added 0.6 
mmol UHP. The mixture was stirred at room temperature for 48 h with continuous monitoring by 
NMR, and only traces of the procucts were observed. 
 
t-BuOOH as oxidant 
 To a solution of alkene (0.1 mmol) in CH2Cl2/CH3OH 25/75 by volume was added t-BuOOH 
(0.3 mmol). The mixture was stirred for 24 h at room temperature, and progress monitored by NMR, 
and only traces of the products were observed. 
  
Iodosyl benzene, PhIO as oxidant 
 Preparation of PhIO 
Finely ground iodosobenzene diacetate (10.7g, 30.0 mol) was placed in a 100 mL beaker, and 50 mL 
of 3M NaOH was added over a 5 minute period with vigorous stirring. The lumps of solid that 
formed were triturated with a stirring rod or a spatula for 15 minutes, and the reaction mixture 
allowed to stand for an additional 45 minutes to ensure the reaction went to completion. Water (20 
mL) was added, and the mixture was stirred vigorously. The crude solid iodosobenzene was 
collected by filtration. The wet solid was returned to the beaker and triturated in 40 ml of water.  
The solid was again collected by vacuum filtration, washed with 40 mL of water, and air-dried. Final 
purification was effected by triturating the dried solid in 75 mL of chloroform in a beaker. The 
iodosobenzene was separated by filtration and air-dried (8.00 g, 96 % yield). The purity was checked 
by iodometric titration as described by Lucas et al.278 
 
Epoxidation reaction 
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 In a 20 mL flask, alkene (1 mmol) was dissolved in CH2Cl2 or CH3CN (0.5 mL). 
Iodosobenzene (0.05 mmol) was added to this mixture and stirred for 48 h with monitoring by NMR. 
No products were observed.  
 
m-CPBA as oxidant 
A solution of alkene (0.1 mmol) and NMO (0.24 mmol) in 1 mL of CH2Cl2 was cooled to 
‒78 oC or 0 oC. Solid m-CPBA (0.2 mmol) was added in two equal portions. The reaction mixture 
was stirred for the appropriate time with monitoring by NMR. After completion of the reaction, 1 M 
NaOH was added. The organic layer was separated and washed with brine (5 mL). The aqueous 
phases were then combined and washed with CH2Cl2, and the combined organic phases were dried 
over anhydrous Na2SO4 and concentrated to 2 mL. The crude mixture was purified by 
chromatography on silica (CH2Cl2/Hex 3:1) to afford the respective epoxides below. 
 
3.4.4.2.  General procedure for the catalysed epoxidation reaction 
NaOCl as oxidant 
A solution of 0.05M Na2B4O710H2O (20 mL) was added to 50 mL of undiluted commercial 
household bleach. The pH of the resulting buffered solution (0.55 M in NaOCl) was adjusted to pH 
11.3 by addition of a few drops of 1 M HCl solution. This solution was cooled to 0 oC and then 0.35 
mL was added at once to a 0 oC solution of the catalyst (5 mole %) and alkene (0.1 mmol) in 0.5 mL 
of CH2Cl2. The two-phase mixture was stirred at room temperature, and the reaction progress was 
monitored by NMR, and only traces of the products were observed. 
 
H2O2 as oxidant 
A 100 ml flask containing alkene (0.1 mmol) and catalyst (5 mole %) in 0.5 mL of CH2Cl2 was 
stirred at 0 oC for 10 minutes, 35% aqueous H2O2 (30 µL, 0.34 mmol) was added in four portions 
over the course of 40 minutes. The progress was monitored by NMR, and only 1% conversion was 
observed. 
 
Urea Hydrogen Peroxide, UHP as oxidant 
To a solution of alkene (0.15 mmol) and catalyst (5 mole %), in a 1:1 mixture of CH3OH: 
CH2Cl2 (1 mL) was added 0.6 mmol UHP. The mixture was stirred at room temperature for 48 h 
with continuous monitoring by NMR, and only traces of the products were observed. 
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 t-BuOOH as oxidant 
 To a solution of alkene (0.1 mmol) and catalyst (5 mole %), in CH2Cl2/CH3OH 25/75 by 
volume was added t-BuOOH (0.3 mmol). The mixture was stirred for 24 h at room temperature, and 
progress monitored by NMR, and only traces of the products were observed. 
  
Iodosyl benzene, PhIO as oxidant 
 In a 20 ml flask, alkene (1 mmol) and catalyst (5 mole %) were dissolved in CH2Cl2 or 
CH3CN (0.5 mL). Iodosobenzene (0.05 mmol) was added to this mixture and stirred for 48 h with 
monitoring by NMR, and the highest conversion observed was 7%. 
 
m-CPBA as oxidant 
A solution of alkene (0.1 mmol) and NMO (28 mg, 0.24 mmol), and catalyst (5 mole %; 139 
= 22 mg, 140 = 26.6 mg, 141 = 26.6 mg, and 142 = 26 mg) in 1 mL of CH2Cl2 was cooled to ‒78 oC 
or 0 oC. Solid m-CPBA (34.5 mg, 0.199 mmol) was added in two equal portions. The reaction 
mixture was stirred for the appropriate time with monitoring by NMR. After completion of the 
reaction, 1 M NaOH was added. The organic layer was separated and washed with brine (5 mL). The 
aqueous phases were then combined and washed with CH2Cl2, and the combined organic phases 
were dried over anhydrous Na2SO4 and concentrated to 2 mL. The crude mixture was purified by 
chromatography on silica (CH2Cl2/Hex 3:1) to afford the respective epoxides below. 
 
3.4.4.3.  Determination of enantioselectivity 
Pure epoxide (10 mg) was weighed into an NMR tube and CDCl3 (0.5 mL) was added. The 
solution was treated with 10 mg Eu(hfc)3 and thoroughly shaken to ensure homogeneity. The 1H 
NMR was then recorded. 
3.4.4.4.  Epoxides 
trans-Methyl styrene oxide 173a279 
 
CH3
O
173a  
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Following the general procedure outlined in 3.4.4.2, trans-methyl styrene (13 µL, 0.10 mmol), NMO 
(28 mg, 0.24 mmol), and m-CPBA (34.5 mg, 0.199 mmol) were used to afford the product as a pale 
yellow oil; 30-70% yield, (11-32% e.e.; see Table 19, page 99); H (400 MHz; CDCl3) 1.40 (d, J = 
1.5 Hz, 3H, CH3), 3.19 (q, J = 3.0 Hz, 1H, CH), 3.60 (s, 1H, CH), 7.28-7.36 (m, 5H, Ar); C (100 
MHz; CDCl3) 18.1 (CH3), 59.2 (CH), 59.7 (CH), 125.6 (2CH, Ar), 128.2 (CH, Ar), 128.6 (2CH, 
Ar), 137.9 (ArC ). IR (neat, cm-1); 2949, 1607, 1497, 1246, 1071, 765, 696. 
 
Styrene oxide 173b222 
 
O
173b  
 
Following the general procedure outlined in 3.4.4.2, styrene (11.4 µL, 0.099 mmol), NMO (28 mg, 
0.24 mmol), and m-CPBA (34.5 mg, 0.199 mmol) were used to afford the product as a pale yellow 
oil; 72-100% yield, (13-33% e.e.; see Table 19, page 99); H (400 MHz; CDCl3) 2.81-2.82 (m, 1H), 
3.16 (t, J=3.2 Hz, 1H), 3.87 (m, J=3.9 Hz, 1H), 7.29-7.38 (m, 5H); C   (100 MHz; CDCl3) 51.1 
(CH2), 55.2 (CH), 125.2 (2CH, Ar), 128.2 (CH, Ar), 130.1 (2  CH, Ar), 137.1 (ArC ). IR (neat, 
cm-1); 3089, 2937, 1453, 1329, 1145, 1003, 911. 
  
trans-Stilbene oxide 173c279 
 
O
173c   
 
Following the general procedure outlined in 3.4.4.2, trans-stilbene (18 mg, 0.099 mmol), NMO (28 
mg, 0.24 mmol), and m-CPBA (34.5 mg, 0.199 mmol) were used to afford the product as white 
crystals, 23-90% yield, (11-28% e.e.; see Table 19, page 99 ); m.p. 65-67 oC; H (400 MHz; CDCl3) 
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3.89 (s, 2H), 7.19-7.42 (m, 10H); C (100 MHz; CDCl3) 64.0 (2CH), 125.2 (4CH, Ar), 128.1 
(2CH, Ar), 128.3 (4CH, Ar), 135.2 (2ArC ). IR (neat, cm-1); 3060, 3036, 1414, 836, 509 
 
cis-Stilbene oxide 173d280 
 
173d
O
  
 
Following the general procedure outlined in 3.4.4.2, cis-stilbene (17.8 µL, 0.099 mmol), NMO (28 
mg, 0.24 mmol), and m-CPBA (34.5 mg, 0.199 mmol) were used to afford the product as a white 
powder, 19-87% yield (see Table 19, page 99); m.p. 38-40 oC; H (400 MHz; CDCl3) 4.45 (s, 2H), 
7.26-7.43 (m, 10H); C (100 MHz; CDCl3) 59.9 (2CH), 123.1 (4CH, Ar), 125.2 (2CH, Ar), 124.1 
(4CH, Ar), 131.2 (2ArC ). IR (neat, cm-1); 3067, 3039, 1412, 833, 512. 
 
 
Indene oxide 173e281 
173e
O
Hd
HbHa
Hc
 
     
Following the general procedure outlined in 3.4.4.2., indene (11.6 µL, 0.099mol), NMO (28 mg, 0.24 
mmol), and m-CPBA (34.5 mg, 0.199 mmol) were used to afford the product as a pale yellow oil; 
72-100% yield, (10-23% e.e; see Table 19, page 99); H (400 MHz; CDCl3) 2.99 (d, J=2.98 Hz, Hb), 
3.22 (d, J=3.22 Hz, Ha), 4.14 (s, Hd), 4.28 (s, Hc), 7.18-7.32 (m, 3H, Ar), 7.51 (d, 1H, Ar); C (100 
MHz; CDCl3) 34.1 (CH2), 54.2 (CH), 59.5 (CH), 123.1 (2CH, Ar), 124.5 (2CH, Ar), 140.1 (ArC ), 
141.3 (ArC ). IR (neat, cm-1); 3039, 2914, 1474, 1418, 1371, 1230, 982. 
3.4.5. Reduction of ketones 
3.4.5.1.  General Procedure for the uncatalysed reduction of ketones 
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Under argon atmosphere, 2-propanol (0.5 mL, 5. mmol), was added to NaBH4 (0.75 mmol) in 
CHCl3 (4 mL). After stirring for 1 h at room temperature, a solution of ketone (0.5 mmol) in 1 mL of 
CHCl3 was poured into the mixture. The mixture was stirred for 24 h at room temperature. The 
reaction was quenched by addition of saturated ammonium chloride, and the product was extracted 
with diethyl ether. The combined organic layers were washed with brine and dried over anhydrous 
Na2SO4. The crude products were purified on silica (hexane/ethyl acetate 3:1) to afford the respective 
alcohols below. 
 
3.4.5.2..  General procedure for the catalysed reduction of ketones 
Under argon atmosphere, 2-propanol (0.5 mL, 5. mmol), was added to NaBH4 (0.75 mmol) in CHCl3 
(4 mL). After stirring for 1 h at room temperature, a solution of the catalyst (10 mole %; 139 = 22 
mg, 140 = 26.6 mg, 141 = 26.6 mg, and 142 = 26 mg) and ketone (0.5 mmol) in 1 mL of CHCl3 was 
poured into the mixture. The mixture was stirred for 24 h at room temperature. The reaction was 
quenched by addition of saturated ammonium chloride, and the product was extracted with diethyl 
ether. The combined organic layers were washed with brine and dried over anhydrous Na2SO4. The 
crude products were purified on silica (hexane/ethyl acetate 3:1) to afford the respective alcohols 
below. 
3.4.5.3.  Determination of enantioselectivity 
A portion of each mixture of enantiomeric alcohols (20 mg/200 µL) was resolved by 
chromatography (HPLC, Phenomenex Lux 5u cellulose chiral column) eluting with hexane/2-
propanol (9:1) at 0.2 mL/minute. The signal for each enantiomer was observed. 
3.4.20.  Alcohols 
1-Phenylethanol 175a282 
OH
175a  
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Following the general procedure outlined in 3.4.5.2., acetophenone (58 µL, 0.50 mmol) and NaBH4 
(30 mg, 0.75 mmol) were used to afford the product as a pale yellow oil; 51-99% yield, (33-68% e.e. 
Retention time 6-8 min; see Table 23, page 107); H (400 MHz; CDCl3) 1.59 (d, J = 4.0 Hz, 3H), 
2.34 (s, 1H), 4.97 (q, J = 4.0 Hz, 1H), 7.38-7.47 (m, 5H); C (100 MHz; CDCl3) 25.1 (CH3), 70.2 
(CH-OH), 124.3 (2CH, Ar), 127.2 (CH, Ar), 130.1 (2CH, Ar). IR (neat, cm-1); 3336, 1450, 1075, 
897, 758, 699. 
   
   3-Chloro-1-phenylpropan-1-ol 175b283 
 
    
Cl
OH
175b  
    
 
Following the general procedure outlined in 3.4.5.2., 3-chloropropiophenone (84.3 mg, 0.5 mmol) 
and NaBH4 (30 mg, 0.75 mmol) were used to afford the product as a pale yellow oil; 93-100% yield, 
(11-13% e.e. Retention time 6-8 min; see Table 23, page 107); H (400 MHz; CDCl3) 1.67 (s, 1H), 
2.06-2.26 (m, 2H), 3.54-3.58 (m, 1H), 3.71-3.76 (m, 1H), 4.93-4.95 (m, 1H), 7.29-7.37 (m, 5H); C 
(100 MHz; CDCl3) 34.6 (CH2-Cl), 39.2 (CH2), 70.2 (CH-OH), 122.4 (CH, Ar), 125.1 (2CH, Ar), 
125.7 (2CH, Ar), 135.2 (ArC ). IR (neat, cm-1); 3358, 1453, 1051, 762, 699, 658. 
 
1,2,3,4-Tetrahydronaphthalen-1-ol 175d245 
 
OH
175d  
Following the general procedure outlined in 3.4.5.2.., -tetralone (67 µL, 0.50 mmol) and NaBH4 
(30 mg, 0.75 mmol) were used to afford the product as a pale brown oil; 51-100% yield, (9-11% e.e. 
Retention time 6-8 min; see Table 23, page 107); H (400 MHz; CDCl3) 1.74-1.81 (m, 1H), 1.88-2.00 
(m, 4H), 2.70-2.75 (m, 1H), 2.80-2.84 (m, 1H), 4.77 (t, J = 5.0 Hz, 1H) 7.09-7.10 (m, 1H), 7.17-7.21 
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(m, 2H), 7.42-7.43 (m, 1H); C (100 MHz; CDCl3) 13.2 (CH2), 28.5 (CH2), 29.1 (CH2), 68.3 (CH-
OH), 123.2 (2CH, Ar), 125.4 (2CH, Ar), 134.3 (2ArC ). IR (neat, cm-1); 3334, 2969, 950, 772, 
699  
 
  1-(1-Hydroxyethyl)naphthalen-2-ol 175e 
 
  
HO CH3
OH
175e    
Following the general procedure outlined in 3.4.5.2., 2-hydroxy-1-acetonapthone (93 mg, 0.49 
mmol) and NaBH4 (30 mg, 0.75 mmol) were used to afford the product as a pale yellow solid, 90-
99% yield, (12-14% e.e. Retention time 6-8 min; see Table 23, page 107); m.p. 75-80oC; H (400 
MHz; CDCl3) 1.66 (d, J = 1.7 Hz, 3H), 3.28 (s, 1H), 5.90 (q, J = 5.9 Hz, 1H), 7.10 (d, J = 7.0 Hz, 
1H), 7.30 (t, J = 7.0 Hz, 1H), 7.43 (t, J = 7.4 Hz, 1H), 7.65-7.67 (m, 2H), 7.7 (d, J = 7.6 Hz, 1H), 
9.33 (s, 1H); C (100 MHz; CDCl3) 19.4 (CH3), 60.2 (CH-OH), 113.3 (ArC), 114.1 (CH, Ar), 119.2 
(CH, Ar), 120.3 (CH, Ar), 123.4 (CH, Ar), 125.4 (CH, Ar), 126.1 (ArC), 127.4 (CH, Ar), 130.1 
(ArC), 149.1 (ArC). IR (neat, cm-1); 3199, 1622, 1464, 1394, 1232, 809, 701. Anal Calcd for 
C12H12O2 % : C, 76.57; H, 6.43. Found : C, 76.61; H, 6.58. 
 
3.4.6. Reductive amination of ketones  
3.4.6.1.  General Procedure for the reduction of imines  
1 mmol of ketone was dissolved in absolute ethanol (5 mL), amine (1 mmol) was added and 
the mixture refluxed for 12 h. The reaction was monitored by TLC and IR. After completion of the 
reaction, the crude mixture was evaporated in vacuo and used for the next step. 
Under argon atmosphere, 2-propanol (0.5 mL, 5. mmol), was added to NaBH4 (0.75 mmol) in 
CHCl3 (4 mL). After stirring for 1 h at room temperature, a solution of the catalyst (10 mole %) and 
imine (0.5 mmol) in 1 ml of CHCl3 was poured into the mixture. The mixture was stirred for 24 h at 
room temperature and the progress was monitored by TLC. No products were isolated. 
 
3.5.   Preparation of Polymer-supported Mn-complexes 182-185 
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Polymer-Bound Imidazole: To a slurry of the Merrifield resin (1 g, 1 mmol) in acetonitrile (6.5 
mL) were added imidazole (0.68 g, 10 mmol) and NaI (0.01 g, 0.07 mmol) and the mixture was 
refluxed with stirring for 48 h. The resin was filtered off and washed successively with acetonitrile 
(55 mL), 10% aq. K2CO3/MeOH (1:1), H2O/MeOH (1:1), MeOH and EtOAc (510 mL each). The 
solid was dried under vacuum overnight to yield polymer-bound imidazole (1.00 g, 99%). IR (neat, 
cm-1 3025, 2919, 1492, 1451, 1265. 
General Procedure for the Immobilisation of the Complexes: To a solution of 50 mg of each 
complex in acetonitrile (5 mL) was added polymer-bound imidazole (375 mg). The mixture was 
vigorously stirred at 80oC for 24 h. After cooling, the brown resin was collected by filtration washed 
thoroughly with acetonitrile, methanol, and ether successively. It was then dried in vacuum at room 
temperature for several hours to afford the appropriate complex in 93% yield. SEM was used for 
characterisation based on morphological changes. 
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